<html class="gs_el_sm gs_pfcs"><head><title>‪Francesco Dazzi‬ - ‪Google Scholar‬</title><meta http-equiv="Content-Type" content="text/html;charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="referrer" content="origin-when-cross-origin"><meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=2"><meta name="format-detection" content="telephone=no"><link rel="shortcut icon" href="/favicon.ico"><link rel="canonical" href="https://scholar.google.com/citations?user=7-4XHiUAAAAJ&amp;hl=en"><meta name="description" content="‪Professor of Regenerative Medicine, King's College London‬ - ‪‪Cited by 17,718‬‬ - ‪mesenchymal stromal cells‬ - ‪cell death‬ - ‪inflammation‬ - ‪bone marrow transplantation‬ - ‪donor lymphocyte infusion‬"><meta property="og:description" content="‪Professor of Regenerative Medicine, King's College London‬ - ‪‪Cited by 17,718‬‬ - ‪mesenchymal stromal cells‬ - ‪cell death‬ - ‪inflammation‬ - ‪bone marrow transplantation‬ - ‪donor lymphocyte infusion‬"><meta property="og:title" content="Francesco Dazzi"><meta property="og:image" content="https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=7-4XHiUAAAAJ&amp;citpid=4"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><style>html,body,form,table,div,h1,h2,h3,h4,h5,h6,img,ol,ul,li,button{margin:0;padding:0;border:0;}table{border-collapse:collapse;border-width:0;empty-cells:show;}html,body{height:100%}#gs_top{position:relative;box-sizing:border-box;min-height:100%;min-width:964px;-webkit-tap-highlight-color:rgba(0,0,0,0);}#gs_top>*:not(#x){-webkit-tap-highlight-color:rgba(204,204,204,.5);}.gs_el_ph #gs_top,.gs_el_ta #gs_top{min-width:320px;}#gs_top.gs_nscl{position:fixed;width:100%;}body,td,input,button{font-size:13px;font-family:Arial,sans-serif;line-height:1.24;}body{background:#fff;color:#222;-webkit-text-size-adjust:100%;-moz-text-size-adjust:none;}.gs_gray{color:#777777}.gs_red{color:#dd4b39}.gs_grn{color:#006621}.gs_lil{font-size:11px}.gs_med{font-size:16px}.gs_hlt{font-weight:bold;}a:link{color:#1a0dab;text-decoration:none}a:visited{color:#660099;text-decoration:none}a:hover,a:hover .gs_lbl{text-decoration:underline}a:active,a:active .gs_lbl,a .gs_lbl:active{color:#d14836}.gs_el_tc a:hover,.gs_el_tc a:hover .gs_lbl{text-decoration:none}.gs_pfcs a:focus,.gs_pfcs button:focus,.gs_pfcs input:focus,.gs_pfcs label:focus{outline:none}.gs_a,.gs_a a:link,.gs_a a:visited{color:#006621}.gs_a a:active{color:#d14836}a.gs_fl:link,.gs_fl a:link{color:#1a0dab}a.gs_fl:visited,.gs_fl a:visited{color:#660099}a.gs_fl:active,.gs_fl a:active{color:#d14836}.gs_fl{color:#777777}.gs_ctc,.gs_ctu{vertical-align:middle;font-size:11px;font-weight:bold}.gs_ctc{color:#1a0dab}.gs_ctg,.gs_ctg2{font-size:13px;font-weight:bold}.gs_ctg{color:#1a0dab}a.gs_pda,.gs_pda a{padding:7px 0 5px 0}.gs_alrt{background:#f9edbe;border:1px solid #f0c36d;padding:0 16px;text-align:center;box-shadow:0 2px 4px rgba(0,0,0,.2);border-radius:2px;}.gs_spc{display:inline-block;width:12px}.gs_br{width:0;font-size:0}.gs_ibl{display:inline-block;}.gs_scl:after{content:"";display:table;clear:both;}.gs_ind{padding-left:8px;text-indent:-8px}.gs_ico,.gs_icm{display:inline-block;background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png);background-position:-23px -161px;background-size:169px;width:21px;height:21px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_ico,.gs_icm{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);}}.gs_el_ta .gs_nta,.gs_ota,.gs_el_ph .gs_nph,.gs_oph{display:none}.gs_el_ta .gs_ota,.gs_el_ph .gs_oph{display:inline}.gs_el_ta div.gs_ota,.gs_el_ph div.gs_oph{display:block}.gs_sth_g{visibility:hidden;max-height:0;}.gs_sth_vis .gs_sth_g{max-height:1000px;}.gs_sth_vis .gs_sth_b{position:fixed;top:0;}@keyframes gs_anm_spin{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}.gs_rimg{display:block;background-color:#e5e5e5;border-radius:50%;overflow:hidden;position:relative;z-index:1;}.gs_rimg>img{position:absolute;margin:auto;left:0;top:0;bottom:0;right:0;}.gs_in_txtw{display:inline-block;vertical-align:middle;}.gs_in_txtb{display:block;}.gs_in_txt{color:#000;background-color:#fff;font-size:16px;box-sizing:border-box;height:29px;line-height:23px;border:1px solid #d9d9d9;border-top-color:#c0c0c0;padding:3px 6px 1px 8px;border-radius:1px;outline:none;-webkit-appearance:none;-moz-appearance:none;}.gs_el_tc .gs_in_txt{font-size:18px;}.gs_in_txtb .gs_in_txt{width:100%;}.gs_in_txt:hover{border-color:#b9b9b9;border-top-color:#a0a0a0;box-shadow:inset 0 1px 2px rgba(0,0,0,.1);}.gs_in_txte .gs_in_txt{border-color:#dd4b39;}.gs_in_txt:focus{border-color:#4d90fe;box-shadow:inset 0 1px 2px rgba(0,0,0,.3);}.gs_in_txt:disabled{color:#b8b8b8;border-color:#f1f1f1;box-shadow:none;}.gs_in_txtm .gs_in_txt{font-size:13px;height:24px;line-height:16px;padding:3px 6px;}.gs_el_tc .gs_in_txtm .gs_in_txt{height:29px;line-height:21px;}.gs_in_txts{font-size:13px;line-height:18px;color:#666;}.gs_in_txte .gs_in_txts{color:#dd4b39;}button{position:relative;z-index:1;box-sizing:border-box;font-size:13px;cursor:pointer;height:29px;line-height:normal;min-width:72px;padding:0 8px;color:#444;border:1px solid rgba(0,0,0,.1);border-radius:3px;text-align:center;background-color:#f5f5f5;-webkit-user-select:none;user-select:none;}button.gs_btn_rnd{border-radius:14px;padding:0 12px;}button.gs_btn_rnd.gs_btn_rndci{padding-left:4px;}button.gs_btn_lrge{height:41px;min-width:82px;padding:0 9px;}button.gs_btn_lrge.gs_btn_rnd{border-radius:20px;padding:0 16px;}button.gs_btn_lrge.gs_btn_rnd.gs_btn_rndci{padding-left:10px;}button.gs_btn_cir{border-radius:14.5px;min-width:29px;}button.gs_btn_lrge.gs_btn_cir{border-radius:20.5px;min-width:41px;}button.gs_btn_mini{padding:0;border:0;}.gs_el_ph button.gs_btn_mph,.gs_el_ta button.gs_btn_mta{height:41px;}button .gs_wr{position:relative;display:inline-block;width:100%;height:100%;}button .gs_wr:before{content:"";width:0;height:100%;}button .gs_wr:before,button .gs_ico,button .gs_rdt,button .gs_lbl,button .gs_icm{display:inline-block;vertical-align:middle;}button .gs_wr{font-size:13px;text-transform:none;}.gs_btn_lrge .gs_wr{font-size:15px;}.gs_btn_lsb .gs_wr{font-size:11px;font-weight:bold;}.gs_btn_lsu .gs_wr{font-size:11px;text-transform:uppercase;}.gs_btn_lrge.gs_btn_lsb .gs_wr,.gs_btn_lrge.gs_btn_lsu .gs_wr{font-size:13px;}.gs_btn_half,.gs_el_ta .gs_btn_hta,.gs_el_ph .gs_btn_hph{min-width:36px;}.gs_btn_lrge.gs_btn_half,.gs_el_ta .gs_btn_lrge.gs_btn_hta,.gs_el_ph .gs_btn_lrge.gs_btn_hph,.gs_el_ta .gs_btn_mta,.gs_el_ph .gs_btn_mph{min-width:41px;}.gs_btn_slt{border-radius:3px 0 0 3px;}.gs_btn_srt{margin-left:-1px;border-radius:0 3px 3px 0;}.gs_btn_smd{margin-left:-1px;border-radius:0;}button:hover{z-index:2;color:#222;border-color:rgba(0,0,0,.2);background-color:#f8f8f8;}button.gs_sel{background-color:#dcdcdc;}button:active{z-index:2;background-color:#f1f1f1;}button:focus{z-index:2;}button::-moz-focus-inner{padding:0;border:0}button:-moz-focusring{outline:1px dotted ButtonText}.gs_pfcs button:-moz-focusring{outline:none}a.gs_in_ib{position:relative;display:inline-block;line-height:16px;padding:6px 0 7px 0;-webkit-user-select:none;user-select:none;}a.gs_btn_lrge{height:40px;padding:0;}a.gs_in_ib .gs_lbl{display:inline-block;padding-left:21px;color:#222;}a.gs_in_ib .gs_lbl:not(:empty){padding-left:29px;}button.gs_in_ib .gs_lbl:not(:empty){padding-left:4px;}a.gs_in_ib:active .gs_lbl,a.gs_in_ib .gs_lbl:active,a.gs_in_ib :active~.gs_lbl{color:#d14836;}.gs_el_ta .gs_btn_hta .gs_lbl,.gs_el_ph .gs_btn_hph .gs_lbl,.gs_el_ta .gs_btn_mta .gs_lbl,.gs_el_ph .gs_btn_mph .gs_lbl,.gs_el_ta .gs_btn_cta .gs_lbl,.gs_el_ph .gs_btn_cph .gs_lbl{display:none;}a.gs_in_ib .gs_ico{position:absolute;top:3px;left:0;}.gs_in_ib.gs_md_li .gs_ico{left:14px;}.gs_el_tc .gs_in_ib.gs_md_li .gs_ico{top:11px;}.gs_in_ib.gs_md_li.gs_md_lix .gs_ico{top:10px;left:16px;}a.gs_btn_lrge .gs_ico{top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}.gs_in_ib .gs_ico{opacity:.55;}.gs_in_ib:hover .gs_ico{opacity:.72;}.gs_in_ib:active .gs_ico,.gs_in_ib .gs_ico:active,.gs_in_ib :active~.gs_ico{opacity:1;}.gs_in_ib:disabled .gs_ico,.gs_in_ib.gs_dis .gs_ico{opacity:.28;}.gs_in_ib.gs_btn_act .gs_ico,.gs_in_ib.gs_btn_cre .gs_ico{opacity:1;}.gs_btn_act:disabled .gs_ico,.gs_btn_cre:disabled .gs_ico{opacity:.72;}.gs_rdt{position:relative;width:0;height:21px;}.gs_rdt:before{content:"";position:absolute;top:2px;right:1px;width:5px;height:5px;border-radius:50%;background-color:#dd4b39;}button.gs_btn_flat{border-color:transparent;background-color:transparent;}button.gs_btn_flat:hover{background-color:rgba(0,0,0,.05);}button.gs_btn_flat:active{background-color:rgba(0,0,0,.1);}button.gs_btn_flat.gs_btn_flact{color:#1a0dab;}button.gs_btn_act{color:#fff;-webkit-font-smoothing:antialiased;background-color:#4d90fe;}button.gs_btn_act:hover{color:#fff;background-color:#3983fe;}button.gs_btn_act.gs_sel{background-color:#2f6bcc;}button.gs_btn_act:active{background-color:#357ae8;}button.gs_btn_cre{color:#fff;-webkit-font-smoothing:antialiased;background-color:#d14836;}button.gs_btn_cre:hover{color:#fff;background-color:#c53727;}button.gs_btn_cre.gs_sel{background-color:#992b1e;}html:not(.gs_pfcs) .gs_btn_act:focus:not(:active){box-shadow:inset 0 0 0 1px rgba(255,255,255,.5);}button.gs_btn_cre:active{background-color:#b0281a;}button:disabled,button:disabled:hover,button:disabled:active{cursor:default;color:#b8b8b8;border-color:rgba(0,0,0,.05);background-color:transparent;z-index:0;}button.gs_btn_flat:disabled{color:#b8b8b8;border-color:transparent;}button.gs_btn_act:disabled{color:#fff;background-color:#a6c8ff;}button.gs_btn_cre:disabled{color:#fff;background-color:#e8a49b;}a.gs_in_ib.gs_dis{cursor:default;pointer-events:none}a.gs_in_ib.gs_dis .gs_lbl{color:#b8b8b8;text-decoration:none}.gs_ttp{position:absolute;top:100%;right:50%;z-index:10;pointer-events:none;visibility:hidden;opacity:0;transition:visibility 0s .13s,opacity .13s ease-out;}button:hover .gs_ttp,button:focus .gs_ttp,a:hover .gs_ttp,a:focus .gs_ttp{transition:visibility 0s .3s,opacity .13s ease-in .3s;visibility:visible;opacity:1;}.gs_md_tb.gs_sel .gs_ttp{transition:none;visibility:hidden;}button.gs_btn_lrge.gs_btn_cir .gs_ttp{top:75%;}.gs_ttp .gs_aro,.gs_ttp .gs_aru{position:absolute;top:-2px;right:-5px;width:0;height:0;line-height:0;font-size:0;border:5px solid transparent;border-top:none;border-bottom-color:#595959;z-index:1;}.gs_ttp .gs_aro{top:-3px;right:-6px;border-width:6px;border-top:none;border-bottom-color:white;}.gs_ttp .gs_txt{display:block;position:relative;top:2px;right:-50%;padding:4px 6px;background:#595959;color:white;font-size:11px;font-weight:bold;line-height:normal;white-space:nowrap;border:1px solid white;border-radius:3px;box-shadow:inset 0 1px 4px rgba(0,0,0,.2);}.gs_press,.gs_in_se,.gs_tan{touch-action:none;}.gs_in_se .gs_lbl:not(:empty){padding-right:14px;}.gs_in_se .gs_icm{position:absolute;top:50%;margin-top:-5.5px;right:0;width:7px;height:11px;background-position:-21px -88px;opacity:.55;}.gs_in_se:hover .gs_icm{opacity:.72;}.gs_in_se:active .gs_icm{opacity:1;}.gs_in_se:disabled .gs_icm{opacity:.28;}.gs_el_ta .gs_btn_hta .gs_icm,.gs_el_ph .gs_btn_hph .gs_icm,.gs_el_ta .gs_btn_mta .gs_icm,.gs_el_ph .gs_btn_mph .gs_icm,.gs_el_ta .gs_btn_cta .gs_icm,.gs_el_ph .gs_btn_cph .gs_icm{display:none;}.gs_btn_mnu .gs_icm{margin-top:-3.5px;height:7px;background-position:0 -110px;}.gs_in_se.gs_btn_act .gs_icm,.gs_in_se.gs_btn_cre .gs_icm{margin-top:-3.5px;height:7px;background-position:-42px -44px;opacity:1;}.gs_btn_act:disabled .gs_icm,.gs_btn_cre:disabled .gs_icm{opacity:.72;}button.gs_btnG .gs_ico{width:21px;height:21px;background-position:-92px -253px;}button .gs_bs{position:absolute;top:50%;left:50%;margin-top:-10px;margin-left:-10px;box-sizing:border-box;width:20px;height:20px;border-radius:50%;border:2px solid #eee;border-top-color:#4d90fe;visibility:hidden;animation:gs_anm_spin .8s linear infinite;}button.gs_bsp .gs_bs{visibility:visible;transition:visibility 0s .4s;}.gs_md_d{text-transform:none;white-space:nowrap;position:absolute;top:0;left:0;border:1px solid #ccc;border-color:rgba(0,0,0,.2);background:#fff;box-shadow:0 2px 4px rgba(0,0,0,.2);z-index:1100;text-align:left;visibility:hidden;max-height:0;margin-top:-1000px;opacity:0;transition:opacity .13s,visibility 0s .13s,max-height 0s .13s,margin-top 0s .13s;}.gs_md_d.gs_vis{visibility:visible;max-height:10000px;margin-top:0;opacity:1;transition:all 0s;}.gs_el_tc .gs_md_d{transform-origin:100% 0;transform:scale(1,0);transition:opacity .218s ease-out,transform 0s .218s,visibility 0s .218s,max-height 0s .218s,margin-top 0s .218s;}.gs_el_ios .gs_md_d{-webkit-backface-visibility:hidden;}.gs_el_tc .gs_md_d.gs_ttzi{transform-origin:50% 50%;transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_ttzr{transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_vis{transform:scale(1,1);transition:transform .218s ease-out;}.gs_md_r{position:relative;display:inline-block;}.gs_md_rmb>.gs_md_d{top:29px}.gs_md_rmbl>.gs_md_d{top:41px}.gs_md_ul{list-style-type:none;word-wrap:break-word;display:inline-block;vertical-align:top;}.gs_md_ul.gs_md_ul_tb{display:block;}.gs_md_li,.gs_in_cb.gs_md_li,.gs_md_li:link,.gs_md_li:visited{display:block;padding:6px 44px 6px 16px;font-size:13px;line-height:16px;color:#222;cursor:pointer;text-decoration:none;position:relative;z-index:0;}a.gs_md_li:hover .gs_lbl,a.gs_md_li:active .gs_lbl{text-decoration:none}.gs_el_tc .gs_md_li{padding-top:14px;padding-bottom:10px;}.gs_md_li.gs_md_lix{font-size:16px;line-height:20px;padding:12px 16px 8px 16px;}.gs_md_li:before{content:"";background-color:#f1f1f1;position:absolute;left:0;right:0;top:0;bottom:0;opacity:0;transition:opacity .13s;z-index:-1;}.gs_md_li:hover:before,.gs_md_li:focus:before{opacity:1;transition:all 0s;}a.gs_in_ib.gs_md_li .gs_lbl{color:#222}a.gs_in_ib.gs_md_li.gs_in_gray .gs_lbl{color:#444}.gs_md_li:active:before{background-color:#ddd}.gs_md_li.gs_sel,a.gs_in_ib.gs_md_li.gs_sel .gs_lbl{color:#d14836}.gs_md_d:focus,.gs_md_li:focus{outline:none}a.gs_md_lix .gs_lbl,a.gs_md_lix .gs_lbl:not(:empty){padding:0 0 0 40px;}a.gs_in_cb:link,a.gs_in_cb:visited,a.gs_in_cb:active,a.gs_in_cb:hover{cursor:pointer;color:#222;text-decoration:none;}.gs_in_cb,.gs_in_ra{position:relative;line-height:16px;display:inline-block;-webkit-user-select:none;user-select:none;}.gs_in_cb.gs_md_li{padding:6px 44px 6px 16px;}.gs_in_cb input,.gs_in_ra input{position:absolute;top:1px;left:1px;width:15px;height:15px;margin:0;padding:0;opacity:0;z-index:2;}.gs_in_ra input{top:0;left:0}.gs_el_tc .gs_in_cb input{top:9px}.gs_el_tc .gs_in_ra input{top:8px}.gs_in_cb.gs_in_cbj input{top:15px;left:15px}.gs_in_cb label,.gs_in_cb .gs_lbl,.gs_in_ra label{display:inline-block;padding-left:21px;min-height:16px;}.gs_in_cb label:empty:before,.gs_in_cb .gs_lbl:empty:before,.gs_in_ra label:empty:before{content:"\200b";}.gs_el_tc .gs_in_cb label,.gs_el_tc .gs_in_cb .gs_lbl,.gs_el_tc .gs_in_ra label{padding-top:8px;padding-bottom:5px;}.gs_in_cb.gs_in_cbj label,.gs_in_cb.gs_in_cbj .gs_lbl{padding:13px 0 12px 41px;}.gs_in_cbb,.gs_in_cbb label,.gs_in_cbb .gs_lbl{display:block;}.gs_in_cb .gs_cbx,.gs_in_ra .gs_cbx{position:absolute}.gs_in_cb .gs_cbx{top:2px;left:2px;width:11px;height:11px;border:1px solid #c6c6c6;border-radius:1px;}.gs_md_li .gs_cbx{top:8px;left:18px}.gs_el_tc .gs_in_cb .gs_cbx{top:10px}.gs_el_tc .gs_md_li .gs_cbx{top:16px}.gs_in_cb.gs_in_cbj .gs_cbx{top:15px;left:15px}.gs_el_tc .gs_in_ra .gs_cbx{top:8px}.gs_in_ra .gs_cbx{top:0;left:0;border:1px solid #c6c6c6;width:13px;height:13px;border-radius:7px;}.gs_in_cb:hover .gs_cbx,.gs_in_ra:hover .gs_cbx{border-color:#666;box-shadow:inset 0 1px 1px rgba(0,0,0,.1);}button.gs_in_cb:hover .gs_cbx{border-color:#c6c6c6;}.gs_in_cb :focus~label,.gs_in_ra :focus~label{outline:1px dotted #222;outline:auto -webkit-focus-ring-color;}.gs_pfcs .gs_in_cb :focus~label,.gs_pfcs .gs_in_ra :focus~label{outline:none;}.gs_in_cb:active .gs_cbx,.gs_in_ra:active .gs_cbx,.gs_in_cb .gs_cbx:active,.gs_in_ra .gs_cbx:active,.gs_in_cb :active~.gs_cbx,.gs_in_ra :active~.gs_cbx{border-color:#666;background-color:#ebebeb;}button.gs_in_cb:active .gs_cbx{border-color:#a6a6a6;}.gs_in_cb :disabled~.gs_cbx,.gs_in_ra :disabled~.gs_cbx,button.gs_in_cb:disabled .gs_cbx{border-color:#f1f1f1;box-shadow:none;}.gs_in_cb :disabled~label,.gs_in_ra :disabled~label{color:#b8b8b8;}.gs_in_cb.gs_err .gs_cbx{border-color:#eda29b;}.gs_in_cb .gs_chk,.gs_in_ra .gs_chk{position:absolute;z-index:1;top:-3px;left:-2px;width:21px;height:21px;}.gs_md_li .gs_chk{top:3px;left:14px}.gs_el_tc .gs_in_cb .gs_chk{top:5px}.gs_el_tc .gs_md_li .gs_chk{top:11px}.gs_in_cb.gs_in_cbj .gs_chk{top:10px;left:11px}.gs_in_ra .gs_chk{top:4px;left:4px;width:7px;height:7px;border-radius:4px;}.gs_el_tc .gs_in_ra .gs_chk{top:12px}.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -69px -67px;opacity:.62;}.gs_in_ra input:checked~.gs_chk{background-color:#666}.gs_in_cb.gs_par .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -21px -44px;opacity:.55;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk,.gs_in_cb.gs_par .gs_chk{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);background-size:169px;}}.gs_in_cb input:checked:disabled~.gs_chk{opacity:.22}.gs_in_ra input:checked:disabled~.gs_chk{background-color:#f1f1f1}.gs_ico_x{background-position:-113px -22px;opacity:.55;}.gs_ico_x:hover{opacity:.72;}.gs_ico_x:active{opacity:1;}.gs_ico_X{background-position:-71px 0;opacity:.55;}.gs_ico_X:hover{opacity:.72;}.gs_ico_X:active{opacity:1;}.gs_el_tc .gs_ico_Xt{background-origin:content-box;background-clip:content-box;padding:10px 6px 10px 14px;}.gs_ico_P{background-position:0 0;opacity:.55;}.gs_ico_P:hover{opacity:.72;}.gs_ico_P:active{opacity:1;}.gs_btnP .gs_ico{background-position:-21px 0;}.gs_btnC .gs_ico{background-position:0 -66px;}.gs_btnL .gs_ico{background-position:-92px -44px;}.gs_ico_LB{background-position:-50px -44px;height:16px;}.gs_btnJ .gs_ico{background-position:-92px -22px;}.gs_btnM .gs_ico{background-position:-92px 0;}.gs_btnMW .gs_ico{background-position:-21px -22px;}.gs_btnSB .gs_ico{background-position:0 -44px;}.gs_btnTSB .gs_ico{background-position:-115px -253px;}.gs_btnPL .gs_ico{background-position:-148px -66px;}.gs_btnPR .gs_ico{background-position:-21px -66px;}.gs_btnPLW .gs_ico{background-position:-0 -230px;}.gs_btnPRW .gs_ico{background-position:-23px -230px;}.gs_btnZI .gs_ico{background-position:-148px -22px;}.gs_btnZO .gs_ico{background-position:-127px -44px;}.gs_btnDE .gs_ico{background-position:-134px 0;}.gs_btnFI .gs_ico{background-position:-50px -66px;}.gs_btnAD .gs_ico{background-position:-141px -88px;opacity:.55;}.gs_btnAD:hover .gs_ico{opacity:.72;}.gs_btnAD:active .gs_ico,.gs_btnAD .gs_ico:active,.gs_btnAD :active~.gs_ico{opacity:1;}.gs_btnBA .gs_ico{background-position:-50px -22px;}.gs_btnADD .gs_ico{background-position:-92px -66px;}.gs_btnMRG .gs_ico{background-position:-113px 0;}.gs_btnLBL .gs_ico{background-position:0 -161px;}.gs_btnCNCL .gs_ico{background-position:-71px 0;}.gs_btnDWL .gs_ico{background-position:-28px -88px;}.gs_btnMNU .gs_ico{background-position:0 -88px;}.gs_btnMNT .gs_ico{background-position:-46px -161px;}.gs_btnALT .gs_ico{background-position:-92px -161px;}.gs_btnART .gs_ico{background-position:-115px -161px;}.gs_btnGSL .gs_ico{background-position:-69px -161px;}.gs_btnCLS .gs_ico{background-position:-138px -161px;}.gs_btnXBLU .gs_ico{background-position:-138px -253px;}.gs_btnSSB .gs_ico{background-position:0 -276px;}.gs_btnSSW .gs_ico{background-position:-23px -276px;}.gs_btnFLT .gs_ico{background-position:0 -184px;}.gs_btnXT .gs_ico{background-position:-46px -184px;}.gs_btnPD .gs_ico{background-position:-69px -184px;}.gs_btnPU .gs_ico {background-position:-92px -276px;}.gs_btnCP .gs_ico{background-position:-92px -184px;}.gs_btnTP .gs_ico{background-position:-138px -184px;}.gs_btnML .gs_ico{background-position:-115px -276px;}.gs_btnCHK .gs_ico{background-position:-71px -66px;}.gs_btnDNB .gs_ico{background-position:-115px -230px;}.gs_btnDNW .gs_ico{background-position:0 -207px;}.gs_btnACA .gs_ico{background-position:-23px -207px;}.gs_btnAPT .gs_ico{background-position:-46px -207px;}.gs_btnAPTW .gs_ico{background-position:-92px -230px;}.gs_btnAFL .gs_ico{background-position:-69px -207px;}.gs_btnAN .gs_ico{background-position:-46px -276px;}.gs_btnAI .gs_ico{background-position:-69px -276px;}.gs_btnPBL .gs_ico{background-position:-92px -207px;}.gs_btnUCT .gs_ico{background-position:-115px -207px;}.gs_btnVRF .gs_ico{background-position:-138px -207px;}.gs_btnLSI .gs_ico{background-position:-46px -230px;}.gs_btnLSG .gs_ico{background-position:-69px -230px;}.gs_btnMOR .gs_ico{background-position:-23px -253px;}.gs_btnADV .gs_ico{background-position:-46px -253px;}.gs_btnPRO .gs_ico{background-position:-69px -253px;}.gs_ico_star{background-position:-71px -44px;width:13px;height:13px;}.gs_btnPLSW .gs_ico{background-position:-138px -230px;}.gs_btnPDF .gs_ico{background-position:0 -253px;}.gs_btnS .gs_ico{background-position:-138px -276px;}.gs_btnUNS .gs_ico{background-position:0 -299px;}.gs_btnMORR .gs_ico{background-position:-23px -299px;}.gs_btnTW .gs_ico{background-position:-46px -299px;}.gs_btnIN .gs_ico{background-position:-69px -299px;}.gs_btnFB .gs_ico{background-position:-92px -299px;}#gs_hdr_drs,#gs_hdr_drw{position:fixed;top:0;left:0;width:100%;height:100%;z-index:1200;visibility:hidden;}#gs_hdr_drs{opacity:0;background-color:#fff;transition:opacity .15s,visibility 0s .15s;}.gs_el_ta #gs_hdr_drs,.gs_el_ph #gs_hdr_drs{background-color:#666;}#gs_hdr_drs.gs_vis{visibility:visible;opacity:.5;transition:opacity .15s,visibility 0s;}.gs_el_tc #gs_hdr_drs{transition:opacity .218s,visibility 0s .218s;}.gs_el_tc #gs_hdr_drs.gs_vis{transition:opacity .218s,visibility 0s;}#gs_hdr_drw{overflow:auto;width:228px;background-color:#fff;box-shadow:2px 2px 4px rgba(0,0,0,.15);outline:none;transform:translate(-100%,0);transition:transform .15s ease-in-out,visibility 0s .15s;}#gs_hdr_drw.gs_vis{visibility:visible;transform:translate(0,0);transition:transform .15s ease-in-out,visibility 0s;}.gs_el_tc #gs_hdr_drw{transition:transform .3s cubic-bezier(.4,0,.6,1),visibility 0s .3s;}.gs_el_tc #gs_hdr_drw.gs_vis{transition:transform .225s cubic-bezier(0,0,.2,1),visibility 0s;}#gs_hdr_drw.gs_abt,.gs_el_tc #gs_hdr_drw.gs_abt{transition:none;}#gs_hdr_drw_in{position:relative;box-sizing:border-box;min-height:100%;padding:0 0 8px 0;}.gs_el_ta #gs_hdr_drw_in,.gs_el_ph #gs_hdr_drw_in{padding:0 0 65px 0;}#gs_hdr_drw_top{position:relative;height:63px;border-bottom:1px solid #e5e5e5;margin-bottom:8px;}.gs_el_ta #gs_hdr_drw_top,.gs_el_ph #gs_hdr_drw_top{height:57px;}#gs_hdr_drw_mnu,#gs_hdr_drw_lgo{position:absolute;top:0;height:100%;}#gs_hdr_drw_mnu{left:0;width:55px;}#gs_hdr_drw_lgo{left:56px;}.gs_hdr_drw_sec:before{display:block;content:" ";height:0;border-bottom:1px solid #e5e5e5;margin:8px 0;}.gs_hdr_drw_sec:first-child:before{display:none;}#gs_hdr_drw_bot{display:none;}.gs_el_ta #gs_hdr_drw_bot,.gs_el_ph #gs_hdr_drw_bot{display:block;position:absolute;left:0;bottom:0;width:100%;height:65px;}#gs_hdr_drw_bot .gs_md_li:before{opacity:0;}#gs_hdr_drw_bot .gs_hdr_pp{display:block;position:absolute;bottom:14px;left:15px;pointer-events:none;}#gs_hdr_drw_bot .gs_lbl{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}#gs_hdr{position:relative;height:63px;background-color:#f5f5f5;border-bottom:1px solid #e5e5e5;display:flex;}.gs_el_ta #gs_hdr,.gs_el_ph #gs_hdr{height:57px;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_lgo,#gs_hdr_lgt,#gs_hdr_md,#gs_hdr_sre,#gs_hdr_act{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}#gs_hdr_md{flex:1 1 auto;}#gs_hdr .gs_hdr_mbo,#gs_hdr .gs_hdr_mbo,.gs_el_ta #gs_hdr .gs_hdr_dso,.gs_el_ph #gs_hdr .gs_hdr_dso{display:none;}.gs_el_ta #gs_hdr .gs_hdr_mbo,.gs_el_ph #gs_hdr .gs_hdr_mbo{display:inline-block;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_sre{width:55px;margin-right:1px;}#gs_hdr_lgo,#gs_hdr_drw_lgo{width:149px;background:no-repeat url('/intl/en/scholar/images/1x/scholar_logo_24dp.png') 0% 50%;background-size:149px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){#gs_hdr_lgo,#gs_hdr_drw_lgo{background-image:url('/intl/en/scholar/images/2x/scholar_logo_24dp.png');}}#gs_hdr_lgo{margin-right:31px;}.gs_el_ph #gs_hdr_lgo{margin-right:0;}#gs_hdr_lgt{min-width:164px;margin-right:16px;}#gs_hdr_lgt:empty{display:none;}#gs_hdr_md{margin-right:16px;min-width:1px;}#gs_hdr_lgt,#gs_hdr_md h1{padding:19px 0 0 0;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:20px;line-height:25px;font-weight:normal;color:#666;max-width:100%;text-align:left;}.gs_el_ta #gs_hdr_md h1,.gs_el_ph #gs_hdr_md h1{padding:16px 0 0 0;}#gs_hdr_srch{padding:14px 0 0 0;max-width:600px;}.gs_el_ta #gs_hdr_srch,.gs_el_ph #gs_hdr_srch{padding:10px 0 0 0;max-width:none;}#gs_hdr_frm{position:relative;padding-right:39px;}#gs_hdr_tsi{height:38px;border-radius:2px 0 0 2px;}#gs_hdr_tsi::-ms-clear{display:none;}#gs_hdr_tsc{display:none;position:absolute;top:3px;right:41px;width:21px;height:21px;padding:6px 10px 7px 10px;}.gs_in_acw[dir="rtl"]~#gs_hdr_tsc{right:auto;left:1px;}#gs_hdr_tsb{position:absolute;top:0;right:0;width:40px;height:38px;border-radius:0 2px 2px 0;}#gs_hdr_frm_ac{top:37px;right:40px;}.gs_el_ph #gs_hdr_frm_ac{right:0;}.gs_el_ph .gs_hdr_ifc #gs_hdr_mnu,.gs_el_ph .gs_hdr_ifc #gs_hdr_bck,.gs_hdr_src #gs_hdr_srch,.gs_hdr_src #gs_hdr_lgt,.gs_hdr_srx #gs_hdr_sre,.gs_hdr_srx #gs_hdr_md h1,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_mbo,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_dso,.gs_el_ta .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_mnu,.gs_el_ph .gs_hdr_srx #gs_hdr_bck{display:none;}.gs_el_ph .gs_hdr_ifc #gs_hdr_md,.gs_el_ph .gs_hdr_srx #gs_hdr_md{margin-left:16px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="ltr"]{padding-right:41px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="rtl"]{padding-left:41px;}.gs_el_tc .gs_hdr_tsc .gs_in_acw~#gs_hdr_tsc{display:block;}#gs_hdr_act{min-width:64px;max-width:200px;text-align:right;float:right;}.gs_el_ta #gs_hdr_act,.gs_el_ph #gs_hdr_act{display:none;}#gs_hdr_act_i,#gs_hdr_act_s{display:inline-block;padding:23px 24px 23px 16px;max-width:100%;box-sizing:border-box;font-size:13px;line-height:17px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:#444;}#gs_hdr_act_s{text-transform:uppercase;}.gs_el_sm #gs_hdr_act_i,.gs_el_sm #gs_hdr_act_s{padding:23px 16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ta #gs_hdr_act_s,.gs_el_ph #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_s{padding:20px 16px;}#gs_hdr_act_i:active,#gs_hdr_act_s:active{color:#d14836;}#gs_hdr_act_i,.gs_el_sm #gs_hdr_act_i{padding-top:15px;padding-bottom:16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_i{padding-top:12px;padding-bottom:13px;}#gs_hdr_act_i .gs_hdr_pp{vertical-align:top;}#gs_hdr_act_d{top:63px;left:auto;right:24px;min-width:288px;max-width:400px;}.gs_el_sm #gs_hdr_act_d{right:16px;}.gs_el_ta #gs_hdr_act_d{top:57px;}.gs_el_ph #gs_hdr_act_d{top:57px;min-width:280px;max-width:280px;max-width:90vw;}/* Account dialog body. */#gs_hdr_act_aw,#gs_hdr_act_ap,.gs_hdr_act_am,#gs_hdr_act_ab{display:block;padding:10px 20px;word-wrap:break-word;white-space:normal;}#gs_hdr_act_aw{background-color:#fef9db;font-size:11px;}#gs_hdr_act_ap,.gs_hdr_act_am{border-bottom:1px solid #ccc;}#gs_hdr_act_ap{padding:20px;}.gs_el_ph #gs_hdr_act_ap{padding:10px;}#gs_hdr_act_apb{margin-top:12px;}#gs_hdr_act_aa:link,#gs_hdr_act_aa:visited{float:right;margin-left:8px;color:#1a0dab;}#gs_hdr_act_aa:active{color:#d14836}.gs_hdr_act_am:link,.gs_hdr_act_am:visited{color:#222;text-decoration:none;background:#fbfbfb;}.gs_hdr_act_am:hover,.gs_hdr_act_am:focus{background:#f1f1f1;}.gs_hdr_act_am:active{background:#eee;}#gs_hdr_act_ab{background:#fbfbfb;padding:10px 0;display:table;width:100%;white-space:nowrap;}#gs_hdr_act_aba,#gs_hdr_act_abs{display:table-cell;padding:0 20px;}#gs_hdr_act_abs{text-align:right;}.gs_el_ph #gs_hdr_act_aba,.gs_el_ph #gs_hdr_act_abs{display:block;padding:10px;text-align:center;}.gs_el_ph #gs_hdr_act_aba button,.gs_el_ph #gs_hdr_act_abs button{width:100%;}#gs_hdr_act_a1,#gs_hdr_act_a2{position:absolute;top:-9px;right:7.5px;width:0;height:0;z-index:1;border:8.5px solid transparent;border-top:none;border-bottom-color:#333;border-bottom-color:rgba(0,0,0,.2);}#gs_hdr_act_a2{top:-8px;border-bottom-color:#fff;}.gs_hdr_act_mw #gs_hdr_act_a2{border-bottom-color:#fef9db;}.gs_hdr_pp{border-radius:50%;overflow:hidden;}#gs_hdr_act_ap .gs_hdr_pp,.gs_hdr_act_am .gs_hdr_pp{float:left;}#gs_hdr_act_ap .gs_hdr_pm{margin-left:116px;}.gs_hdr_act_am .gs_hdr_pm{margin:6px 0 0 58px;}#gs_ab{position:relative;height:41px;border-bottom:1px solid #e5e5e5;display:flex;white-space:nowrap;background-color:#fff;z-index:1000;}.gs_el_ta #gs_ab.gs_nta,.gs_el_ph #gs_ab.gs_nph{display:none;}#gs_ab_g{height:42px;}.gs_sth_vis #gs_ab{position:fixed;}#gs_ab_ico,#gs_ab_ttl,#gs_ab_md,#gs_ab_btns{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}.gs_el_ph #gs_ab_md{display:block;}#gs_ab_ico{width:55px;margin-right:1px;}#gs_ab_ico .gs_ico{position:absolute;top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}#gs_ab_ttl{min-width:172px;padding-right:8px;}.gs_el_sm #gs_ab_ttl{min-width:68px;}.gs_el_ta #gs_ab_ttl,.gs_el_ph #gs_ab_ttl{min-width:0;}#gs_ab_ttl,#gs_ab_ttll{font-size:18px;color:#666;text-transform:none;}.gs_el_sm #gs_ab_ttl,.gs_el_sm #gs_ab_ttll{font-size:16px;}#gs_ab_ttll{overflow:hidden;text-overflow:ellipsis;max-width:200px;}#gs_ab_md{flex:1 0 auto;}.gs_ab_st #gs_ab_md{flex:1 1 auto;font-size:13px;line-height:17px;padding:0 8px;color:#999;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gs_ab_st #gs_ab_md{visibility:hidden;padding:0;}#gs_ab_btns{margin-right:8px;}.gs_el_sm #gs_ab_btns{margin-right:0;}.gs_el_ta #gs_ab_btns,.gs_el_ph #gs_ab_btns{margin-right:4px;}#gs_ab_ttl:before,#gs_ab_md:before,#gs_ab_btns:before{content:"";display:inline-block;width:0;height:100%;vertical-align:middle;}#gs_ab_md>button,#gs_ab_btns>button,#gs_ab_md>.gs_in_ib,#gs_ab_btns>.gs_in_ib,#gs_ab_md>.gs_md_r,#gs_ab_btns>.gs_md_r,#gs_ab .gs_ab_mdw,#gs_ab .gs_ab_btw{margin:0 8px;vertical-align:middle;}#gs_ab .gs_ab_mdw,.gs_ab_btw{display:inline-block;margin:0;}#gs_ab_btns>.gs_in_ib{margin:0 16px 0 8px;}#gs_ab .gs_ab_btw{margin:0 12px 0 16px;}.gs_el_ta .gs_ab_sel #gs_ab_ico,.gs_el_ph .gs_ab_sel #gs_ab_ico,.gs_el_ta .gs_ab_sel #gs_ab_ttl,.gs_el_ph .gs_ab_sel #gs_ab_ttl,.gs_el_ta .gs_ab_sel #gs_ab_btns,.gs_el_ph .gs_ab_sel #gs_ab_btns{display:none;}#gs_bdy{display:table;table-layout:fixed;width:100%;}#gs_bdy_sb{vertical-align:top;width:228px;word-wrap:break-word;display:none;}.gs_el_sm #gs_bdy_sb{}.gs_el_ta #gs_bdy_sb,.gs_el_ph #gs_bdy_sb{}.gs_bdy_sb_sec{margin:0 40px 0 56px;}.gs_bdy_sb_sec:before{display:block;content:" ";height:0;margin:13px 0;border-top:1px solid #eee;}.gs_bdy_sb_sec:first-child:before{margin:21px 0 0 0;border:none;}#gs_bdy_sb ul{list-style-type:none;}.gs_bdy_sb_sec a:link,.gs_bdy_sb_sec a:visited{color:#222;}.gs_bdy_sb_sec a:active{color:#d14836;}.gs_bdy_sb_sel a:link,.gs_bdy_sb_sel a:visited{color:#d14836;text-decoration:none;}.gs_el_tc .gs_bdy_sb_sec li.gs_ind,.gs_el_tc .gs_bdy_sb_sec li.gs_ind a{padding-top:8px;padding-bottom:5px;}.gs_el_tc .gs_bdy_sb_sec:first-child li.gs_ind:first-child{margin-top:-8px;}#gs_bdy_sb .gs_ind,#gs_bdy_sb .gs_inw{margin-bottom:4px;}.gs_el_tc #gs_bdy_sb .gs_ind,.gs_el_tc #gs_bdy_sb .gs_inw{margin-bottom:0;}#gs_bdy_ccl{display:table-cell;vertical-align:top;padding:0 24px 0 16px;}.gs_el_sm #gs_bdy_ccl{padding:0 16px;}.gs_el_ta #gs_bdy_ccl,.gs_el_ph #gs_bdy_ccl{padding:0 16px;}.gs_el_ph #gs_bdy_ccl{padding:0;}#gs_ftr_sp{height:62px;}.gs_el_sm #gs_ftr_sp{height:57px;}#gs_ftr{position:absolute;bottom:0;left:0;width:100%;white-space:nowrap;border-top:1px solid #e4e4e4;background-color:#f2f2f2;display:flex;}#gs_ftr_rt{box-sizing:border-box;max-width:100%;overflow-x:auto;margin-left:auto;padding:0 12px;}.gs_el_sm #gs_ftr_rt{padding:0 8px;}.gs_el_ph #gs_ftr_rt:after{content:" ";position:absolute;top:0;right:0;width:16px;height:100%;background-image:linear-gradient(to right,rgba(242,242,242,0),rgba(242,242,242,1) 80%);}#gs_ftr_rt a{display:inline-block;line-height:16px;padding:12px;white-space:nowrap;}.gs_el_sm #gs_ftr_rt a{padding:12px 8px;}#gs_ftr_rt a:link,#gs_ftr_rt a:visited{color:#666}#gs_ftr_rt a:active{color:#d14836}#gsc_a_t{width:100%;table-layout:fixed;}#gsc_a_tr0,#gsc_a_trh{box-sizing:border-box;}#gsc_a_tr0 th.gsc_a_x,#gsc_a_tr0 th.gsc_a_t,#gsc_a_tr0 th.gsc_a_c,#gsc_a_tr0 th.gsc_a_y{height:0;}#gsc_a_trh{z-index:700;background-color:#f5f5f5;height:42px;}.gs_el_ta #gsc_a_trh,.gs_el_ph #gsc_a_trh,.gs_el_ta #gsc_a_t td,.gs_el_ph #gsc_a_t td{background-color:#fff;border-bottom:1px solid #e5e5e5;}#gsc_a_t th.gsc_a_x,#gsc_a_t th.gsc_a_t,#gsc_a_t th.gsc_a_c,#gsc_a_t th.gsc_a_y{box-sizing:border-box;text-transform:uppercase;vertical-align:middle;padding-top:0;padding-bottom:0;}#gsc_x_all{z-index:1;}.gsc_a_x,.gsc_a_t,.gsc_a_c,.gsc_a_y,.gsc_a_e{font-weight:normal;padding:16px 16px 0 16px;vertical-align:top;text-align:right;}.gsc_a_c{padding:16px 8px 0 8px;}.gs_el_sm .gsc_a_x,.gs_el_sm .gsc_a_t,.gs_el_sm .gsc_a_c{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_x,.gs_el_ta .gsc_a_t,.gs_el_ta .gsc_a_c,.gs_el_ph .gsc_a_x,.gs_el_ph .gsc_a_t,.gs_el_ph .gsc_a_c{padding:12px 8px;}.gs_el_sm .gsc_a_y{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_y{padding-bottom:12px;}.gsc_a_x{width:41px;padding:4px 0 0 0;}.gs_el_sm .gsc_a_x{padding:0;}.gsc_a_t{text-align:left;}.gs_el_ph .gsc_a_t{padding-left:16px;}#gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:16px;}.gs_el_ph #gsc_a_ta{display:none}.gs_el_ph .gsc_a_c{padding-right:16px;}th.gsc_a_c{width:64px;white-space:nowrap;}.gsc_art_sel #gsc_a_ta,.gsc_art_sel #gsc_a_ca,.gsc_art_sel .gsc_a_h{display:none;}.gsc_a_ac,.gsc_a_hc{margin-top:3px;}th.gsc_a_y{width:88px;white-space:nowrap;}.gs_el_sm th.gsc_a_y{width:58px;}.gs_el_ph th.gsc_a_y,.gs_el_ph td.gsc_a_y{width:0;padding:0;}.gs_el_ph .gsc_a_h{display:none}@media print{#gs_top th.gsc_a_y{width:58pt;}#gs_top #gsc_a_tr0{display:none}#gs_top #gsc_a_trh{position:static}}.gsc_a_e{padding:16px;text-align:center;}.gsc_a_a{padding:8px 0}.gsc_a_at{padding:8px 0;font-size:16px}a.gsc_a_acm{text-decoration:line-through;}a.gsc_a_acm:hover,a.gs_a_acm:active{text-decoration:underline;}.gsc_a_m{position:absolute;}.gs_el_ph .gsc_a_m{display:block;position:static;}.gsc_a_am{font-size:24px;position:absolute;top:-18px;left:-2px;padding:8px 12px 4px 8px;}.gs_el_ph .gsc_a_am{display:inline-block;position:static;padding:6px 16px;margin-bottom:-6px;}#gsc_a_sp{visibility:hidden;}#gsc_a_sp.gs_vis{visibility:visible;padding:16px 0;height:25px;border-bottom:1px solid #ccc;}#gsc_a_sp:after{display:block;height:100%;content:" ";background:url('/intl/en/scholar/images/spinner.gif') no-repeat 50% 50%;opacity:0;}#gsc_a_sp.gs_vis:after{opacity:1;transition:opacity 0s .4s;}#gsc_a_err{display:none;padding:28px 0;}#gsc_a_err.gs_vis{display:block;}#gsc_md_iad{width:800px;max-width:94%;}.gs_el_ph #gsc_md_iad{width:100%;max-width:100%;}#gsc_md_iad .gs_md_prg{min-height:400px;}.gs_el_ph #gsc_iads_res .gs_md_prg{margin:0 16px;}#gsc_iad_tart,.gsc_iad_tsel.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tart #gsc_iad_tgrp,.gsc_iad_tsel #gsc_iad_tgrp,#gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tart,#gsc_napb_hdr #gsc_iad_tgrp{display:none;}#gsc_iad_tgrp,.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tsel #gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tsel{display:inline-block;}#gsc_iad_t:not(.gsc_iad_tsel) #gsc_iad_tsel{pointer-events:none;color:#b5b5b5;}.gs_el_ph #gsc_napb #gsc_iads_frm{margin:0 16px;}#gsc_iads_res{position:relative;margin:8px 0 16px 0;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_md_iad #gsc_iads_res{margin:8px -16px 16px -16px;}.gs_el_ph #gsc_napb #gsc_iads_pp{margin-right:16px;}#gsc_iadb_hdr{display:table;table-layout:fixed;width:100%;}#gsc_iadb_hdr_cb,#gsc_iadb_hdr_instr{display:table-cell;vertical-align:middle;height:41px;}#gsc_iadb_hdr_cb{width:41px;}#gsc_iadb_hdr_cb:empty{width:0;}.gs_el_ph #gsc_iadb_hdr_cb:empty{width:16px;}#gsc_iadb_hdr_instr{font-size:16px;}.gs_el_ph #gsc_iadb_hdr_instr{padding-right:16px;}.gsc_oic{position:relative;}.gsc_oic_cb{font-weight:normal;border-top:1px solid #e5e5e5;border-bottom:1px solid #e5e5e5;background-color:#fcfcfc;padding-right:16px;}.gsc_oict{display:block;overflow:hidden;}.gsc_oict_name{display:block;font-size:16px;line-height:20px;word-wrap:break-word;}.gsc_oict_inf{display:block;float:right;margin-left:16px;white-space:nowrap;}.gsc_oict_all,.gsc_oict_prf{font-size:13px;text-transform:uppercase;line-height:20px;}.gsc_oict_all[data-a]{color:#1a0dab;cursor:pointer;}.gsc_oict_all[data-a]:hover{text-decoration:underline;}.gsc_oict_all[data-a]:active{color:#d14836;}.gsc_oict_prf{padding-left:8px;margin-left:8px;border-left:1px solid #e0e0e0;}.gsc_oict_prf:empty{display:none;}.gs_el_ph .gsc_oict_all,.gs_el_ph .gsc_oict_prf{float:right;clear:both;margin:0;padding:0;border:none;}.gs_el_ph .gsc_oict_prf{margin-top:2px;}.gsc_oic_res{margin:8px 0 12px 41px;}.gs_el_ph .gsc_oic_res{margin-right:16px;}.gsc_oic_res h4{font-size:13px;font-weight:normal;}.gsc_oic_dis .gsc_oic_name,.gsc_oic_dis .gsc_oic_all,.gsc_oic_dis .gsc_oic_prf{color:#777;}.gsc_oic_dis .gsc_oict_all[data-a]{color:#1a0dab;opacity:.66;}.gsc_oic_dis .gsc_oic_res{opacity:.5;}.gsc_iadb_art{border-top:1px solid #e5e5e5;overflow:hidden;}.gsc_iadb_art_cb{float:left;}.gsc_iadb_art_added{float:right;margin:12px;font-size:11px;text-transform:uppercase;color:#777;}.gs_el_ph .gsc_iadb_art_added{display:block;float:none;text-align:right;margin:8px 16px;}.gsc_iadb_art_added:empty{display:none;}.gsc_iadb_art_body{margin:12px 0 12px 41px;}.gs_el_ph .gsc_iadb_art_body{margin:12px 16px 12px 41px;}.gsc_iadb_art_body h3{font-size:13px;font-weight:normal;}.gsc_iadb_art_dis .gsc_iadb_art_body{opacity:.5;}#gsc_md_mopt,#gsc_md_cbyd,#gsc_md_cbym{width:600px;}.gs_el_ta #gsc_md_mopt,.gs_el_ta #gsc_md_cbyd,.gs_el_ta #gsc_md_cbym{width:500px;}.gs_el_ph #gsc_md_mopt,.gs_el_ph #gsc_md_cbyd,.gs_el_ph #gsc_md_cbym{width:100%;}.gsc_mob_art{vertical-align:top;padding:8px 0;}.gs_el_tc .gsc_mob_art>.gs_in_ra{margin-top:-8px;}.gsc_mob_cby{vertical-align:top;text-align:right;padding:8px 12px;position:relative;}.gsc_mob_ttl,.gsc_mob_pub{display:block;}.gsc_mob_pub{color:#666;}.gsc_mob_cbym{text-decoration:line-through}.gsc_mob_cbm{font-size:24px;position:absolute;padding:4px 0 0 4px;line-height:16px;}.gs_fsvg line{stroke:#222222}a:link .gs_fsvg{fill:#1a0dab;}a:link .gs_fsvg line{stroke:#1a0dab;}a:visited .gs_fsvg{fill:#660099;}a:visited .gs_fsvg line{stroke:#660099;}a:active .gs_fsvg{fill:#d14836;}a:active .gs_fsvg line{stroke:#d14836;}a .gs_fsvg{border-bottom:1px solid transparent;}a:hover .gs_fsvg,a:focus .gs_fsvg{border-bottom-color:inherit;}.gs_fsml{font-size:13px}.gs_fscp{font-variant:small-caps}.gsh_clim{display:table-row}.gsh_clil,.gsh_clic{display:table-cell;padding-bottom:8px}.gsh_clil{padding-right:8px;}.gsh_lla{list-style-type:lower-alpha}.gsh_lua{list-style-type:upper-alpha}.gsh_llr{list-style-type:lower-roman}.gsh_lur{list-style-type:upper-roman}.gsh_l>li{margin-left:32px;}.gsh_h3{font-size:inherit;font-weight:normal}.gsh_h3,.gsh_csp{margin:16px 0}.gsh_h3+.gsh_csp{margin-top:-8px}.gsh_ovln{text-decoration:overline}.gsh_small .gsh_l .gsh_csp{margin:8px 0}.gsh_small .gsh_csp:first-child,.gsh_small .gsh_h3:first-child{margin-top:0}.gsh_small .gsh_csp:last-child{margin-bottom:0}.gsh_dspfr{text-align:center}.gsh_dspfr svg{margin:8px 0}.gs_pp_tn,.gs_el_ta .gs_pp_mo_tn,.gs_el_ph .gs_pp_mo_tn{width:32px;height:32px;}.gs_pp_sm,.gs_el_ta .gs_pp_mo_sm,.gs_el_ph .gs_pp_mo_sm{width:56px;height:56px;}.gs_pp_nm,.gs_el_ta .gs_pp_mo_nm,.gs_el_ph .gs_pp_mo_nm{width:128px;height:128px;}.gs_ai_pho{float:left;}.gs_ai_t{margin-left:72px;}.gs_ai_pho_pst+.gs_ai_t{margin-left:48px;}.gs_ai_t.gs_ai_pss{margin-left:64px;}.gs_ai_pho_pst+.gs_ai_t.gs_ai_pss{margin-left:40px;}.gs_ai_name{font-size:17px;font-weight:normal;margin-bottom:4px;}.gs_ai_name a{padding:6px 0 4px 0;}.gs_ai_name.gs_ai_name_nlsb{font-size:15px;}.gs_ai_name.gs_ai_name_nlsb a:link,.gs_ai_name.gs_ai_name_nlsb a:visited{padding:7px 0 5px 0; color:#222;}.gs_ai_name.gs_ai_name_nlsb a:active{color:#d14836;}.gs_ai_int{margin-top:5px;}.gs_ai_eml:empty,.gs_ai_int:empty,.gs_ai_cby:empty{display:none;}.gs_ai_one_int{vertical-align:top;font-size:13px;margin-right:8px;white-space:nowrap;display:inline-block;max-width:200px;text-overflow:ellipsis;overflow:hidden;}.gs_el_tc a.gs_ai_one_int{padding:8px 0 5px 0;}.gs_el_ph .gs_ai_eml,.gs_el_ph .gs_ai_cby{margin-top:8px;}.gs_ai_ilnl .gs_ai_int,.gs_ai_ilnl .gs_ai_cby{margin-top:8px;color:#666;}.gs_ai.gs_ai_chpr{position:relative;}.gs_ai_chpr .gs_ai_t{margin-right:276px;}.gs_el_sm .gs_ai_chpr .gs_ai_t{margin-right:156px;}.gs_el_ph .gs_ai_chpr .gs_ai_t{margin-right:0;}.gs_ai_chpr .gs_ai_cby{position:absolute;top:4px;right:0;text-align:right;}.gs_el_sm .gs_ai_chpr .gs_ai_cby,.gs_el_ta .gs_ai_chpr .gs_ai_cby{width:132px;word-wrap:break-word;}.gs_el_ph .gs_ai_chpr .gs_ai_cby{text-align:left;position:static;width:auto;}#gsc_bdy{position:relative;max-width:1200px;margin:0 auto;}.gs_el_ph #gsc_bdy,.gs_el_ta #gsc_bdy{display:flex;flex-flow:column;}.gsc_lcl{position:relative;margin:0 350px 0 0;order:3;}.gs_el_sm .gsc_lcl{margin-right:334px;}.gs_el_ta .gsc_lcl,.gs_el_ph .gsc_lcl{margin:0;}#gsc_prf_t_wrp{position:relative;order:2;overflow:hidden;}.gs_el_tc #gsc_prf_t_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;right:0;width:12px;height:100%;background-image:linear-gradient(to right,rgba(247,247,247,0),rgba(247,247,247,1) 80%);}#gsc_prf_t{width:100%;background-color:#f5f5f5;display:none;white-space:nowrap;overflow-x:auto;padding:0 4px;}.gs_el_ta #gsc_prf_t,.gs_el_ph #gsc_prf_t{display:block;}#gsc_prf_t:after{content:"\00A0";padding:0 4px;}.gsc_prf_tab,.gsc_prf_tab:link{font-size:13px;text-transform:uppercase;padding:13px 12px;display:inline-block;color:#666;cursor:pointer;}.gsc_prf_tab:hover{color:#000;text-decoration:none}.gsc_prf_tab:active{color:#4d90fe;}.gsc_prf_tab[aria-selected="true"]{border-bottom:2px solid #4d90fe;color:#0461f9;cursor:default;}.gs_el_ta #gsc_art,.gs_el_ph #gsc_art,.gs_el_ta #gsc_rsb_cit,.gs_el_ph #gsc_rsb_cit,.gs_el_ta #gsc_rsb_mnd,.gs_el_ph #gsc_rsb_mnd,.gs_el_ta #gsc_rsb_awd,.gs_el_ph #gsc_rsb_awd,.gs_el_ta #gsc_rsb_co,.gs_el_ph #gsc_rsb_co{display:none;}#gsc_bdy[data-tab="gsc_prf_t-art"] #gsc_art,#gsc_bdy[data-tab="gsc_prf_t-cit"] #gsc_rsb_cit,#gsc_bdy[data-tab="gsc_prf_t-mnd"] #gsc_rsb_mnd,#gsc_bdy[data-tab="gsc_prf_t-awd"] #gsc_rsb_awd,#gsc_bdy[data-tab="gsc_prf_t-ath"] #gsc_rsb_co{display:block;}.gsc_rsb{float:right;width:317px;order:4;border-left:1px solid #eee;margin-top:32px;}.gs_el_sm .gsc_rsb{margin-top:16px;}.gs_el_ph .gsc_rsb,.gs_el_ta .gsc_rsb{float:none;width:auto;border:none;margin:0;}.gsc_rsb_s{margin:0 0 48px 16px;position:relative;}.gs_el_sm .gsc_rsb_s{margin:0 0 32px 16px;}.gs_el_ph .gsc_rsb_s,.gs_el_ta .gsc_rsb_s{margin:0;}.gsc_rsb_s:last-child{margin-bottom:0;}.gsc_rsb_header{padding:8px 8px 12px 8px;border-bottom:1px solid #e5e5e5;font-weight:normal;font-size:15px;}.gs_el_sm .gsc_rsb_header{padding:4px 8px 9px 8px;}.gs_el_ph .gsc_rsb_header,.gs_el_ta .gsc_rsb_header{display:none;}.gsc_rsb_action{position:absolute;top:-3px;right:-2px;}.gs_el_sm .gsc_rsb_action{top:-8px;}.gsc_rsb_tap{display:block;position:absolute;right:2px;top:12px;opacity:.5;z-index:1;}.gs_el_ta .gsc_rsb_tap,.gs_el_ph .gsc_rsb_tap{top:24px;right:10px;}.gsc_rsb_hm{border-bottom:1px solid #e5e5e5;padding:3px 6px;}#gsc_rsb_gpl{display:block;margin-top:3px;padding:6px 16px;line-height:15px;color:#0461f9;border:1px solid #4d90fe;border-radius:2px;text-align:center;text-transform:uppercase;}.gs_el_sm #gsc_rsb_gpl{margin-top:0;}.gs_el_ta #gsc_rsb_gpl,.gs_el_ph #gsc_rsb_gpl{display:none;}#gsc_rsb_st{width:100%;}.gsc_rsb_std{text-align:right;padding-right:8px;}.gs_el_ta .gsc_rsb_std,.gs_el_ph .gsc_rsb_std{padding-right:16px;}.gsc_rsb_sc1{text-align:left;padding:2px 8px;}.gs_el_sm .gsc_rsb_sc1{padding:0 8px;}.gs_el_ta .gsc_rsb_sc1,.gs_el_ph .gsc_rsb_sc1{padding:4px 16px;}.gsc_rsb_sth{font-weight:normal;padding:8px 8px 8px 0;border-bottom:1px solid #e5e5e5;text-align:right;}.gs_el_sm .gsc_rsb_sth{padding:4px 8px 4px 0;}.gs_el_ta .gsc_rsb_sth,.gs_el_ph .gsc_rsb_sth{padding:16px 16px 16px 0;}#gsc_rsb_st tbody:before,#gsc_rsb_st tbody:after{content:'';display:block;height:8px;}.gs_el_sm #gsc_rsb_st tbody:before,.gs_el_sm #gsc_rsb_st tbody:after{height:4px;}.gs_el_ph #gsc_hist_opn,.gs_el_ta #gsc_hist_opn{display:none;}.gsc_rsb_f{max-width:118px;word-wrap:break-word;white-space:normal;}.gs_el_ta .gsc_rsb_f{max-width:none;}.gsc_rsb_f:link,.gsc_rsb_f:visited{color:#222;}.gsc_rsb_m_na{color:#dd4b39;}.gsc_rsb_m_a{color:#006621;float:right;position:relative;}.gsc_rsb_m_bar{width:100%;height:4px;margin:8px 0 8px 0;background:#006621;}.gsc_rsb_m_bar_na{background:#dd4b39;width:100%;height:100%;z-index:1;}.gsc_rsb_m{padding:8px;}.gs_el_ta .gsc_rsb_m,.gs_el_ph .gsc_rsb_m{padding:8px 16px;}.gsc_rsb_m_desc{padding-top:16px;color:#777;}.gsc_rsb_m_s{font-size:24px;position:absolute;line-height:0.3;}#gsc_lwp_mndt_lnk{text-transform:uppercase;margin-left:16px;margin-right:-9px;text-align:right;font-size:13px;padding:12px 9px;border-radius:3px;}#gsc_lwp_mndt_lnk:hover,#gsc_lwp_mndt_lnk:active,#gsc_lwp_mndt_lnk:visited{text-decoration:none;color:#1a0dab;}#gsc_lwp_mndt_lnk:hover{background-color:rgba(0,0,0,.05);}#gsc_lwp_mndt_lnk:active{background-color:rgba(0,0,0,.1);}.gsc_rsb_m_title{padding-bottom:12px;}.gsc_rsb_m_header{display:flex;align-items:flex-end;justify-content:space-between;padding:0 8px;}.gs_el_sm .gsc_rsb_m_header{padding:0 8px;}.gsc_rsb_hmv{text-align:center;padding-top:16px;}.gsc_rsb_a{list-style:none;}.gsc_rsb_a>li{position:relative;}.gs_el_ta .gsc_rsb_a>li,.gs_el_ph .gsc_rsb_a>li{border-bottom:1px solid #e5e5e5;}.gsc_rsb_a>li:first-child{margin-top:8px;}.gsc_rsb_a_pht{float:left;width:32px;height:32px;}.gsc_rsb_a_desc{margin:0 33px 0 48px;min-height:32px;display:block;}.gs_el_ph .gsc_rsb_a_desc,.gs_el_ta .gsc_rsb_a_desc{margin:0 33px 0 64px;min-height:56px;}.gsc_rsb_a_desc a{color:#222;}.gsc_rsb_a_ext{display:block;color:#777;font-size:13px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gsc_rsb_a_ext,.gs_el_ta .gsc_rsb_a_ext{white-space:normal;}.gsc_rsb_a_ext2{display:none;}.gs_el_ph .gsc_rsb_a_ext2,.gs_el_ta .gsc_rsb_a_ext2{display:block;}.gsc_rsb_aa{display:block;padding:8px;line-height:normal;cursor:pointer;}.gs_el_ph .gsc_rsb_aa,.gs_el_ta .gsc_rsb_aa{font-size:17px;padding:12px 16px;}.gsc_rsb_aa:hover,.gsc_rsb_aa:active{text-decoration:none;background:#f1f1f1;}.gsc_rsb_aa a:hover{text-decoration:none;}#gsc_prf_w{order:1;padding:32px 0;overflow:hidden;}.gs_el_sm #gsc_prf_w{padding:16px 0;}#gsc_prf_pu{float:left;width:128px;height:128px;text-align:center;}.gs_el_ph #gsc_prf_pu{float:none;width:100%;margin:0 0 8px 0;}#gsc_prf_pua{line-height:0;width:128px;height:128px;}.gs_el_ph #gsc_prf_pua{margin:0 auto;}#gsc_prf_pufi{width:0;height:0;overflow:hidden;}.gsc_prf_pufo #gsc_prf_pufi{width:auto;height:auto;overflow:visible;position:relative;z-index:10;}.gsc_prf_pufo #gsc_prf_pufi2{display:inline-block;background:#fcfcfc;padding:8px 8px 8px 0;}.gsc_prf_puic{position:absolute;bottom:0;width:100%;padding:8px 0;background-color:#000;opacity:.6;}.gsc_prf_pel{cursor:pointer;}#gsc_prf_i{margin:0 16px 0 160px;}.gs_el_sm #gsc_prf_i{margin:0 16px 0 144px;}.gs_el_ph #gsc_prf_i{margin:0 16px;text-align:center;}#gsc_prf_btne{vertical-align:top;margin:-9px 4px;}.gs_el_ph #gsc_prf_btne{position:absolute;top:60px;right:8px;margin:0;}#gsc_prf_btnf{float:right;margin:3px 0 16px 16px;}.gs_el_sm #gsc_prf_btnf{margin-top:0;}.gs_el_ph #gsc_prf_btnf{float:none;margin:0;position:absolute;top:8px;right:8px;border-radius:50%;}#gsc_prf_btnf .gs_lbl{padding:0 4px;}#gsc_prf_in{font-size:24px;line-height:24px;padding:3px 0 12px 0;word-wrap:break-word;}.gs_el_sm #gsc_prf_in{font-size:22px;padding:3px 0 8px 0;}.gs_el_ph #gsc_prf_in{font-size:20px;padding:0 0 2px 0;}.gsc_prf_il{font-size:15px;line-height:18px;padding:1px 0;}.gs_el_ph .gsc_prf_il{font-size:13px;line-height:16px;}.gsc_prf_ila:link,.gsc_prf_ila:visited{text-decoration:underline;color:#222;}#gsc_prf_int{margin-top:5px;}#gsc_prf_int:empty{display:none;}.gsc_prf_inta{margin-right:16px;white-space:nowrap;max-width:200px;text-overflow:ellipsis;overflow:hidden;vertical-align:top;}.gsc_prf_inta:last-child{margin:0}.gs_el_tc .gsc_prf_ila,.gs_el_tc .gsc_prf_inta{padding:8px 0 5px 0;}.gsc_md_pro_tt,.gsc_md_pro_ch #gsc_md_pro_lgtm,#gsc_md_pro_save{display:none;}.gsc_md_pro_ed #gsc_md_pro_ted,.gsc_md_pro_aa #gsc_md_pro_taa,.gsc_md_pro_ra #gsc_md_pro_tra,.gsc_md_pro_an #gsc_md_pro_tan,.gsc_md_pro_ai #gsc_md_pro_tai,.gsc_md_pro_ch #gsc_md_pro_save{display:inline-block;}.gsc_md_pro_el{color:#777;}.gsc_md_pro_ev{padding:4px 0 16px 0;}#gsc_dd_add-d,#gsc_dd_exp-d,#gsc_dd_sort-d,#gsc_dd_mor-d{top:42px;}#gsc_dd_add-d,#gsc_dd_mor-d,#gsc_dd_sort-d{white-space:normal;word-wrap:break-word;width:208px;width:-webkit-max-content;width:max-content;min-width:100px;max-width:208px;}.gs_el_ph #gsc_dd_add-d{left:-9px;}.gs_el_ph #gsc_dd_exp-d{left:auto;right:12px;}.gs_el_ph #gsc_dd_mor-d{left:-58px;}.gs_el_ph #gsc_dd_sort-d{left:10px;}.gs_el_ph #gsc_dd_sort-r{margin-left:-10px;}.gsc_dd_sec,#gsc_dd_exp-d{padding:8px 0;}.gs_el_tc .gsc_dd_sec,.gs_el_tc #gsc_dd_exp-d{padding:4px 0 8px 0;}.gsc_dd_sep{border-top:1px solid #ebebeb;}#gsc_dd_mor-s .gsc_dd_mor-sel,#gsc_dd_sort-s .gsc_dd_sort-sel{color:#dd4b39;}#gsc_dd_mor-p{padding:14px 44px 14px 16px;color:#777;}.gs_el_tc #gsc_dd_mor-p{padding:18px 44px 18px 16px;}.gsc_art_sel #gsc_dd_add-r,.gsc_art_sel #gsc_dd_mor-r,#gsc_btn_mer,#gsc_btn_del,#gsc_dd_exp-r{display:none;}#gsc_dd_mor-r,.gsc_art_sel #gsc_btn_mer,.gsc_art_sel #gsc_btn_del,.gsc_art_sel #gsc_dd_exp-r{display:inline-block;}html:not(.gs_el_ph) #gsc_dd_sort-r{display:none;}#gsc_lwp{margin:24px 0;text-align:center;}.gs_el_sm #gsc_lwp{margin:16px 0;}#gsc_bpf{display:inline-block;verticle-align:middle;}#gsc_a_nn{display:inline-block;vertical-align:middle;padding-right:16px;font-size:13px;}.gs_el_ph #gsc_a_nn{display:none;}@media print{#gs_top #gs_md_s,#gs_top #gs_md_w,#gs_top #gs_hdr,#gs_top #gs_hdr_drs,#gs_top #gs_hdr_drw,#gs_top #gs_ftr,#gs_top #gsc_nag,#gs_top #gsc_prf_nbar_btns,#gs_top #gsc_prf_btne,#gs_top #gsc_prf_btnf,#gs_top #gsc_prf_ivh,#gs_top #gsc_prf_puf,#gs_top #gsc_rsb_co,#gs_top #gsc_bdy #gsc_rsb_co,#gs_top .gsc_g_hist_wrp,#gs_top #gsc_prf_t_wrp,#gs_top .gsc_rsb_header,#gs_top .gsc_a_tb,#gs_top .gsc_a_x,#gs_top #gsc_lwp,#gs_top .gsc_prf_puic,#gs_top #gsc_dd_add-r,#gs_top #gsc_dd_mor-r,#gs_top #gsc_dd_sort-r{display:none;}#gs_top,#gs_top #gsc_bdy,#gs_top #gsc_prf_w,#gs_top #gsc_prf,#gs_top #gsc_prf_pu,#gs_top #gsc_prf_pua,#gs_top #gsc_prf_i,#gs_top .gsc_rsb_s,#gs_top .gsc_lcl,#gs_top .gsc_rsb,#gs_top #gsc_a_tw,#gs_top #gsc_a_t,#gs_top .gsc_prf_il,#gs_top .gsc_prf_ila,#gs_top .gsc_prf_inta,#gs_top #gsc_rsb_st{background:none;border:none;padding:0;margin:0;height:auto;width:auto;min-width:0;max-width:none;float:none;display:block;position:static;color:black;font-weight:normal;font-size:12pt;text-decoration:none;}#gs_top .gsc_a_ac,#gs_top .gsc_a_a,#gs_top #gsc_a_ca,#gs_top .gsc_a_at,#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std,#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh,#gs_top .gsc_a_m,#gs_top .gsc_a_am{color:black;font-weight:normal;font-size:12pt;padding:0;margin:0;background:none;border:none;}#gs_top #gsc_a_trh,#gs_top #gsc_a_trh th{height:0;}#gs_top #gsc_a_ta,#gs_top #gsc_a_ca,#gs_top #gsc_a_ha,#gs_top .gsc_a_a{font-size:11pt;}#gs_top .gsc_a_ac{font-size:10pt}#gs_top #gsc_prf_pu{width:80pt;height:auto;float:left;margin:0 7pt 7pt 0;}#gs_top #gsc_prf_pua{left:auto;transform:none;border-radius:0;}#gs_top #gsc_prf_pua>img{position:static;}#gs_top #gsc_prf_i{margin:0 7pt 7pt 87pt;text-align:left;}#gs_top #gsc_prf_in{font-size:18pt;line-height:18pt;padding:0 0 4pt 0;}#gs_top .gsc_prf_il{padding:2pt 0;}#gs_top #gsc_prf_w{float:left;width:64%;}#gs_top .gsc_rsb{float:right;width:35%;}#gs_top #gsc_art{clear:both;}#gs_top #gsc_rsb_st{display:table;width:100%;max-width:none;margin-top:3pt;}#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std{font-size:10pt;}#gs_top th.gsc_rsb_sc1,#gs_top .gsc_rsb_sth{border-bottom:1pt solid #ccc;}#gs_top .gsc_rsb_f{max-width:60pt;}#gs_top .gsc_rsb_sth{padding-left:14pt;}#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh{padding:6pt 0;}#gs_top #gsc_a_trh{border-bottom:1pt solid #ccc;}#gs_top #gsc_a_ca{display:block;width:auto;}#gs_top #gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:12pt;}#gs_top .gsc_a_h{display:inline;font-size:10pt;}#gs_top .gsc_a_at{color:#008;}#gs_top .gsc_a_m,#gs_top .gsc_a_am{display:inline;position:absolute;}#gs_top .gsc_a_am{padding: 11pt 0 0 8pt;}#gs_top .gsc_a_t .gs_gray{color:black;font-size:10pt;}}.gsc_lwpds_frm{position:relative;height:29px;}.gsc_lwpds_tsiw{position:absolute;top:0;left:0;right:38px;}.gsc_lwpds_tsiw input{border-radius:3px 0 0 3px;}.gsc_lwpds_tsbw{position:absolute;top:0;right:0;}.gsc_lwpds_tsbw button{border-radius:0 3px 3px 0;}.gsc_pgn{text-align:right;font-weight:bold;line-height:29px;}.gsc_pgn_ppn{margin:0 8px;}.gsc_ccb_ck{padding:11px 10px 9px 10px;}.gsc_ccb_svg{stroke:#666;stroke-width:2px;fill:#fff;width:21px;height:21px;vertical-align:top;}.gsc_ccb_lim .gsc_ccb_svg,.gsc_ccb_dis .gsc_ccb_svg{fill:#e2e2e2;stroke:#fff;}.gsc_ccb_lim .gsc_ccb_svg>circle,.gsc_ccb_dis .gsc_ccb_svg>circle{stroke:#e2e2e2;}.gsc_ccb_on .gsc_ccb_svg{fill:#4d90fe;stroke:#fff;}.gsc_ccb_on .gsc_ccb_svg>circle{stroke:#4d90fe;}.gsc_ccb_del:active .gsc_ccb_svg>circle,.gsc_ccb_add:active .gsc_ccb_svg>circle{fill:#2f6de1;}#gsc_md_cod{width:800px;max-width:94%;}.gs_el_ph #gsc_md_cod{width:100%;max-width:100%;}#gsc_md_cod .gs_md_prg{min-height:400px;}.gsc_codb_instr{font-size:16px;margin:1em 0;}#gsc_cods_res{position:relative;margin-bottom:24px;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_cods_res{margin-bottom:16px;}.gsc_cods_hide,.gsc_cod_sugg #gsc_cod_tedit,.gsc_cod_sugg #gsc_cods_frm,.gsc_cod_sugg #gsc_cods_pp,.gsc_cod_lc #gsc_cod_tadd,.gsc_cod_changed #gsc_cod_tedit,.gsc_cod_changed #gsc_cod_tadd,.gsc_cod_lim #gsc_cod_tedit,.gsc_cod_lim #gsc_cod_tadd{display:none;}#gsc_cods_frm{margin:0 0 24px 0;}.gs_el_ph #gsc_cods_frm{margin:0 0 16px 0;}.gsc_ucoar{padding:24px 0;border-bottom:1px solid #eee;}.gs_el_ph .gsc_ucoar{padding:16px 0px;}.gsc_ucoar:first-child{padding-top:0;}.gsc_ucoar:last-child{border-bottom:none;}.gsc_ucoar_cb{float:right;margin-top:-8px;}#gsc_cod_trev{display:none;color:#666;pointer-events:none;}.gsc_cod_changed #gsc_cod_trev,.gsc_cod_lim #gsc_cod_trev{display:inline-block;}.gsc_cod_changed #gsc_cod_trev{color:#1a0dab;pointer-events:auto;}.gsc_fol_cr{margin:0 0 8px 0;}.gs_el_tc .gsc_fol_cr{margin:0;}.gs_el_tc .gsc_fol_cr:first-child{margin-top:-8px;}#gsc_fol_ml{display:block;color:#777;padding:12px 0 4px 0;}</style><script>!function(GSP){/*

 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
var aa="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},ba;if("function"==typeof Object.setPrototypeOf)ba=Object.setPrototypeOf;else{var da;a:{var ea={a:!0},fa={};try{fa.__proto__=ea;da=fa.a;break a}catch(a){}da=!1}ba=da?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null}
var ha=ba,ia=function(a,b){a.prototype=aa(b.prototype);a.prototype.constructor=a;if(ha)ha(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.na=b.prototype},ja=function(){},ka=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var d=c.slice();d.push.apply(d,arguments);return a.apply(this,d)}};var g=function(){this.o=this.o;this.F=this.F};g.prototype.o=!1;g.prototype.isDisposed=function(){return this.o};g.prototype.T=function(){this.o||(this.o=!0,this.H())};g.prototype.H=function(){if(this.F)for(;this.F.length;)this.F.shift()()};function la(a){var b=[],c=0,d;for(d in a)b[c++]=d;return b};function l(a,b){a.classList.add(b)}function n(a,b){a.classList.remove(b)}function p(a,b){return a.classList?a.classList.contains(b):!1}function q(a,b,c){c=void 0!==c?c:!p(a,b);(c?l:n)(a,b)};function r(a){return 0<=(navigator.userAgent||"").indexOf(a)}var ma=r("iPhone")||r("iPad")||r("iPod"),na=r("iPhone")||r("Android")&&r("Mobile");function oa(){if(void 0===b){var a=window.screen;a={width:window.innerWidth,height:window.innerHeight,ma:a.width,la:a.height}}else a=b;var b=a;a=b.width;var c=b.height,d=b.ma;b=b.la;var e=4;if(600>a||48E4>d*b||na)e=1;else if(982>a)e=2;else if(1136>a||590>c)e=3;return e}var pa,qa=/[?&]tc=([01])/.exec(location.search||"");
pa=qa?0<+qa[1]:r("Android")?!0:window.matchMedia&&window.matchMedia("(pointer)").matches?window.matchMedia("(pointer:coarse)").matches:!r("Firefox")||r("Mobile")||r("Tablet")?ma||"ontouchstart"in window||0<(navigator.msMaxTouchPoints||0):!1;function ra(){if(void 0==sa){sa=!1;try{var a=Object.defineProperty({},"passive",{get:function(){sa=!0}});window.addEventListener("testPassive",ja,a);window.removeEventListener("testPassive",ja,a)}catch(b){}}return sa}var sa;var ta=function(a){this.Y=a},ua=new ta("INPUT"),va=new ta("TABLE");function t(a){return document.getElementById(a)}function x(a){return a.id||(a.id="gs_id"+wa++)}function xa(a){a=(void 0===a?null:a)||document.body;return"rtl"==(a?window.getComputedStyle(a,null):null).direction}
function ya(a){var b=[];a=a.elements;for(var c=a.length,d=0;d<c;d++){var e=a[d],f=encodeURIComponent(e.name||""),h=e.type;!f||e.disabled||!("checkbox"!=h&&"radio"!=h||e.checked)||b.push(f+"="+encodeURIComponent(e.value||""))}return b.join("&")}function za(a,b){var c=a.elements[b];c||(c=document.createElement(ua.Y),c.type="hidden",c.name=b,a.appendChild(c));return c}function Aa(a){t("gsc_md_cbyd_c").href=a&&a.match(Ba)?a:"javascript:void(0)"}function Ca(a){a.match(Ba)&&(window.location.href=a)}
var wa=100,Da=/\S+/g,Ba=/^(?:https?:|[^:/?#]*(?:[/?#]|$))/i,Ea=/^(?:#|\/[a-z0-9_-]*(?:[?].*)?$)/i;function y(a){return a.hasOwnProperty("gs_uid")?a.gs_uid:a.gs_uid=++Fa}var Fa=0;var z=function(){this.i=[];this.A={};this.O=this.v=0};z.prototype.add=function(a){var b=y(a);this.A[b]||(this.i.push(a),this.A[b]=this.i.length,++this.v)};z.prototype.remove=function(a){a=y(a);var b=this.A[a];b&&(this.i[b-1]=null,delete this.A[a],2*--this.v<this.i.length&&!this.O&&Ga(this))};z.prototype.notify=function(a){var b=this.i;try{++this.O;for(var c=0;c<b.length;c++){var d=b[c];d&&d.apply(null,arguments)}}finally{!--this.O&&2*this.v<b.length&&Ga(this)}};
var Ga=function(a){var b=a.i,c=b.length;a=a.A;for(var d=0,e=0;e<c;e++){var f=b[e];f&&(b[d]=f,a[y(f)]=++d)}b.length=d};function B(a,b,c,d,e){Ha(a,b,c,void 0===d?!1:d,void 0===e?!1:e,Ia)}function C(a,b,c,d){Ha(a,b,c,void 0===d?!1:d,!1,Ja)}function Ka(a,b,c,d){function e(h){C(f,a,e,c);b(h)}var f=document;c=void 0===c?!1:c;B(f,a,e,c,void 0===d?!1:d)}function D(a){La?La.add(a):a()}var Ma=window.requestAnimationFrame?function(a){window.requestAnimationFrame(a)}:function(a){setTimeout(a,33)};function Na(a){a.stopPropagation();a.preventDefault()}
function Oa(a){return(a.ctrlKey?1:0)|(a.altKey?2:0)|(a.metaKey?4:0)|(a.shiftKey?8:0)}function Ia(a,b,c,d,e){var f=a.addEventListener;e=e&&ra();f.call(a,b,c,e?{passive:e,capture:d}:d)}function Ja(a,b,c,d){a.removeEventListener(b,c,d)}function Ha(a,b,c,d,e,f){if("string"===typeof b)f(a,b,c,d,e);else for(var h=b.length,k=0;k<h;k++)f(a,b[k],c,d,e)}function Pa(){La.notify();La=null}function Qa(){"complete"==document.readyState&&(C(document,"readystatechange",Qa),Pa())}
var La,Ra=!!document.attachEvent,Sa=document.readyState;if(Ra?"complete"!=Sa:"loading"==Sa)La=new z,Ra?B(document,"readystatechange",Qa):Ka("DOMContentLoaded",Pa);function Ta(){Ka(["mousedown","touchstart"],function(){q(document.documentElement,"gs_pfcs",!0);B(document,"keydown",Ua,!0)},!0,!0)}function Ua(a){9==a.keyCode&&(q(document.documentElement,"gs_pfcs",!1),C(document,"keydown",Ua,!0),Ta())}Ta();function Va(a,b,c,d,e){var f=t(a);Wa(f,function(){l(f,"gs_vis");b&&b()},function(){n(f,"gs_vis");c&&c()},d,e)}function Wa(a,b,c,d,e){var f=x(a);if(!E[f]){var h=document.activeElement;Xa(Ya(a),!0);b&&b();G.push(function(k){delete E[f];try{k||(e||h).focus()}catch(m){}c&&c()});E[f]=G.length;h&&a.contains(h)||setTimeout(function(){var k=d,m=k&&"text"==k.type;if(!k||m&&pa)k=a;try{k.focus(),m&&(k.value=k.value)}catch(w){}},0)}}function H(a){Xa((E[a]||1E6)-1,!1)}
function Za(a){a=void 0===a?!1:a;G.pop()(a)}function Xa(a,b){for(b=void 0===b?!1:b;G.length>a;)Za(b||G.length>a+1)}function Ya(a){for(var b=0;a&&!(b=E[a.id]||0);)a=a.parentNode;return b}var G=[],E={};B(document,"click",function(a){var b=G.length;b&&!Oa(a)&&b>Ya(a.target)&&Za(!0)});B(document,"keydown",function(a){27==a.keyCode&&!Oa(a)&&G.length&&Za()});
B(document,"focus",function(a){var b=G.length;if(b)for(var c=Ya(a.target);c<b;){var d="",e;for(e in E)if(E[e]==b){d=e;break}a:{d=(t(d).getAttribute("data-wfc")||"").match(Da)||[];for(var f=0;f<d.length;f++){var h=t(d[f]);if(h&&h.offsetWidth){d=h;break a}}d=void 0}if(d){Na(a);d.focus();break}else Za(!0),--b}},!0);var $a={},ab={},bb;try{bb=window.sessionStorage}catch(a){};function J(a){return"object"==typeof a?a:null}function cb(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.pushState(b,"",a):window.location.assign(a)}function ib(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.replaceState(b,"",a):window.location.replace(a)}function fb(a){var b=[],c;for(c in a)b.push(encodeURIComponent(c)+"="+encodeURIComponent(a[c]));return(a=b.sort().join("&"))?"#"+a:""}
function jb(a){var b={};a=a.split("&");for(var c=0;c<a.length;c++){var d=a[c],e=d.indexOf("=");if(e+1){var f=d.substr(0,e);d=d.substr(e+1)}else f=d,d="";f&&(b[decodeURIComponent(f)]=decodeURIComponent(d))}return b}function kb(a){var b=a.indexOf("#")+1;return jb(b?a.substr(b):"")}function lb(a){var b=a.indexOf("?")+1;a=b?a.substr(b):"";b=a.indexOf("#");return jb(b+1?a.substr(0,b):a)}function mb(a,b){for(var c in b){var d=b[c];void 0!==d?a[c]=d:delete a[c]}}
function eb(a){var b=kb(window.location.hash);mb(b,a);return b}function db(a){var b=gb||J(window.history.state),c={},d;for(d in b)c[d]=b[d];mb(c,a);return c}function nb(){setTimeout(function(){if(!ob){var a=window.history.state;ob=!0;gb=J(a);rb.notify()}sb=!1},0)}var rb=new z,gb,ob=!1,sb=!0,hb="pushState"in window.history,tb;
if("undefined"==typeof GSP)tb=!1;else{var ub=.001*Date.now(),vb=GSP.eventId,wb=!1,K,xb=bb;if(!("nh"in $a)){var yb=xb&&xb.getItem("nh"),zb;if(yb)try{zb=JSON.parse(yb)}catch(a){}ab.nh=zb}K=ab.nh;K instanceof Array||(K=[]);for(var Ab=K.length,Bb=0,Cb=0;Cb<Ab;Cb++){var Db=K[Cb];if(Db instanceof Array&&2==Db.length){var Eb=Db[1]==vb;wb=wb||Eb;10>=Ab-Cb&&+Db[0]>ub-86400&&!Eb&&(K[Bb++]=Db)}}K.length=Bb;K.push([ub,vb]);var Fb=K,Gb=bb;ab.nh=Fb;try{Gb&&Gb.setItem("nh",JSON.stringify(Fb))}catch(a){}tb=wb}
var Hb=tb;"onpageshow"in window?B(window,"pageshow",nb):D(nb);B(window,hb?"popstate":"hashchange",function(a){"loading"!=document.readyState&&(a=a.state,ob=!0,gb=J(a),rb.notify())});function Ib(){Jb&&(C(t("gs_alrt_l"),"click",Jb),Jb=void 0)}function Kb(){var a=Lb();l(a,"gs_anm");l(a,"gs_vis");B(document,"click",Mb);clearTimeout(Nb);Nb=setTimeout(Mb,4E3);++Ob;setTimeout(Pb,0)}function Mb(){Ob||(C(document,"click",Mb),clearTimeout(Nb),Nb=void 0,Ib(),n(Lb(),"gs_vis"))}function Lb(){return t("gs_alrt")}function Pb(){Ob=0}var Nb,Ob=0,Jb;D(function(){var a=t("gs_alrt_m");a&&(a.innerHTML&&!Hb&&Kb(),B(window,"pagehide",function(){Ob=0;Mb();n(Lb(),"gs_anm")}))});function Qb(a,b,c){var d=new XMLHttpRequest;d.onreadystatechange=function(){if(4==d.readyState){var e=d.status,f=d.responseText,h=d.responseURL,k=window.location,m=k.protocol;k="//"+k.host+"/";h&&h.indexOf(m+k)&&h.indexOf("https:"+k)&&(e=0,f="");c(e,f)}};d.open(b?"POST":"GET",a,!0);d.setRequestHeader("X-Requested-With","XHR");b&&d.setRequestHeader("Content-Type","application/x-www-form-urlencoded");b?d.send(b):d.send();return d}function Rb(a){a&&(a.onreadystatechange=ja,a.abort())};var Sb=function(a,b,c){this.type=a;this.currentTarget=this.target=b;this.g=void 0===c?null:c;this.P=!1};Sb.prototype.stopPropagation=function(){this.g&&this.g.stopPropagation();this.P=!0};var L=function(a){a.g&&Na(a.g);a.P=!0};var M=function(a,b){this.R=a;this.ka=b},Tb=function(a,b,c){this.R=a;this.types=b;this.listener=c};function Ub(a,b){var c=b.length;if(c){var d=y(a),e=Vb[d];if(!e){e=Vb[d]=[];d=Wb(b[0].R);for(var f in d){var h=Xb[f];h||(h=Xb[f]=Object.create(null));for(var k in d[f]){var m=h[k];m||(m=h[k]=[]);m.push(a)}}Yb(a,e,b[0],Zb);for(f=1;f<c;f++)Yb(a,e,b[f],$b)}}}function O(a,b,c){ac(new Sb(a,b,void 0===c?null:c))}
function P(a,b,c){var d=bc;"string"===typeof b&&(cc[0]=b,b=cc);var e=b.length;a=Wb(a);for(var f in a)for(var h in a[f])for(var k=0;k<e;k++)d(f,h,b[k],c)}function Wb(a){"string"===typeof a&&(dc[0]=a,a=dc);for(var b=a.length,c=Object.create(null),d=0;d<b;d++){var e=a[d],f=e.charAt(0),h=e.substr(1);if("#"!=f&&"."!=f||!h)throw Error("bad selector: "+e);(e=c[f])||(e=c[f]=Object.create(null));e[h]=!0}return c}
function bc(a,b,c,d){var e=ec[c];e||("touchstart"!=c&&"mouseover"!=c&&"mouseout"!=c&&B(document,c,fc,"focus"==c||"blur"==c),e=ec[c]=Object.create(null));(c=e[a])||(c=e[a]=Object.create(null));(a=c[b])||(a=c[b]=new z);a.add(d)}function fc(a){var b=a.target;b&&3==b.nodeType&&(b=b.parentNode);ac(new Sb(a.type,b,a))}
function ac(a){for(var b=a.target;b&&b!=document&&!b.disabled&&!p(b,"gs_dis");){a.currentTarget=b;var c=b.id;if(c&&!gc("#",c,a))break;c=b.classList||[];for(var d=c.length,e=0;e<d;e++)if(!gc(".",c[e],a))return;b=b.parentNode}}function gc(a,b,c){var d=ec[c.type];(b=(a=d&&d[a])&&a[b])&&b.notify(c);return!c.P}function Yb(a,b,c,d){var e=c.R;c=c.ka;for(var f in c){var h=ka(d,a,c[f]);P(e,f,h);b.push(new Tb(e,f,h))}}function Zb(a,b,c){var d=c.currentTarget;a=hc(a,d)||a;a=ic(a,d);b.call(a,c)}
function $b(a,b,c){a:{for(var d=c.currentTarget;d&&d!=document;){var e=hc(a,d);if(e){a=ic(e,d);break a}d=d.parentNode}a=void 0}a&&b.call(a,c)}function ic(a,b){var c=jc(b),d=kc[c];d||(d=kc[c]=[]);for(var e=d.length,f=0;f<e;f++){var h=d[f];if(h instanceof a)return h}b=new a(b);d.push(b);a=y(a);(d=lc[a])||(d=lc[a]=[]);d.push(c);return b}function hc(a,b){var c,d=b.id;d&&(c=mc(a,c,"#",d));b=b.classList||[];d=b.length;for(var e=0;e<d;e++)c=mc(a,c,".",b[e]);return c}
function mc(a,b,c,d){c=(d=(c=Xb[c])&&c[d])?d.length:0;for(var e=0;e<c;e++){var f=d[e];!(f===a||f.prototype instanceof a)||b&&!(f===b||f.prototype instanceof b)||(b=f)}return b}function jc(a){var b=a.getAttribute("data-duid");b||a.setAttribute("data-duid",b=""+nc++);return b}var ec=Object.create(null),dc=[""],cc=[""],Xb=Object.create(null),Vb=Object.create(null),lc=Object.create(null),kc=Object.create(null),nc=100;window.gs_evt_dsp=fc;function oc(){var a=".gs_md_li";if("string"===typeof a){var b=a.charAt(0),c=a.slice(1);if("#"==b)a=function(d){return d.id==c&&0<d.offsetWidth};else if("."==b)a=function(d){return p(d,c)&&0<d.offsetWidth};else throw Error("bad selector: "+a);}return a}function pc(a,b){return a&&((void 0===b?0:b)?a.lastElementChild:a.firstElementChild)}function qc(a,b){return a&&((void 0===b?0:b)?a.previousElementSibling:a.nextElementSibling)}function rc(a,b,c){c=void 0===c?!1:c;return sc(a,b,oc(),c,!1)}
function sc(a,b,c,d,e){for(var f;b&&a;){if(c(b)){if(e)return b}else for(f=pc(b,d);f;f=qc(f,d))if(e=sc(f,f,c,d,!0))return e;for(e=!0;;){if(b==a)return null;f=b.parentNode;if(b=qc(b,d))break;b=f}}return null};function tc(a){return!!p(a,"gs_sel")+2*!!p(a,"gs_par")}function uc(a){return+a.getAttribute("data-s")}function vc(a,b,c){c=void 0===c?!1:c;q(a,"gs_sel",1==b);q(a,"gs_par",2==b);a.setAttribute("aria-checked",wc[b]);c||a.setAttribute("data-s",""+b)}var wc=["false","true","mixed"];var Q=function(){this.j=Object.create(null);this.l=0};Q.prototype.clear=function(){this.j=Object.create(null);this.l=0};Q.prototype.has=function(a){return a in this.j};Q.prototype.get=function(a){return this.j[a]};Q.prototype.set=function(a,b){this.has(a)||this.l++;this.j[a]=b};Q.prototype.delete=function(a){this.has(a)&&(delete this.j[a],this.l--)};var xc=function(a){var b=window,c=this;this.i=new z;this.V=0;this.S=[b,a,function(){c.V++||Ma(d)},!1];var d=function(){c.V=0;c.i.notify()}};xc.prototype.addListener=function(a){this.i.v||B.apply(null,this.S);this.i.add(a)};xc.prototype.removeListener=function(a){this.i.remove(a);this.i.v||C.apply(null,this.S)};var yc=new xc("scroll"),zc=new xc("resize");var Ac=new z;function Bc(){var a=document.documentElement,b=oa();b={gs_el_ph:1==b,gs_el_ta:2==b,gs_el_sm:4!=b,gs_el_tc:pa||1==b};var c;for(c in b){var d=b[c];if(p(a,c)!=d){var e=!0;q(a,c,d)}}e&&Ac.notify()}q(document.documentElement,"gs_el_ios",ma);Bc();zc.addListener(Bc);B(window,["pageshow","load"],Bc);function R(a,b,c,d){function e(){var u=ca&&p(h,"gs_el_ph");q(F,"gs_vis",!u);h.style.overflowY=Yd&&!u?"scroll":""}function f(){var u=h.clientHeight,I=+A.getAttribute("data-h");I||(w.style.maxHeight="none",I=m.offsetHeight);I=Math.max((u-I)/2,10);u=Math.max(u-48-2*I,10);var Jc=ca&&p(h,"gs_el_ph");m.style.top=Jc?"auto":I+"px";w.style.maxHeight=Jc?"none":u+"px";Cc(w)}b=void 0===b?"":b;c=void 0===c?"":c;d=void 0===d?"":d;var h=document.documentElement,k=t("gs_top"),m=t(a),w=t(a+"-bdy"),v=t(m.getAttribute("data-cid")||
m.id+"-bdy")||m,F=t(m.getAttribute("data-shd")||"gs_md_s"),A=Dc(m),ca=!!A&&p(A,"gs_md_wmw"),N=window.pageYOffset,Yd=k.scrollHeight>h.clientHeight,pb=!!E[a],qb=pb?"":S,Lc=b&&"#"!=b[0]&&!d,$d=a==S&&b==Ec&&c==T;Fc=b;Lc?(pb?q(v,"gs_md_ldg",!0):Gc(m,v,'<div class="gs_md_prg">'+t("gs_md_ldg").innerHTML+"</div>"),O("gs-md-ldin",v)):(d&&Gc(m,v,d),O("gs-md-lded",v));qb&&(++Hc,H(qb),--Hc);S=a;Ec=b;T=c;Ic=d;$d||Hc||(Kc+=1,(qb?ib:cb)(Mc(),Nc()));pb||Wa(m,function(){A&&l(A,"gs_vis");l(m,"gs_vis");q(m,"gs_abt",
sb);Oc(a);Ac.add(e);e();A&&w&&(f(),zc.addListener(f));l(k,"gs_nscl");k.style.top=-N+"px"},function(){Ac.remove(e);zc.removeListener(f);A&&n(A,"gs_vis");n(m,"gs_vis");n(m,"gs_abt");n(F,"gs_vis");h.style.overflowY="";n(k,"gs_nscl");k.style.top="auto";Rb(U);U=null;window.scrollTo(0,N);S=Ec=T=Ic="";var u=Kc;Kc=0;Hc||(0<u?window.history.go(-u):ib(Mc(),Nc()))},Pc(m),Qc(m));Lc&&(Rb(U),U=null,U=Qb(b,c,function(u,I){U=null;u=200==u;Gc(m,v,u?I:Rc());u&&a==S&&b==Ec&&c==T&&(Ic=I,ib(Mc(),Nc()));O("gs-md-lded",
v)}))}function Dc(a){a=a.parentNode;return p(a,"gs_md_wnw")?a:null}function Pc(a){return(a=a.getAttribute("data-ifc"))?t(a):null}function Qc(a){return(a=a.getAttribute("data-cfc"))?t(a):null}
function Gc(a,b,c){q(b,"gs_md_ldg",!1);for(var d=b.querySelectorAll("[data-duid]"),e=d.length,f={},h=0;h<e;h++){for(var k=jc(d[h]),m=kc[k],w=m?m.length:0,v=0;v<w;v++){var F=m[v],A=y(F.constructor),ca=f[A];ca||(ca=f[A]={});ca[k]=!0;F&&"function"==typeof F.T&&F.T()}delete kc[k]}for(var N in f){N=+N;d=f[N];h=(e=lc[N])?e.length:0;for(m=k=0;m<h;m++)w=e[m],w in d||(e[k++]=w);k?e.length=k:delete lc[N]}b.innerHTML=c;Oc(a.id);Rb(U);U=null}
function Oc(a){if(a=document.querySelector("#"+a+">.gs_md_bdy"))a.scrollTop=a.scrollLeft=0,Cc(a)}function Cc(a){var b=a.style,c="padding"+(xa(a)?"Left":"Right");b[c]="";var d=a.offsetWidth-a.clientWidth;2<d&&(a=parseInt(window.getComputedStyle(a,null)[c],10)||0,b[c]=Math.max(a-d,0)+"px")}function Rc(){return'<div class="gs_md_prg"><div class="gs_alrt">'+t("gs_md_err").innerHTML+"</div></div>"}function Mc(){return{d:S||void 0,u:Ec||void 0,p:T?"1":void 0}}function Nc(){return{n:Kc,p:T,h:Ic}}
var U=null,Fc="",S="",Ec="",T="",Ic="",Kc=0,Hc=0;rb.add(function(){var a=kb(window.location.hash),b=a.d||"",c=b?t(b):null;++Hc;if(c){c=a.u||"";a=0<+a.p;var d=gb||J(window.history.state)||{},e=+d.n||0,f=""+(d.p||"");d=""+(d.h||"");c.match(Ea)||(c="");a!=!!f?R(b,"","",Rc()):b==S&&c==Ec&&f==T&&d==Ic||R(b,c,f,d);Kc=e}else S&&H(S);--Hc});var Sc=function(a){g.call(this);this.D=a;this.K=Object.create(null);this.C=null;a=a.querySelectorAll(".gs_in_txtw>input[type=text]");for(var b=a.length;b--;){var c=a[b],d=c.parentNode.querySelector(".gs_in_txts");c=c.name;d&&c&&(this.K[c]=d.innerHTML)}};ia(Sc,g);Sc.prototype.H=function(){Rb(this.C);this.D=this.C=null;g.prototype.H.call(this)};
Sc.prototype.ga=function(a){var b=this;L(a);if((a=this.D)&&!this.C){var c="json=&"+ya(a);Tc(this,!0);this.C=Qb(a.action,c,function(d,e){b.C=null;Tc(b,!1);var f=b.D,h=f.getAttribute("data-alrt");if(h=h?t(h):null)h.innerHTML="";try{var k=200==d&&JSON.parse(e)}catch(A){}k&&"object"==typeof k||(Uc(h,t("gs_md_err").innerHTML),k={});if(d=k.L)Ca(""+d);else{(d=k.M)&&Uc(h,d);d=1E6;if(h&&h.innerHTML){var m=h;d=h.getBoundingClientRect().top}f=f.elements;k=k.E;"object"==typeof k||(k=Object.create(null));for(var w in b.K){h=
f[w];e=void 0;var v=""+(k[w]||""),F=h.parentNode.querySelector(".gs_in_txts");q(h.parentNode,"gs_in_txte",!!v);F&&(F.innerHTML=v||b.K[w]||"");v&&(e=h.getBoundingClientRect().top)<d&&(m=h,d=e)}m&&m.scrollIntoView&&(0>d||d+20>window.innerHeight)&&m.scrollIntoView()}})}};
var Tc=function(a,b){a=a.D;var c=a.getAttribute("data-bsel");a=c?document.querySelectorAll(c):a.querySelectorAll("button");for(c=a.length;c--;){var d=a[c];d.disabled=b;q(d,"gs_bsp",b)}},Uc=function(a,b){if(a)a.innerHTML=b;else{var c=void 0===c?"":c;var d=void 0===d?"":d;var e=void 0===e?[]:e;t("gs_alrt_m").innerHTML=b;Lb().action=d.match(Ba)?d:"";a=t("gs_alrt_l");a.textContent=c;c=t("gs_alrt_h");c.innerHTML="";for(var f in e)b=document.createElement("input"),b.type="hidden",b.name=f,b.value=e[f],
c.appendChild(b);Ib();q(a,"gs_fm_s",!0);Kb()}};Ub(Sc,[new M(".gs_ajax_frm",{submit:Sc.prototype.ga})]);var Vc=[[1,0,1],[2,0,1]];P(".gs_cb_gen","click",function(a){var b=a.currentTarget,c=tc(b),d=2==+b.getAttribute("data-s");vc(b,Vc[+d][c],!0);O("gs-change",b,a.g)});P(".gs_cb_gen",["keydown","keyup"],function(a){var b=a.currentTarget,c=a.g.keyCode;"BUTTON"!=b.tagName||13!=c&&32!=c||(L(a),"keydown"==a.type&&b.click())});P([".gs_cb_gen",".gs_md_li"],"keydown",function(a){var b=a.currentTarget,c=b.tagName,d=a.g.keyCode;"BUTTON"!=c&&(32==d||13==d&&"A"!=c)&&(L(a),b.click())});var Wc=["click","contextmenu","mouseup"].concat(navigator.sendBeacon?[]:["mousedown","touchstart"]),Xc="",Yc=null;function Zc(){Yc=null}function $c(a){navigator.sendBeacon?navigator.sendBeacon(a):Yc&&a==Yc.src||((Yc=new Image).src=a,setTimeout(Zc,1E3))}function ad(){var a=lb(document.location.href).hl||"";a="/scholar_bfnav?url="+encodeURIComponent(document.location.href)+"&hl="+encodeURIComponent(a)+"&ei="+GSP.eventId;$c(a)}D(function(){Xc=Hb?"&bn=1":"";Hb&&ad()});
B(window,"pageshow",function(a){a.persisted&&(Xc="&bn=1",ad())});
B(document,Wc,function(a){if(!("click"==a.type&&a.button||"mouseup"==a.type&&1!=a.button)){var b,c;a:{for(a=a.target;a;){var d=a.nodeName;if("A"==d)break a;if("SPAN"==d||"B"==d||"I"==d||"EM"==d||"IMG"==d)a=a.parentNode;else break}a=null}a&&(b=a.getAttribute("href"))&&(c=a.getAttribute("data-clk"))&&(b="/scholar_url?url="+encodeURIComponent(b)+"&"+c+"&ws="+window.innerWidth+"x"+window.innerHeight+"&at=",c=encodeURIComponent,a=(a=a.getAttribute("data-clk-atid"))&&t(a),b=b+c(a&&a.innerText||"")+Xc,$c(b))}},
!1,!0);P(".gs_fm_s","click",function(a){a=a.currentTarget.getAttribute("data-fm")||"";(a=t(a))&&a.submit()});var V=function(a){this.m=x(a.querySelector(".gs_md_d"));this.G=x(a.querySelector(".gs_md_tb"))};V.prototype.I=function(a){var b=t(this.m);return void 0!==a?rc(b,b,a):null};V.prototype.open=function(a){a=this.I(a);if(p(t(this.G),"gs_sel"))try{a&&a.focus()}catch(c){}else{var b=t(this.G);Va(this.m,function(){l(b,"gs_sel")},function(){n(b,"gs_sel")},a,b)}};V.prototype.close=function(){H(this.m)};V.prototype.Z=function(a){L(a);p(t(this.G),"gs_sel")?this.close():this.open("keydown"==a.g.type?!1:void 0)};
V.prototype.U=function(a){var b=a.g.keyCode;if(38==b||40==b)L(a),this.open(38==b)};V.prototype.aa=function(a){a.target.id==this.m&&this.U(a)};Ub(V,[new M(".gs_md_rmb",{}),new M(".gs_md_tb",{"gs-press":V.prototype.Z,keydown:V.prototype.U}),new M(".gs_md_d",{keydown:V.prototype.aa})]);var W=function(a){V.call(this,a);this.ia=x(a.querySelector(".gs_md_in"));this.ja=x(a.querySelector(".gs_md_tb .gs_lbl"))};ia(W,V);W.prototype.I=function(){return t(this.m).querySelector(".gs_md_li[aria-selected]")};W.prototype.ba=function(a){bd(this,a)};W.prototype.J=function(a){var b=a.g.keyCode;13!=b&&32!=b||bd(this,a)};
var bd=function(a,b){var c=b.currentTarget,d=t(a.ia),e=a.I();c!=e&&(d.value=c.getAttribute("data-v"),t(a.ja).innerHTML=c.innerHTML,e&&cd(e,!1),cd(c,!0));L(b);a.close();O("gs-change",d,b.g)},cd=function(a,b){q(a,"gs_sel",b);b?a.setAttribute("aria-selected","true"):a.removeAttribute("aria-selected")};Ub(W,[new M(".gs_md_ris",{}),new M(".gs_md_li",{click:W.prototype.ba,keydown:W.prototype.J})]);P("#gs_lp","click",function(a){L(a);R("gs_lp_d")});P("#gs_lp_cur","click",function(a){L(a);H("gs_lp_d")});var dd=function(a){this.W=x(a)};dd.prototype.J=function(a){var b=a.currentTarget,c=a.g.keyCode;if(38==c||40==c){var d=t(this.W);d=rc(d,b,38==c)||rc(d,d,38==c)}else if(37==c||39==c)a:{c=!!(37==c^xa(b.parentNode));d=b.parentNode;var e=d.children,f=e.length;if(d.id!=this.W){for(;e[--f]!=b;);d=qc(d,c)||pc(d.parentNode,c);e=d.children;if(f=Math.min(f+1,e.length))if(d=e[f-1],p(d,"gs_md_li")&&d.offsetLeft!=b.offsetLeft)break a}d=void 0}d&&(L(a),d.focus())};
Ub(dd,[new M(".gs_md_ulr",{}),new M(".gs_md_li",{keydown:dd.prototype.J})]);P("#gs_hdr_mnu","click",function(a){L(a);R("gs_hdr_drw")});P("#gs_hdr_drw_mnu","click",function(a){L(a);H("gs_hdr_drw")});P("#gs_hdr_act_i","click",function(a){L(a);1==oa()?Ca(document.querySelector("#gs_hdr_drw_bot>a").href):Va("gs_hdr_act_d")});P("#gs_hdr_drw","keydown",function(a){var b=a.g.keyCode;if(38==b||40==b){var c=a.currentTarget;if(b=rc(c,c,38==b))L(a),b.focus()}});
P("#gs_hdr_tsi",["focus","blur"],function(a){function b(){var h=d.getBoundingClientRect().top-10;10<Math.abs(h)&&window.scrollBy(0,h);clearTimeout(e);c()}function c(){C(window,f,b)}var d=a.target;a="focus"==a.type;q(t("gs_hdr"),"gs_hdr_ifc",a);if(a&&pa&&!(749<window.innerHeight)){var e=setTimeout(c,1E3),f=["scroll","resize"];B(window,f,b)}});P("#gs_hdr_tsi",["input","gs-change"],function(a){q(t("gs_hdr_frm"),"gs_hdr_tsc",!!a.currentTarget.value)});
P("#gs_hdr_tsc","mousedown",function(a){L(a);var b=t("gs_hdr_tsi");b.value="";b.focus();O("input",b,a.g)});P("#gs_hdr_sre","click",function(a){L(a);var b=t("gs_hdr");Va("gs_hdr_frm",function(){n(b,"gs_hdr_src");l(b,"gs_hdr_srx")},function(){l(b,"gs_hdr_src");n(b,"gs_hdr_srx")},t("gs_hdr_tsi"))});P(".gs_md_x","click",function(a){(a=a.currentTarget.getAttribute("data-mdx"))&&H(a)});var X=function(){},ed,fd;X.prototype.$=function(a){a.g.button||(L(a),gd(a))};X.prototype.ca=function(a){hd(a)&&(L(a),gd(a))};X.prototype.da=function(a){hd(a)&&L(a)};X.prototype.ea=function(a){if(!a.g.button){L(a);var b=a.g;b&&(id=b.clientX||0,jd=b.clientY||0,B(document,kd,ld,!0),clearTimeout(ed),ed=setTimeout(md,2E3));gd(a)}};X.prototype.ha=function(a){L(a);if(nd){var b=a.g;if(b=(b=b&&b.touches)&&1==b.length&&b[0])od=b.clientX,pd=b.clientY,B(document,qd,rd,!0),clearTimeout(fd),fd=setTimeout(sd,2E3)}gd(a)};
var hd=function(a){a=a.g.keyCode;return 32==a||13==a},gd=function(a){O("gs-press",a.currentTarget,a.g)},md=function(){C(document,kd,ld,!0);clearTimeout(ed);ed=void 0},ld=function(a){"mousedown"!=a.type&&10>Math.abs(a.clientX-id)&&10>Math.abs(a.clientY-jd)?(Na(a),"click"==a.type&&md()):md()},sd=function(){C(document,qd,rd,!0);clearTimeout(fd);fd=void 0},rd=function(a){"touchstart"!=a.type&&10>Math.abs(a.clientX-od)&&10>Math.abs(a.clientY-pd)?(Na(a),"click"==a.type&&sd()):sd()},id=0,jd=0,kd=["mousedown",
"mouseup","click"],nd=r("Android")&&!r("Chrome"),od=0,pd=0,qd=["touchstart","mousedown","mouseup","click"];Ub(X,[new M(".gs_press",{click:X.prototype.$,keydown:X.prototype.ca,keyup:X.prototype.da,mousedown:X.prototype.ea,touchstart:X.prototype.ha})]);function td(){var a=0>ud.getBoundingClientRect().top;vd!=a&&(vd=a,q(wd,"gs_sth_vis",a),a?xd():(yd.style.left="",yd.style.width="",zd()))}function xd(){if(vd){var a=ud.getBoundingClientRect();yd.style.left=a.left+"px";yd.style.width=a.width+"px";zd()}}function zd(){O("gs-sth-change",t("gs_sth"))}var wd,ud,yd,vd=!1;D(function(){if(wd=t("gs_sth"))ud=wd.querySelector(".gs_sth_g"),yd=wd.querySelector(".gs_sth_b"),yc.addListener(td),zc.addListener(xd),td()});function Ad(){var a=t("gsc_rsb_co");if(a){a=a.querySelectorAll("img.gs_pp_df");for(var b=0;b<a.length;b++){var c=a[b];c.getAttribute("data-srcset")&&(c.setAttribute("srcset",c.getAttribute("data-srcset")),c.removeAttribute("data-srcset"));c.getAttribute("data-src")&&(c.setAttribute("src",c.getAttribute("data-src")),c.removeAttribute("data-src"))}}};var Bd=/\S+@\S+\.\S+/;function Cd(a){return p(a,"gsc_ccb_dis")||p(a,"gsc_ccb_lim")}function Dd(){for(var a=0>=Ed(),b=t("gsc_cods_res").querySelectorAll(".gsc_ccb_add"),c=b.length;c--;){var d=b[c];p(d,"gsc_ccb_on")||q(d,"gsc_ccb_lim",a)}};var Fd=function(a){this.X=a};Fd.prototype.fa=function(a){L(a);a=a.currentTarget.getAttribute("data-a");this.X.setAttribute("data-a",a||"");O("gsc-navigate",this.X)};var Gd=[new M(".gsc_pgn",{}),new M([".gsc_pgn_ppr",".gsc_pgn_pnx"],{click:Fd.prototype.fa})];function Hd(a,b){b=void 0===b?"":b;var c=t("gsc_md_cod");a+=fb({t:Id});R(c.id,a,"",b)}function Jd(a){if(Id!=a){var b=t("gsc_md_cod");n(b,Id);l(b,a);Id=a}}function Kd(){var a=kb(Fc).t;"gsc_cod_sugg"!=a&&"gsc_cod_lc"!=a||Jd(a)}function Ld(){var a=Md();a=a?a.value:"";var b=(t("gsc_cods_urls").getAttribute("data-sa")||"").replace(Nd,"$1"+encodeURIComponent(a));a=a?b:t("gsc_cods_urls").getAttribute("data-lc")||"";Hd(a)}
function Od(a){var b=t("gsc_cods_frm");if(b){b=b.elements;var c=b[1];b[0].disabled=c.disabled=a;q(c,"gs_bsp",a)}a=a?null:t("gsc_codb_data");if(c=t("gsc_cods_pp")){var d=a&&a.getAttribute("data-prev");b=a&&a.getAttribute("data-next");var e=a&&a.getAttribute("data-start"),f=a&&a.getAttribute("data-end");c.querySelector(".gsc_pgn_ppn").textContent=e&&f?e+" - "+f:"";e=c.querySelector(".gsc_pgn_ppr");e.disabled=!d;e.setAttribute("data-a",d||"");c=c.querySelector(".gsc_pgn_pnx");c.disabled=!b;c.setAttribute("data-a",
b||"")}a&&(Pd=+a.getAttribute("data-max")||0,za(t("gsc_cods_save"),"xsrf").value=a.getAttribute("data-xsrf")||"")}function Qd(){var a=0<Y.l||0<Z.l,b=Ed(),c=0>=b;t("gsc_cod_done").disabled=!a||0>b;q(t("gsc_cod_t"),"gsc_cod_changed",a);a=t("gsc_cod_trev");a.textContent=a.getAttribute(c?"data-lim":"data-txt")||"";q(t("gsc_cod_t"),"gsc_cod_lim",c)}function Ed(){return Pd-Y.l+("gsc_cod_sugg"==Id?0:Z.l)}function Md(){return t("gsc_cods_tsi")}
function Rd(a){for(var b="",c=la(a.j),d=c.length;d--;)b+=a.get(c[d]);return b}var Id="gsc_cod_lc",Pd=0,Nd=/([?&]mauthors=)([^&]*)/,Y=new Q,Z=new Q;function Sd(a){q(t("gsc_a_sp"),"gs_vis",0==a);q(t("gsc_a_err"),"gs_vis",2==a)}function Td(){return document.querySelectorAll("#gsc_a_t input[type=checkbox]")}function Ud(){O("gsc-works-change",t("gsc_a_t"))}function Vd(){var a=t("gsc_x_all");if(a){var b=document.querySelectorAll("#gsc_a_t input[type=checkbox]:checked");var c=b.length;var d=Td().length;c=c?c==d?1:2:0;vc(a,c);2==c&&(Wd=b)}Ud()}var Wd=[];var Xd="",Zd=0,ae=0;function be(a){for(var b=[!1,!1,!1],c=0;c<b.length;c++){var d=t(ce[c]);d&&(b[c]=!!a(d))}return b}function de(){var a=t("gsc_fol_m");if(a){var b=t("gsc_fol_b");if(!(a=!Bd.test(a.value))){a:{a=be(tc);for(var c=be(uc),d=0;d<a.length;d++)if(a[d]!=c[d]){a=!0;break a}a=!1}a=!a}b.disabled=a}}var ce=["gsc_fol_a","gsc_fol_c","gsc_fol_r"],ee=["follow_articles_btn","follow_citations_btn","follow_related_btn"];function fe(){p(document.documentElement,"gs_el_ph")||p(document.documentElement,"gs_el_ta")||Ad()};function ge(a){if(a){a.id&&a.removeAttribute("id");for(var b=0;b<a.children.length;b++)ge(a.children[b])}};function he(){var a=t("gsc_prf_pufii");if(r("MSIE ")){var b=t("gsc_prf_puf");Va("gsc_prf_pufi",function(){l(b,"gsc_prf_pufo")},function(){n(b,"gsc_prf_pufo")},a)}else a.click()};function ie(){var a=document.querySelectorAll(".gsc_prf_pnl"),b=document.documentElement;b=p(b,"gs_el_ph")||p(b,"gs_el_ta");for(var c=0;c<a.length;c++)a[c].setAttribute("role",b?"tabpanel":"region")};var je=kb(window.location.hash),ke=je.u||"";"gs_md_cita-d"==je.d&&ke.match(Ea)&&0<=ke.indexOf("view_citation")&&Ca(ke);P("#gsc_md_cod","gs-md-ldin",function(){Kd();Od(!0)});P("#gsc_md_cod","gs-md-lded",function(){Kd();Od(!1);for(var a=t("gsc_cods_res").querySelectorAll(".gsc_ccb_ck"),b=a.length;b--;){var c=a[b];if(!Cd(c)){var d=c.getAttribute("data-authorid")||"";d=(p(c,"gsc_ccb_add")?Y:Z).has(d);q(c,"gsc_ccb_on",d)}}Dd();Qd();a=lb(Fc);(b=Md())&&(b.value=a.mauthors||"")});
P("#gsc_cods_frm","gsc-lwpds-submit",Ld);P("#gsc_cods_pp","gsc-navigate",function(a){(a=a.currentTarget.getAttribute("data-a"))&&Hd(a)});
P([".gsc_ccb_add",".gsc_ccb_del"],"click",function(a){a=a.currentTarget;if(!Cd(a)){var b=!p(a,"gsc_ccb_on");q(a,"gsc_ccb_on",b);var c=p(a,"gsc_ccb_add")?".gsc_ccb_del":".gsc_ccb_add",d=a.parentNode;(c=d&&d.querySelector(c))&&n(c,"gsc_ccb_on");c=a.getAttribute("data-authorid")||"";Y.delete(c);Z.delete(c);b&&(p(a,"gsc_ccb_add")?Y:Z).set(c,t("gsc_ucoar-"+c).outerHTML);Dd();Qd()}});
P("#gsc_cod_trev","click",function(){var a=t("gsc_cods_res").cloneNode(!0),b=a.querySelector("#gsc_codb_content");b||(b=document.createElement("div"),b.id="gsc_codb_content",a.appendChild(b));var c=Rd(Y)+Rd(Z);b.innerHTML=c;(b=Md())&&(b.value="");Hd("",a.innerHTML)});P("#gsc_cod_done","click",function(){var a=t("gsc_cods_save");za(a,"colleague_add").value=la(Y.j).join(",");za(a,"colleague_del").value=la(Z.j).join(",");a.submit()});
P(["#gsc_coauth_opn",".gsc_rsb_btne",".gsc_rsb_btnv"],"click",function(){Jd("gsc_cod_lc");Pd=0;Y.clear();Z.clear();var a=Md();a&&(a.value="");Ld()});P(".gsc_rsb_aa",["click","keydown"],function(a){if("keydown"!=a.type||a.g&&!Oa(a.g)&&13==a.g.keyCode)a.g&&Na(a.g),(a=(a=a.currentTarget.querySelector("a"))?a.getAttribute("href"):"")&&Ca(a)});P("#gsc_prf_t-ath","click",function(){Ad()});D(function(){Ac.add(fe);fe()});P(".gsc_lwpds_frm","submit",function(a){L(a);O("gsc-lwpds-submit",a.target)});
var le=window.location.href.split("#")[0];Xd=le.replace(/([?&])(cstart|pagesize)=[^&]*/g,"$1");Zd=Math.max(+le.replace(/.*[?&]cstart=([^&]*).*/,"$1")||0,0);ae=+le.replace(/.*[?&]pagesize=([^&]*).*/,"$1")||0;ae=Math.max(Math.min(ae,100),20);
P("#gsc_bpf_more","click",function(a){var b=a.currentTarget,c=ae,d=100>c?100-c:100;a=(Xd+"&cstart="+(Zd+c)+"&pagesize="+d).replace(/([?&])&+/g,"$1");Sd(0);b.disabled=!0;Qb(a,"json=1",function(e,f){b.disabled=!1;try{var h=200==e&&JSON.parse(f)}catch(m){}if(h&&"object"==typeof h){ae=c+=d;Sd(1);e=t("gsc_a_b");f=document.createElement(va.Y);f.innerHTML=""+h.B;f=Array.prototype.slice.call(f.rows);for(var k=0;k<f.length;k++)e.appendChild(f[k]);Vd();if(e=t("gsc_a_nn"))f=e.innerHTML.replace(/[0-9]+$/,""+
t("gsc_a_b").rows.length),e.innerHTML=f;b.disabled=!h.N}else Sd(2)})});P(["#gsc_fol_a","#gsc_fol_c","#gsc_fol_r"],"gs-change",de);P("#gsc_fol_m","input",de);P("#gsc_fol_f","submit",function(a){a.g&&a.g.preventDefault();a=t("gsc_fol_f");var b=t("gsc_fol_inp");b.innerHTML="";for(var c=be(tc),d=be(uc),e=0;e<c.length;e++)if(c[e]!=d[e]){var f=ee[e],h=document.createElement("input");h.type="hidden";h.name=c[e]?f:"un"+f;b.appendChild(h)}O("gsc-fol-submit",a)});P("#gsc_fol_f","gsc-fol-submit",function(a){a.currentTarget.submit()});
P("#gsc_md_hist","gs-md-lded",function(){var a=t("gsc_md_hist_c");if(!a.innerHTML){var b=document.getElementsByClassName("gsc_g_hist_wrp");1==b.length&&(a.appendChild(b[0].cloneNode(!0)),ge(a.lastChild))}});P(["#gsc_hist_opn",".gsc_md_hist_b"],"click",function(){var a=document.documentElement;!t("gsc_hist_opn")||p(a,"gs_el_ph")||p(a,"gs_el_ta")||R("gsc_md_hist")});
P("#gsc_lwp_mndt_lnk","click",function(a){var b=a.currentTarget.getAttribute("href")+"&tzom="+(new Date).getTimezoneOffset();window.location.assign(b);a.g.preventDefault()});P("#gsc_prf_btne","click",function(){var a=t("gsc_md_pro-d");a.setAttribute("data-ifc","");R(a.id,fb({t:"gsc_md_pro_ed"}))});P("#gsc_prf_btnf","click",function(){R("gsc_md_fol")});P("#gsc_md_fol_pub","click",function(){t("gsc_fol_mpf").submit()});P("#gsc_prf_iv_tg","click",function(){q(t("gsc_prf_w"),"gsc_prf_why")});
P(".gsc_prf_pel",["click","keydown"],function(a){("keydown"!=a.type||13==a.g.keyCode&&a.g&&!Oa(a.g))&&he()});P("#gsc_prf_pufii","change",function(){t("gsc_prf_puf").submit()});P(".gsc_prf_tab","click",function(a){var b=t("gsc_bdy");b.setAttribute("data-tab",a.currentTarget.id);b=b.querySelectorAll(".gsc_prf_tab");for(var c=0;c<b.length;c++){var d=b[c];d.setAttribute("aria-selected",""+(d==a.currentTarget))}});D(function(){Ac.add(ie);ie()});
P("#gsc_md_cbyd","gs-md-ldin",function(){var a=t("gsc_md_cbyd_merge");a&&(a.disabled=!0);Aa("")});P("#gsc_md_cbyd","gs-md-lded",function(){var a=t("gsc_md_cbyd_f"),b=t("gsc_md_cbyd_merge"),c=Fc,d=lb(c).s||"";c=kb(c).c||"";a.elements.s.value=d;Aa(c);b&&a.elements.choose&&(b.disabled=!1,b.getBoundingClientRect().bottom<window.innerHeight&&b.focus())});
P("#gsc_md_cbym",["gs-md-ldin","gs-md-lded"],function(){var a=lb(Fc).s||"",b=t("gsc_md_cbym_e");b&&a&&0>a.indexOf("&")&&b.setAttribute("data-href",(b.getAttribute("data-href")||"").replace(/(&citation_for_view=)[^&]*/,"$1"+a))});P("#gsc_md_cbym_e","click",function(a){a=a.currentTarget.getAttribute("data-href")||"";R("gs_md_cita-d",a)});Ub(Fd,Gd);D(function(){return setTimeout(Vd,0)});P(".gsc_a_x","change",Vd);
P("#gsc_x_all","gs-change",function(a){a=tc(a.currentTarget);for(var b=2==a?Wd:Td(),c=b.length;c--;)b[c].checked=0!=a;Ud()});P(".gsc_a_acm","click",function(a){L(a);var b=a.currentTarget;a=b.href;var c=b.getAttribute("data-eid")||"";b=b.getAttribute("data-eud")||"";a=t("gsc_md_cbyd_f").action+"&update_op=merge_options&s="+(b+","+c)+fb({c:a});R("gsc_md_cbyd",a)});
P(".gsc_a_am","click",function(a){a=a.currentTarget.getAttribute("data-eid")||"";a=(t("gsc_md_cbym_l").getAttribute("data-act")||"")+"&update_op=merge_options&s="+a;R("gsc_md_cbym",a)});P("#gs_sth","gs-sth-change",function(a){var b=t("gsc_a_tr0"),c=t("gsc_a_trh"),d=b.querySelector(".gsc_a_t"),e=c.querySelector(".gsc_a_t");p(a.currentTarget,"gs_sth_vis")?(e.style.width=d.offsetWidth+"px",b.style.height=c.offsetHeight+"px"):e.style.width=b.style.height="auto"});
P("#gs_md_cita-b-save","click",function(){var a=t("gsc_ecd_form");za(a,"continue").value=window.location.pathname+window.location.search;O("submit",a)});P(".gsc_ecd_form_tsel","click",function(a){var b=t("gsc_ecd_table"),c=za(t("gsc_ecd_form"),"articletype");a=a.currentTarget;c.value=a.getAttribute("data-type")||"";b.className=a.getAttribute("data-class")||"";b=document.querySelectorAll("#gsc_ecd_citation_type button");for(c=b.length;c--;)q(b[c],"gs_sel",b[c]==a)});
}({"customAC":2,"eventId":"fds9Yd-9MMi1mwGW7rLoCQ"});</script></head><body><div id="gs_top" onclick=""><style>#gs_md_s,.gs_md_wnw{z-index:1200;position:fixed;top:0;left:0;width:100%;height:100%;visibility:hidden;}#gs_md_s{background-color:#fff;opacity:.5;}.gs_el_ta #gs_md_s,.gs_el_ph #gs_md_s{background-color:#666;}.gs_md_wnw{transition:all 0s .218s;}#gs_md_s.gs_vis,.gs_md_wnw.gs_vis{visibility:visible;transition:all 0s;}.gs_md_wnw>.gs_md_d{position:relative;margin:0 auto;width:464px;box-shadow:2px 2px 8px rgba(0,0,0,.2);white-space:normal;}.gs_el_ta .gs_md_wnw>.gs_md_d,.gs_el_ph .gs_md_wnw>.gs_md_d{box-shadow:2px 2px 8px rgba(0,0,0,.65);}.gs_el_ph .gs_md_wnw>.gs_md_d{width:80%;max-width:440px;}.gs_el_ph .gs_md_wmw>.gs_md_d{width:100%;height:100%;max-width:none;border:none;box-shadow:none;transform:translate(0,100%);transform:translate(0,100vh);transition:transform .27s cubic-bezier(.4,0,.6,1),opacity 0s .27s,visibility 0s .27s,max-height 0s .27s;}.gs_el_ph .gs_md_wmw>.gs_md_d.gs_vis{transform:translate(0,0);transition:transform .3s cubic-bezier(0,0,.2,1);}.gs_md_wmw>.gs_md_d.gs_abt,.gs_el_ph .gs_md_wmw>.gs_md_d.gs_abt{transition:none;}.gs_md_hdr{display:flex;align-items:center;height:47px;border-bottom:1px solid #e0e0e0;border-bottom-color:rgba(0,0,0,.12);background-color:#f5f5f5;}.gs_md_hdr>a,.gs_md_hdr>a.gs_btn_lrge{flex:0 0 auto;width:41px;height:47px;}.gs_el_ph .gs_md_hdr>a{margin:0 2px 0 0;}.gs_el_ph a.gs_md_hdr_c{margin:0 0 0 2px;}.gs_md_hdr_b{margin:0 41px 0 16px;}.gs_el_ph .gs_md_hdr_b{margin:0 16px;}.gs_md_hdr_t:empty~.gs_md_hdr_b{margin-left:0;}.gs_md_hdr_b:empty{width:41px;margin:0;}.gs_el_ph .gs_md_hdr_b:empty{margin-right:2px;}.gs_md_hdr_b:empty:not(:last-child){display:none;}.gs_md_hdr_b>button{min-width:51px;height:33px;}.gs_md_hdr_t{flex:1 1 auto;font-size:18px;font-weight:normal;color:#666;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;text-align:center;}.gs_md_bdy{overflow-y:auto;box-sizing:border-box;padding:24px 41px 0 41px;}.gs_md_bdy:after{display:block;content:"";clear:both;padding-bottom:24px;}.gs_el_ph .gs_md_bdy{padding:16px 16px 0 16px;}.gs_el_ph .gs_md_bdy:after{padding-bottom:16px;}.gs_el_ph .gs_md_wmw .gs_md_bdy{position:absolute;width:100%;top:48px;bottom:0;}.gs_md_lbl{display:block;font-size:16px;margin:0 0 16px 0;word-wrap:break-word;}.gs_md_btns{margin:24px 0 0 0;white-space:nowrap;}.gs_el_ph .gs_md_btns{margin:16px 0 0 0;}.gs_md_btns button{margin-right:16px;}.gs_md_btns button:last-child{margin-right:0;}.gs_md_prg{margin:24px 0;text-align:center;}.gs_md_prg .gs_alrt{padding:4px 16px;}.gs_md_ldg:before{content:"";position:absolute;top:0;left:0;bottom:0;right:0;background-color:#fff;opacity:.5;z-index:100;}</style><div id="gs_md_ldg" style="display:none">Loading...</div><div id="gs_md_err" style="display:none">The system can't perform the operation now. Try again later.</div><div id="gs_md_s"></div><div data-h="0" class="gs_md_wnw"><div id="gsc_md_hist" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_hist-t" data-wfc="gsc_md_hist-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_hist-x" role="button" aria-label="Cancel" data-mdx="gsc_md_hist" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_hist-t" class="gs_md_hdr_t">Citations per year</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_hist-bdy" class="gs_md_bdy"><style>#gsc_md_hist{width:80%;max-width:386px;}#gsc_md_hist_c{position:relative;width:100%;}</style><div id="gsc_md_hist_c"></div></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbyd" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbyd-t" data-cid="gsc_md_cbyd_l" data-wfc="gsc_md_cbyd-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbyd-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbyd" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbyd-t" class="gs_md_hdr_t">Duplicate citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbyd-bdy" class="gs_md_bdy"><form id="gsc_md_cbyd_f" action="/citations?hl=en&amp;user=7-4XHiUAAAAJ&amp;view_op=list_works" method="post"><input type="hidden" name="s" value=""><div class="gs_md_lbl">The following articles are merged in Scholar. Their <a id="gsc_md_cbyd_c" href="javascript:void(0)">combined citations</a> are counted only for the first article.</div><div id="gsc_md_cbyd_l"></div></form></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbym" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbym-t" data-cid="gsc_md_cbym_l" data-wfc="gsc_md_cbym-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbym-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbym" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbym-t" class="gs_md_hdr_t">Merged citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbym-bdy" class="gs_md_bdy"><div class="gs_md_lbl">This "Cited by" count includes citations to the following articles in Scholar. The ones marked <span id="gsc_md_cbym_s">*</span> may be different from the article in the profile.</div><div id="gsc_md_cbym_l" data-act="/citations?hl=en&amp;user=7-4XHiUAAAAJ&amp;view_op=list_works"></div></div></div></div><div data-h="900" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cod" class="gs_md_d gs_ttzi gsc_cod_lc" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cod-t" data-cid="gsc_cods_res" data-wfc="gsc_md_cod-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cod-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cod" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cod-t" class="gs_md_hdr_t"><span id="gsc_cod_t"><span id="gsc_cod_tadd">Add co-authors</span><span id="gsc_cod_tedit">Co-authors</span><a id="gsc_cod_trev" href="javascript:void(0)" data-txt="Review" data-lim="Limit reached"></a></span></h2><div class="gs_md_hdr_b"><button type="button" id="gsc_cod_done" aria-label="Add co-authors" disabled="" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gsc_md_cod-bdy" class="gs_md_bdy"><div id="gsc_cods_urls" class="gsc_cods_hide" data-ls="" data-lc="/citations?view_op=list_colleagues&amp;hl=en&amp;json=&amp;user=7-4XHiUAAAAJ" data-sa=""></div><form id="gsc_cods_save" action="" method="POST"><input type="hidden" name="colleague_add"><input type="hidden" name="colleague_del"></form><div id="gsc_cods_res"></div></div></div></div><div data-h="800" class="gs_md_wnw gs_md_wmw"><div id="gs_md_cita-d" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gs_md_cita-d-t" data-cid="gs_md_cita-l" data-wfc="gs_md_cita-d-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gs_md_cita-d-x" role="button" aria-label="Cancel" data-mdx="gs_md_cita-d" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gs_md_cita-d-t" class="gs_md_hdr_t"></h2><div class="gs_md_hdr_b"><button type="button" id="gs_md_cita-b-save" aria-label="Save" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gs_md_cita-d-bdy" class="gs_md_bdy"><style>#gs_md_cita-d{width:90%;max-width:1000px;}.gs_el_ph #gs_md_cita-d{width:100%;max-width:none;}#gs_md_cita-d .gs_md_prg{min-height:600px;}</style><div id="gs_md_cita-l" aria-live="assertive"></div></div></div></div><div data-h="0" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_fol" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_fol-t" data-wfc="gsc_md_fol-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_fol-x" role="button" aria-label="Cancel" data-mdx="gsc_md_fol" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_fol-t" class="gs_md_hdr_t">Follow this author</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_fol-bdy" class="gs_md_bdy"><form method="post" id="gsc_fol_f" action="/citations?hl=en&amp;user=7-4XHiUAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYT8s_cDbNjJhH1s4GtF5DvG1F6hdBW2g"><input type="hidden" name="user" value="7-4XHiUAAAAJ"><div id="gsc_fol_inp"></div><div id="gsc_fol_cb"><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_a" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles by this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_c" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New citations to this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_r" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles related to this author's research</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div></div><div id="gsc_fol_email"><label id="gsc_fol_ml" for="gsc_fol_m">Email address for updates</label><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="email_for_op" value="" id="gsc_fol_m" maxlength="100" autocapitalize="off" autocorrect="off"></div></div><div class="gs_md_btns"><button type="submit" id="gsc_fol_b" disabled="" class=" gs_btn_act gs_btn_lrge gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">Done</span></span></button></div></form></div></div></div><!--[if lte IE 9]><div class="gs_alrt" style="padding:16px"><div>Sorry, some features may not work in this version of Internet Explorer.</div><div>Please use <a href="//www.google.com/chrome/">Google Chrome</a> or <a href="//www.mozilla.com/firefox/">Mozilla Firefox</a> for the best experience.</div></div><![endif]--><div id="gs_hdr_drs"></div><div id="gs_hdr_drw" class="gs_md_ulr" role="dialog" tabindex="-1" data-shd="gs_hdr_drs" data-wfc="gs_hdr_drw_mnu" data-cfc="gs_hdr_mnu"><div id="gs_hdr_drw_in"><div id="gs_hdr_drw_top"><a href="javascript:void(0)" id="gs_hdr_drw_mnu" role="button" aria-controls="gs_hdr_drw" aria-label="Options" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_drw_lgo" href="/schhp?hl=en" aria-label="Homepage"></a></div><div><div class="gs_hdr_drw_sec"><a href="/citations?hl=en" role="menuitem" class="gs_btnPRO gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My profile</span></a><a href="/scholar?scilib=1&amp;hl=en" role="menuitem" class="gs_btnL gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My library</span></a><a href="/citations?view_op=metrics_intro&amp;hl=en" role="menuitem" class="gs_btnJ gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Metrics</span></a><a href="/scholar_alerts?view_op=list_alerts&amp;hl=en" role="menuitem" class="gs_btnM gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Alerts</span></a></div><div class="gs_hdr_drw_sec"><a href="/scholar_settings?hl=en" role="menuitem" class="gs_btnP gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Settings</span></a></div></div><div id="gs_hdr_drw_bot" class="gs_hdr_drw_sec"><a href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den" class=" gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Sign in</span></a></div></div></div><div id="gs_hdr" role="banner" class="gs_hdr_src"><a href="javascript:void(0)" id="gs_hdr_mnu" role="button" aria-controls="gs_hdr_drw" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_lgo" class="" href="/schhp?hl=en" aria-label="Homepage"></a><div id="gs_hdr_md"><div id="gs_hdr_srch"><form id="gs_hdr_frm" action="/citations"><input type="hidden" name="view_op" value="search_authors"><input type="hidden" name="hl" value="en"><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="mauthors" value="" id="gs_hdr_tsi" placeholder="Search profiles" size="50" maxlength="2048" autocapitalize="off" aria-label="Search"></div><span id="gs_hdr_tsc"><span class="gs_ico gs_ico_X"></span></span><button type="submit" id="gs_hdr_tsb" name="btnG" aria-label="Search" class="gs_btnG gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></form></div></div><a href="javascript:void(0)" id="gs_hdr_sre" role="button" aria-controls="gs_hdr_frm" aria-label="Search" class="gs_btnTSB gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><div id="gs_hdr_act"><a id="gs_hdr_act_s" href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den">Sign in</a></div></div><style>#gs_alrt{position:fixed;bottom:48px;left:16px;max-width:384px;z-index:1250;display:flex;justify-content:space-between;align-items:center;font-size:13px;line-height:16px;color:#e2e2e2;background:#333;text-align:left;border-radius:3px;box-shadow:0 3px 5px -1px rgba(0,0,0,.2),0 6px 10px 0 rgba(0,0,0,.14),0 1px 18px 0 rgba(0,0,0,.12);visibility:hidden;transform-origin:center;transform:scale(0.8,0.8) translate(0,100%);}.gs_el_ph #gs_alrt{bottom:0;left:0;width:100%;max-width:none;border-radius:0;box-shadow:none;transform:scale(1,1) translate(0,100%);}#gs_alrt.gs_vis{visibility:visible;transform:scale(1,1) translate(0,0);}#gs_alrt.gs_anm{transition:transform .067s cubic-bezier(.4,0,1,1),visibility 0s .067s;}#gs_alrt.gs_vis.gs_anm{transition:transform .067s cubic-bezier(0,0,.2,1);}.gs_el_ph #gs_alrt.gs_anm{transition:transform .084s cubic-bezier(.4,0,1,1),visibility 0s .084s;}.gs_el_ph #gs_alrt.gs_vis.gs_anm{transition:transform .1s cubic-bezier(0,0,.2,1);}#gs_alrt_m{display:block;padding:16px;}#gs_alrt_l{display:block;padding:8px;margin:0 8px 0 -8px;border-radius:3px;color:#fcc934;text-transform:uppercase;text-decoration:none;}#gs_alrt_l:hover{background-color:rgba(255,255,255,.05)}#gs_alrt_l:active{background-color:rgba(255,255,255,.1)}#gs_alrt_l:empty{display:none}#gs_alrt_m a{padding:8px 0;color:#e2e2e2;text-decoration:underline;}#gs_alrt_m a:active{color:#f6aea9}</style><form action="" method="post" id="gs_alrt"><span id="gs_alrt_m"></span><span id="gs_alrt_h"></span><a id="gs_alrt_l" href="javascript:void(0)" class="gs_fm_s" data-fm="gs_alrt"></a></form><div id="gs_bdy"><div id="gs_bdy_sb" role="navigation"><div id="gs_bdy_sb_in"></div></div><div id="gs_bdy_ccl" role="main"><div id="gsc_bdy" class="gs_scl" data-tab="gsc_prf_t-art"><div class="gsc_rsb" role="navigation"><a id="gsc_rsb_gpl" class="gsc_rsb_s" href="/citations?hl=en">Get my own profile</a><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_cit" role="region" aria-labelledby="gsc_prf_t-cit"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Cited by</span><button type="button" id="gsc_hist_opn" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu gsc_rsb_action"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></h3><table id="gsc_rsb_st"><thead><tr><th class="gsc_rsb_sth"></th><th class="gsc_rsb_sth">All</th><th class="gsc_rsb_sth">Since 2016</th></tr></thead><tbody><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="This is the number of citations to all publications. The second column has the &quot;recent&quot; version of this metric which is the number of new citations in the last 5 years to all publications.">Citations</a></td><td class="gsc_rsb_std">17718</td><td class="gsc_rsb_std">5661</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="h-index is the largest number h such that h publications have at least h citations. The second column has the &quot;recent&quot; version of this metric which is the largest number h such that h publications have at least h new citations in the last 5 years.">h-index</a></td><td class="gsc_rsb_std">67</td><td class="gsc_rsb_std">39</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="i10-index is the number of publications with at least 10 citations. The second column has the &quot;recent&quot; version of this metric which is the number of publications that have received at least 10 new citations in the last 5 years.">i10-index</a></td><td class="gsc_rsb_std">134</td><td class="gsc_rsb_std">90</td></tr></tbody></table><style>.gsc_g_t{position:absolute;bottom:0;color:#777;font-size:11px;}.gsc_g_a{position:absolute;bottom:13px;width:15px;background:#777;}.gsc_g_a:hover,.gsc_g_a:focus,.gsc_g_a:active{text-decoration:none;cursor:default;}.gsc_g_al{position:absolute;bottom:15px;left:7px;color:#222;background:white;font-size:11px;padding:1px;border:1px solid #777;border-radius:1px;visibility:hidden;opacity:0;transition:opacity .218s,visibility 0s .218s;}.gsc_g_a:hover .gsc_g_al,.gsc_g_a:focus .gsc_g_al,.gsc_g_a:active .gsc_g_al{visibility:visible;opacity:1;transition:all 0s;}#gsc_md_hist{max-width:834px;}.gsc_md_hist_w{position:relative;overflow:hidden;margin-right:43px;}.gs_md_bdy .gsc_md_hist_w,.gs_el_ph .gsc_md_hist_w,.gs_el_ta .gsc_md_hist_w{overflow-x:auto;padding-bottom:16px;}.gsc_md_hist_b{position:relative;height:174px;width:100%;}.gsc_md_hist_b .gsc_g_a{bottom:auto;}.gsc_md_hist_b .gsc_g_t{bottom:auto;top:161px;}.gsc_md_hist_b:after{position:absolute;right:792px;content:"\00A0";}.gsc_g_hist_x{position:relative;margin-right:45px;}.gsc_g_hist_xl{position:absolute;right:8px;width:35px;}.gs_el_ta .gsc_g_hist_xl,.gs_el_ph .gsc_g_hist_xl{right:16px;}.gsc_g_hist_wrp{padding-top:32px;position:relative;}.gs_el_ta .gsc_g_hist_wrp,.gs_el_ph .gsc_g_hist_wrp{padding-right:8px;}.gs_md_bdy .gsc_g_hist_wrp{border-top:0;}.gs_el_tc .gs_md_bdy .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ph .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ta .gsc_g_hist_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;left:0;width:20px;height:100%;background-image:linear-gradient(to left,rgba(255,255,255,0),rgba(255,255,255,1) 80%);}.gsc_g_x,.gsc_g_xt{position:absolute;left:0;border-bottom:1px solid #eee;width:100%;text-align:right;}.gsc_g_x{border-bottom:1px solid #eee;}.gsc_g_xtl{position:absolute;color:#777;}.gsc_g_gtr{position:absolute;}.gsc_g_a:last-child .gsc_g_al{right:0;left:auto;}</style><div class="gsc_g_hist_wrp" dir="rtl"><div class="gsc_g_hist_x"><div class="gsc_g_x" style="top:160px;"></div><div class="gsc_g_xt" style="top:0px;"></div><div class="gsc_g_xt" style="top:80px;"></div><div class="gsc_g_xt" style="top:120px;"></div><div class="gsc_g_xt" style="top:40px;"></div></div><div class="gsc_g_hist_xl"><div class="gsc_g_xtl" style="top:153px;">0</div><div class="gsc_g_xtl" style="top:-7px;">1400</div><div class="gsc_g_xtl" style="top:73px;">700</div><div class="gsc_g_xtl" style="top:113px;">350</div><div class="gsc_g_xtl" style="top:33px;">1050</div></div><div class="gsc_md_hist_w"><div class="gsc_md_hist_b"><span class="gsc_g_t" style="right:739px">1998</span><span class="gsc_g_t" style="right:707px">1999</span><span class="gsc_g_t" style="right:675px">2000</span><span class="gsc_g_t" style="right:643px">2001</span><span class="gsc_g_t" style="right:611px">2002</span><span class="gsc_g_t" style="right:579px">2003</span><span class="gsc_g_t" style="right:547px">2004</span><span class="gsc_g_t" style="right:515px">2005</span><span class="gsc_g_t" style="right:483px">2006</span><span class="gsc_g_t" style="right:451px">2007</span><span class="gsc_g_t" style="right:419px">2008</span><span class="gsc_g_t" style="right:387px">2009</span><span class="gsc_g_t" style="right:355px">2010</span><span class="gsc_g_t" style="right:323px">2011</span><span class="gsc_g_t" style="right:291px">2012</span><span class="gsc_g_t" style="right:259px">2013</span><span class="gsc_g_t" style="right:227px">2014</span><span class="gsc_g_t" style="right:195px">2015</span><span class="gsc_g_t" style="right:163px">2016</span><span class="gsc_g_t" style="right:131px">2017</span><span class="gsc_g_t" style="right:99px">2018</span><span class="gsc_g_t" style="right:67px">2019</span><span class="gsc_g_t" style="right:35px">2020</span><span class="gsc_g_t" style="right:3px">2021</span><a href="javascript:void(0)" class="gsc_g_a" style="right:744px;top:152px;height:8px;z-index:24"><span class="gsc_g_al">71</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:712px;top:146px;height:14px;z-index:23"><span class="gsc_g_al">128</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:680px;top:142px;height:18px;z-index:22"><span class="gsc_g_al">162</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:648px;top:136px;height:24px;z-index:21"><span class="gsc_g_al">214</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:616px;top:134px;height:26px;z-index:20"><span class="gsc_g_al">234</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:584px;top:117px;height:43px;z-index:19"><span class="gsc_g_al">381</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:552px;top:118px;height:42px;z-index:18"><span class="gsc_g_al">368</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:520px;top:115px;height:45px;z-index:17"><span class="gsc_g_al">397</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:488px;top:106px;height:54px;z-index:16"><span class="gsc_g_al">474</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:456px;top:90px;height:70px;z-index:15"><span class="gsc_g_al">614</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:424px;top:70px;height:90px;z-index:14"><span class="gsc_g_al">789</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:392px;top:54px;height:106px;z-index:13"><span class="gsc_g_al">928</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:360px;top:37px;height:123px;z-index:12"><span class="gsc_g_al">1080</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:328px;top:24px;height:136px;z-index:11"><span class="gsc_g_al">1194</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:296px;top:30px;height:130px;z-index:10"><span class="gsc_g_al">1145</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:264px;top:9px;height:151px;z-index:9"><span class="gsc_g_al">1326</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:232px;top:30px;height:130px;z-index:8"><span class="gsc_g_al">1146</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:200px;top:42px;height:118px;z-index:7"><span class="gsc_g_al">1034</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:168px;top:47px;height:113px;z-index:6"><span class="gsc_g_al">993</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:136px;top:67px;height:93px;z-index:5"><span class="gsc_g_al">818</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:104px;top:62px;height:98px;z-index:4"><span class="gsc_g_al">859</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:72px;top:45px;height:115px;z-index:3"><span class="gsc_g_al">1014</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:40px;top:38px;height:122px;z-index:2"><span class="gsc_g_al">1075</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:8px;top:58px;height:102px;z-index:1"><span class="gsc_g_al">894</span></a></div></div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_mnd" role="region" aria-labelledby="gsc_prf_t-mnd"><div class="gsc_rsb_header gsc_rsb_m_header"><div class="gsc_rsb_m_title">Public access</div><a href="/citations?view_op=list_mandates&amp;hl=en&amp;user=7-4XHiUAAAAJ" id="gsc_lwp_mndt_lnk">View all</a></div><div class="gsc_rsb_hm gs_ota gs_oph"><button type="button" onclick="window.location='/citations?view_op\x3dlist_mandates\x26hl\x3den\x26user\x3d7-4XHiUAAAAJ'" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></div><div class="gsc_rsb_m"><div class="gsc_rsb_m_a"><span>28 articles</span></div><div class="gsc_rsb_m_na"><div>1 article</div></div><div class="gsc_rsb_m_bar"><div class="gsc_rsb_m_bar_na" style="width:3%"></div></div><div class="gsc_rsb_m_a"><span>available</span></div><div class="gsc_rsb_m_na"><span>not available</span></div><div class="gsc_rsb_m_desc">Based on funding mandates</div></div></div></div><div class="gsc_lcl" role="main" id="gsc_prf_w"><div id="gsc_prf"><button type="button" id="gsc_prf_btnf" class="gs_btnMW gs_in_ib gs_btn_act gs_btn_lsu gs_btn_mph"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Follow</span></span></button><div id="gsc_prf_pu"><div id="gsc_prf_pua" class="gs_rimg"><style>#gsc_prf_pup-img{width:122px;height:128px;}@media print{#gs_top #gsc_prf_pup-img{width:76pt;height:80pt;}}</style><img alt="Francesco Dazzi" sizes="print 76px,122px" src="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=7-4XHiUAAAAJ&amp;citpid=4" id="gsc_prf_pup-img" srcset="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=7-4XHiUAAAAJ&amp;citpid=4 122w,https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=7-4XHiUAAAAJ&amp;citpid=4 244w"></div></div><div id="gsc_prf_i"><div id="gsc_prf_in">Francesco Dazzi</div><div class="gsc_prf_il">Professor of Regenerative Medicine, <a href="/citations?view_op=view_org&amp;hl=en&amp;org=1087198676816281164" class="gsc_prf_ila">King's College London</a></div><div class="gsc_prf_il" id="gsc_prf_ivh">Verified email at kcl.ac.uk</div><div class="gsc_prf_il" id="gsc_prf_int"><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:mesenchymal_stromal_cells" class="gsc_prf_inta gs_ibl">mesenchymal stromal cells</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:cell_death" class="gsc_prf_inta gs_ibl">cell death</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:inflammation" class="gsc_prf_inta gs_ibl">inflammation</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:bone_marrow_transplantation" class="gsc_prf_inta gs_ibl">bone marrow transplantation</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:donor_lymphocyte_infusion" class="gsc_prf_inta gs_ibl">donor lymphocyte infusion</a></div></div></div></div><div id="gsc_prf_t_wrp" role="navigation"><div id="gsc_prf_t" role="tablist"><a id="gsc_prf_t-art" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_art" aria-selected="true">Articles</a><a id="gsc_prf_t-cit" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_cit">Cited by</a><a id="gsc_prf_t-mnd" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_mnd">Public access</a></div></div><div class="gsc_lcl gsc_prf_pnl" id="gsc_art" role="region" aria-labelledby="gsc_prf_t-art"><form method="post" action="/citations?hl=en&amp;user=7-4XHiUAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYT8s_cDbNjJhH1s4GtF5DvG1F6hdBW2g"><div id="gsc_a_tw"><table id="gsc_a_t"><thead><tr id="gsc_a_tr0" aria-hidden="true"><th class="gsc_a_t"></th><th class="gsc_a_c"></th><th class="gsc_a_y"></th></tr><tr id="gsc_a_trh"><th class="gsc_a_t" scope="col"><span id="gsc_a_ta"><a href="/citations?hl=en&amp;user=7-4XHiUAAAAJ&amp;view_op=list_works&amp;sortby=title" class="gsc_a_a">Title</a></span><div id="gsc_dd_sort-r" class="gs_md_r gs_md_rmb gs_md_rmbl"><button type="button" id="gsc_dd_sort-b" aria-controls="gsc_dd_sort-d" aria-haspopup="true" ontouchstart="gs_evt_dsp(event)" class=" gs_in_se gs_btn_mnu gs_btn_flat gs_btn_lrge gs_btn_half gs_btn_lsu gs_press gs_md_tb"><span class="gs_wr"><span class="gs_lbl">Sort</span><span class="gs_icm"></span></span></button><div id="gsc_dd_sort-d" class="gs_md_d gs_md_ulr" role="menu" tabindex="-1"><div id="gsc_dd_sort-s" class="gs_oph gsc_dd_sec gsc_dd_sep"><a role="menuitem" href="/citations?hl=en&amp;user=7-4XHiUAAAAJ&amp;view_op=list_works" tabindex="-1" class="gs_md_li gsc_dd_sort-sel">Sort by citations</a><a role="menuitem" href="/citations?hl=en&amp;user=7-4XHiUAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" tabindex="-1" class="gs_md_li">Sort by year</a><a role="menuitem" href="/citations?hl=en&amp;user=7-4XHiUAAAAJ&amp;view_op=list_works&amp;sortby=title" tabindex="-1" class="gs_md_li">Sort by title</a></div></div></div></th><th class="gsc_a_c" scope="col" dir="rtl"><span id="gsc_a_ca"><div class="gs_nph">Cited by</div><div class="gs_oph">Cited by</div></span></th><th class="gsc_a_y" scope="col"><span class="gsc_a_h" id="gsc_a_ha"><a href="/citations?hl=en&amp;user=7-4XHiUAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" class="gsc_a_a">Year</a></span></th></tr></thead><tbody id="gsc_a_b"><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;citation_for_view=7-4XHiUAAAAJ:u5HHmVD_uO8C" class="gsc_a_at">Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide</a><div class="gs_gray">M Krampera, S Glennie, J Dyson, D Scott, R Laylor, E Simpson, F Dazzi</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 101 (9), 3722-3729<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15246934606408848571" class="gsc_a_ac gs_ibl">2055</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;citation_for_view=7-4XHiUAAAAJ:u-x6o8ySG0sC" class="gsc_a_at">Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells</a><div class="gs_gray">S Glennie, I Soeiro, PJ Dyson, EWF Lam, F Dazzi</div><div class="gs_gray">Blood 105 (7), 2821-2827<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10181603844018408073" class="gsc_a_ac gs_ibl">1388</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;citation_for_view=7-4XHiUAAAAJ:IjCSPb-OGe4C" class="gsc_a_at">Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle</a><div class="gs_gray">R Ramasamy, H Fazekasova, EWF Lam, I Soeiro, G Lombardi, F Dazzi</div><div class="gs_gray">Transplantation 83 (1), 71-76<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10828351385814652554" class="gsc_a_ac gs_ibl">550</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;citation_for_view=7-4XHiUAAAAJ:d1gkVwhDpl0C" class="gsc_a_at">The Risk of Recurrent Venous Thromboembolism in Patients with an Arg<sup>506</sup>→Gln Mutation in the Gene for Factor V (Factor V Leiden)</a><div class="gs_gray">P Simioni, P Prandoni, AWA Lensing, A Scudeller, C Sardella, MH Prins, ...</div><div class="gs_gray">New England Journal of Medicine 336 (6), 399-403<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10346692490724478068" class="gsc_a_ac gs_ibl">519</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;citation_for_view=7-4XHiUAAAAJ:Y0pCki6q_DkC" class="gsc_a_at">Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth</a><div class="gs_gray">R Ramasamy, EWF Lam, I Soeiro, V Tisato, D Bonnet, F Dazzi</div><div class="gs_gray">Leukemia 21 (2), 304-310<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8399929671167277294" class="gsc_a_ac gs_ibl">473</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;citation_for_view=7-4XHiUAAAAJ:qjMakFHDy7sC" class="gsc_a_at">The role of mesenchymal stem cells in haemopoiesis</a><div class="gs_gray">F Dazzi, R Ramasamy, S Glennie, SP Jones, I Roberts</div><div class="gs_gray">Blood reviews 20 (3), 161-171<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14798776044280182231" class="gsc_a_ac gs_ibl">457</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;citation_for_view=7-4XHiUAAAAJ:ULOm3_A8WrAC" class="gsc_a_at">Mesenchymal stem cells: the fibroblasts’ new clothes?</a><div class="gs_gray">MA Haniffa, MP Collin, CD Buckley, F Dazzi</div><div class="gs_gray">Haematologica 94 (2), 258<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6450597209076832708" class="gsc_a_ac gs_ibl">412</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;citation_for_view=7-4XHiUAAAAJ:zYLM7Y9cAGgC" class="gsc_a_at">Characterization and Clinical Application of Human CD34<sup>+</sup> Stem/Progenitor Cell Populations Mobilized into the Blood by Granulocyte Colony‐Stimulating Factor</a><div class="gs_gray">MY Gordon, N Levičar, M Pai, P Bachellier, I Dimarakis, F Al‐Allaf, ...</div><div class="gs_gray">Stem cells 24 (7), 1822-1830<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13183313662738456888" class="gsc_a_ac gs_ibl">391</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;citation_for_view=7-4XHiUAAAAJ:W7OEmFMy1HYC" class="gsc_a_at">European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor</a><div class="gs_gray">D Marin, D Milojkovic, E Olavarria, JS Khorashad, H De Lavallade, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (12), 4437-4444<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10213996745533773651" class="gsc_a_ac gs_ibl">386</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;citation_for_view=7-4XHiUAAAAJ:9yKSN-GCB0IC" class="gsc_a_at">Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia</a><div class="gs_gray">F Dazzi, RM Szydlo, C Craddock, NCP Cross, J Kaeda, A Chase, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 95 (1), 67-71<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5508644949313666449" class="gsc_a_ac gs_ibl">384</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;citation_for_view=7-4XHiUAAAAJ:5icHVeHT4IsC" class="gsc_a_at">Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation</a><div class="gs_gray">A Galleu, Y Riffo-Vasquez, C Trento, C Lomas, L Dolcetti, TS Cheung, ...</div><div class="gs_gray">Science translational medicine 9 (416)<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1045883969730562573" class="gsc_a_ac gs_ibl">332</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;citation_for_view=7-4XHiUAAAAJ:_FxGoFyzp5QC" class="gsc_a_at">The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells</a><div class="gs_gray">S Jones, N Horwood, A Cope, F Dazzi</div><div class="gs_gray">The Journal of Immunology 179 (5), 2824-2831<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7092592515314492881" class="gsc_a_ac gs_ibl">301</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;citation_for_view=7-4XHiUAAAAJ:6ZxmRoH8BuwC" class="gsc_a_at">International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials</a><div class="gs_gray">J Galipeau, M Krampera, J Barrett, F Dazzi, RJ Deans, J DeBruijn, ...</div><div class="gs_gray">Cytotherapy 18 (2), 151-159<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2384753707202201801" class="gsc_a_ac gs_ibl">300</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;citation_for_view=7-4XHiUAAAAJ:2osOgNQ5qMEC" class="gsc_a_at">Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia</a><div class="gs_gray">F Dazzi, RM Szydlo, NCP Cross, C Craddock, J Kaeda, E Kanfer, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 96 (8), 2712-2716<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3575627439388472079" class="gsc_a_ac gs_ibl">296</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;citation_for_view=7-4XHiUAAAAJ:i2xiXl-TujoC" class="gsc_a_at">Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice</a><div class="gs_gray">T Ruutu, A Gratwohl, T De Witte, B Afanasyev, J Apperley, A Bacigalupo, ...</div><div class="gs_gray">Bone marrow transplantation 49 (2), 168-173<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=931985988069857034" class="gsc_a_ac gs_ibl">281</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;citation_for_view=7-4XHiUAAAAJ:mVmsd5A6BfQC" class="gsc_a_at">The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function</a><div class="gs_gray">R Ramasamy, CK Tong, HF Seow, S Vidyadaran, F Dazzi</div><div class="gs_gray">Cellular immunology 251 (2), 131-136<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15112538908865124046" class="gsc_a_ac gs_ibl">258</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;citation_for_view=7-4XHiUAAAAJ:YsMSGLbcyi4C" class="gsc_a_at">HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation</a><div class="gs_gray">M Krampera, A Pasini, A Rigo, MT Scupoli, C Tecchio, G Malpeli, ...</div><div class="gs_gray">Blood 106 (1), 59-66<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16525103795616175893" class="gsc_a_ac gs_ibl">251</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;citation_for_view=7-4XHiUAAAAJ:0EnyYjriUFMC" class="gsc_a_at">Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease</a><div class="gs_gray">V Tisato, K Naresh, J Girdlestone, C Navarrete, F Dazzi</div><div class="gs_gray">Leukemia 21 (9), 1992-1999<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14615706724883617028" class="gsc_a_ac gs_ibl">232</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;citation_for_view=7-4XHiUAAAAJ:UeHWp8X0CEIC" class="gsc_a_at">Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose</a><div class="gs_gray">C Guglielmi, W Arcese, F Dazzi, R Brand, D Bunjes, LF Verdonck, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 100 (2), 397-405<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8062333621299464371" class="gsc_a_ac gs_ibl">230</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;citation_for_view=7-4XHiUAAAAJ:ZeXyd9-uunAC" class="gsc_a_at">The immunosuppressive properties of mesenchymal stem cells</a><div class="gs_gray">G Siegel, R Schäfer, F Dazzi</div><div class="gs_gray">Transplantation 87 (9S), S45-S49<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15000330025941682453" class="gsc_a_ac gs_ibl">210</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:YOwf2qJgpHMC" class="gsc_a_at">Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses</a><div class="gs_gray">H Karlsson, S Samarasinghe, LM Ball, B Sundberg, AC Lankester, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (3), 532-541<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15302025213276620267" class="gsc_a_ac gs_ibl">207</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:LkGwnXOMwfcC" class="gsc_a_at">Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31&nbsp;…</a><div class="gs_gray">A Tyndall, UA Walker, A Cope, F Dazzi, C De Bari, W Fibbe, S Guiducci, ...</div><div class="gs_gray">Arthritis research &amp; therapy 9 (1), 1-10<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9227769450331255696" class="gsc_a_ac gs_ibl">207</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:4TOpqqG69KYC" class="gsc_a_at">Long‐term clinical results of autologous infusion of mobilized adult bone marrow derived CD34<sup>+</sup> cells in patients with chronic liver disease</a><div class="gs_gray">N Levičar, M Pai, NA Habib, P Tait, LR Jiao, SB Marley, J Davis, F Dazzi, ...</div><div class="gs_gray">Cell proliferation 41, 115-125<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4545211593589145982" class="gsc_a_ac gs_ibl">204</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:70eg2SAEIzsC" class="gsc_a_at">The immunomodulatory properties of mesenchymal stem cells</a><div class="gs_gray">I Marigo, F Dazzi</div><div class="gs_gray">Seminars in immunopathology 33 (6), 593-602<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16162381485602930694" class="gsc_a_ac gs_ibl">194</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:TIZ-Mc8IlK0C" class="gsc_a_at">Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment</a><div class="gs_gray">F Mussai, C De Santo, I Abu-Dayyeh, S Booth, L Quek, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (5), 749-758<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8951986731046388268" class="gsc_a_ac gs_ibl">191</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:Tyk-4Ss8FVUC" class="gsc_a_at">Early detection of <i>BCR-ABL</i> transcripts by quantitative reverse transcriptase–polymerase chain reaction predicts outcome after allogeneic stem cell transplantation&nbsp;…</a><div class="gs_gray">E Olavarria, E Kanfer, R Szydlo, J Kaeda, K Rezvani, K Cwynarski, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 97 (6), 1560-1565<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4532271329727723342" class="gsc_a_ac gs_ibl">187</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:j3f4tGmQtD8C" class="gsc_a_at">Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis</a><div class="gs_gray">F Vianello, F Villanova, V Tisato, S Lymperi, KK Ho, AR Gomes, D Marin, ...</div><div class="gs_gray">Haematologica 95 (7), 1081<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3038105929566828492" class="gsc_a_ac gs_ibl">177</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:WF5omc3nYNoC" class="gsc_a_at">Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro</a><div class="gs_gray">K Cwynarski, R Laylor, E Macchiarulo, J Goldman, G Lombardi, JV Melo, ...</div><div class="gs_gray">Leukemia 18 (8), 1332-1339<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11264897081654923051" class="gsc_a_ac gs_ibl">156</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:8k81kl-MbHgC" class="gsc_a_at">Potential of mesenchymal stem cell therapy</a><div class="gs_gray">F Dazzi, NJ Horwood</div><div class="gs_gray">Current opinion in oncology 19 (6), 650-655<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1013523668575517560" class="gsc_a_ac gs_ibl">149</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:hFOr9nPyWt4C" class="gsc_a_at">Strontium can increase some osteoblasts without increasing hematopoietic stem cells</a><div class="gs_gray">S Lymperi, N Horwood, S Marley, MY Gordon, AP Cope, F Dazzi</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 111 (3), 1173-1181<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16505136620723752604" class="gsc_a_ac gs_ibl">145</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:NMxIlDl6LWMC" class="gsc_a_at">Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo</a><div class="gs_gray">S Lymperi, A Ersek, F Ferraro, F Dazzi, NJ Horwood</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 117 (5), 1540-1549<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16600334931527742211" class="gsc_a_ac gs_ibl">144</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:MXK_kJrjxJIC" class="gsc_a_at">Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may&nbsp;…</a><div class="gs_gray">J Kaeda, D O'shea, RM Szydlo, E Olavarria, F Dazzi, D Marin, S Saunders, ...</div><div class="gs_gray">Blood 107 (10), 4171-4176<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16164823270084097155" class="gsc_a_ac gs_ibl">144</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:t6usbXjVLHcC" class="gsc_a_at">Mesenchymal stromal cells and regulatory T cells: the Yin and Yang of peripheral tolerance?</a><div class="gs_gray">SP Burr, F Dazzi, OA Garden</div><div class="gs_gray">Immunology and cell biology 91 (1), 12-18<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16828738365896744225" class="gsc_a_ac gs_ibl">143</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:roLk4NBRz8UC" class="gsc_a_at">Chronic myeloid leukemia in chronic phase responding to imatinib: the occurrence of additional cytogenetic abnormalities predicts disease progression</a><div class="gs_gray">S Marktel, D Marin, N Foot, R Szydlo, M Bua, A Karadimitris, VA De Melo, ...</div><div class="gs_gray">Haematologica 88 (3), 260-267<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18285570188997437411" class="gsc_a_ac gs_ibl">143</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:eQOLeE2rZwMC" class="gsc_a_at">Two distinct HLA-A0201–presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTL</a><div class="gs_gray">I Bellantuono, L Gao, S Parry, S Marley, F Dazzi, J Apperley, JM Goldman, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 100 (10), 3835-3837<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2569408474118605519" class="gsc_a_ac gs_ibl">140</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:ufrVoPGSRksC" class="gsc_a_at">Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand</a><div class="gs_gray">F Dazzi, RM Szydlo, JM Goldman</div><div class="gs_gray">Experimental hematology 27 (10), 1477-1486<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17217049170544686267" class="gsc_a_ac gs_ibl">135</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:pqnbT2bcN3wC" class="gsc_a_at">Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate</a><div class="gs_gray">C Capelli, E Gotti, M Morigi, C Rota, L Weng, F Dazzi, O Spinelli, ...</div><div class="gs_gray">Cytotherapy 13 (7), 786-801<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4860449823033106319" class="gsc_a_ac gs_ibl">133</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:RGFaLdJalmkC" class="gsc_a_at">Mesenchymal stem cells and autoimmune diseases</a><div class="gs_gray">F Dazzi, M Krampera</div><div class="gs_gray">Best Practice &amp; Research Clinical Haematology 24 (1), 49-57<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9991535308265170012" class="gsc_a_ac gs_ibl">129</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:5nxA0vEk-isC" class="gsc_a_at">4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis</a><div class="gs_gray">MT Sartori, B Wiman, S Vettore, F Dazzi, A Girolami, GM Patrassi</div><div class="gs_gray">Thrombosis and haemostasis 80 (12), 956-960<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4742778615281114801" class="gsc_a_ac gs_ibl">127</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:KxtntwgDAa4C" class="gsc_a_at">Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation</a><div class="gs_gray">A Chaidos, S Patterson, R Szydlo, MS Chaudhry, F Dazzi, E Kanfer, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 119 (21), 5030-5036<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4019898301054752099" class="gsc_a_ac gs_ibl">124</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:IWHjjKOFINEC" class="gsc_a_at">The highway code of T cell trafficking</a><div class="gs_gray">FM Marelli‐Berg, L Cannella, F Dazzi, V Mirenda</div><div class="gs_gray">The Journal of Pathology: A Journal of the Pathological Society of Great&nbsp;…<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5785729692214386652" class="gsc_a_ac gs_ibl">123</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:3fE2CSJIrl8C" class="gsc_a_at">Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for&nbsp;…</a><div class="gs_gray">D Marin, J Kaeda, R Szydlo, S Saunders, A Fleming, J Howard, ...</div><div class="gs_gray">Leukemia 19 (4), 507-512<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=633937932606468632" class="gsc_a_ac gs_ibl">120</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:4DMP91E08xMC" class="gsc_a_at">Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans</a><div class="gs_gray">E James, JG Chai, H Dewchand, E Macchiarulo, F Dazzi, E Simpson</div><div class="gs_gray">Blood 102 (1), 388-393<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11155149369734717042" class="gsc_a_ac gs_ibl">120</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:Se3iqnhoufwC" class="gsc_a_at">Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease.</a><div class="gs_gray">G Pizzolo, M Chilosi, F Vinante, F Dazzi, M Lestani, G Perona, F Benedetti, ...</div><div class="gs_gray">British journal of cancer 55 (4), 427<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5107806898118798132" class="gsc_a_ac gs_ibl">118</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:hqOjcs7Dif8C" class="gsc_a_at">Cytomegalovirus seropositivity adversely influences outcome after T‐depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft&nbsp;…</a><div class="gs_gray">C Craddock, RM Szydlo, F Dazzi, E Olavarria, K Cwynarski, A Yong, ...</div><div class="gs_gray">British journal of haematology 112 (1), 228-236<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17469767448271083013" class="gsc_a_ac gs_ibl">117</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:kNdYIx-mwKoC" class="gsc_a_at">Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration</a><div class="gs_gray">R Dong, K Cwynarski, A Entwistle, F Marelli-Berg, F Dazzi, E Simpson, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 101 (9), 3560-3567<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17283129410127993553" class="gsc_a_ac gs_ibl">115</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:sJsF-0ZLhtgC" class="gsc_a_at">Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters&nbsp;…</a><div class="gs_gray">M Chilosi, G Semenzato, G Cetto, A Ambrosetti, L Fiore-Donati, G Perona, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13642428738154189175" class="gsc_a_ac gs_ibl">115</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:_kc_bZDykSQC" class="gsc_a_at">Minor H antigens: genes and peptides</a><div class="gs_gray">E Simpson, D Scott, E James, G Lombardi, K Cwynarski, F Dazzi, ...</div><div class="gs_gray">Transplant immunology 10 (2-3), 115-123<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1128557419241416807" class="gsc_a_ac gs_ibl">111</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:UebtZRa9Y70C" class="gsc_a_at">Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantation</a><div class="gs_gray">E Olavarria, C Craddock, F Dazzi, D Marin, S Marktel, JF Apperley, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 99 (10), 3861-3862<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7893757188338302030" class="gsc_a_ac gs_ibl">106</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:hC7cP41nSMkC" class="gsc_a_at">Mesenchymal stem cells for graft‐<i>versus</i>‐host disease: Close encounters with T cells</a><div class="gs_gray">F Dazzi, FM Marelli‐Berg</div><div class="gs_gray">European journal of immunology 38 (6), 1479-1482<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1982198726194907803" class="gsc_a_ac gs_ibl">105</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:aqlVkmm33-oC" class="gsc_a_at">Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigens</a><div class="gs_gray">F Dazzi, E D'andrea, G Biasi, G De Silvestro, G Gaidano, M Schena, ...</div><div class="gs_gray">Clinical immunology and immunopathology 75 (1), 26-32<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15856112718532558437" class="gsc_a_ac gs_ibl">102</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:Wp0gIr-vW9MC" class="gsc_a_at">Cell therapy for autoimmune diseases</a><div class="gs_gray">F Dazzi, JM van Laar, A Cope, A Tyndall</div><div class="gs_gray">Arthritis research &amp; therapy 9 (2), 1-9<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16772980772188310932" class="gsc_a_ac gs_ibl">101</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:KlAtU1dfN6UC" class="gsc_a_at">The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation</a><div class="gs_gray">P Raanani, F Dazzi, J Sohal, RM Szydlo, F Van Rhee, A Reiter, F Lin, ...</div><div class="gs_gray">British journal of haematology 99 (4), 945-950<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13730511292489753774" class="gsc_a_ac gs_ibl">88</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:Zph67rFs4hoC" class="gsc_a_at">Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors</a><div class="gs_gray">F Van Rhee, D Savage, J Blackwell, K Orchard, F Dazzi, F Lin, A Chase, ...</div><div class="gs_gray">Bone marrow transplantation 21 (10), 1055-1061<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2094160656940872653" class="gsc_a_ac gs_ibl">87</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:wbdj-CoPYUoC" class="gsc_a_at">Mesenchymal stromal cells: a key player in ‘innate tolerance’?</a><div class="gs_gray">F Dazzi, L Lopes, L Weng</div><div class="gs_gray">Immunology 137 (3), 206-213<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3775280028644842038" class="gsc_a_ac gs_ibl">84</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:4vMrXwiscB8C" class="gsc_a_at">Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials</a><div class="gs_gray">A Palumbo, A Waage, C Hulin, M Beksac, S Zweegman, F Gay, P Gimsing, ...</div><div class="gs_gray">haematologica 98 (1), 87<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=960340004573105731,77689817358808686" class="gsc_a_ac gs_ibl">82</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:qxL8FJ1GzNcC" class="gsc_a_at">The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor’s&nbsp;…</a><div class="gs_gray">F Dazzi, D Capelli, R Hasserjian, F Cotter, M Corbo, A Poletti, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 92 (4), 1390-1396<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11618399027120031182" class="gsc_a_ac gs_ibl">81</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:bKqednn6t2AC" class="gsc_a_at">Signed languages and globalization</a><div class="gs_gray">A Hiddinga, O Crasborn</div><div class="gs_gray">Language in society 40 (4), 483-505<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13209552662701206010,16531339169880366443,15955769337981752370,5439014840440644177" class="gsc_a_ac gs_ibl">80</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:dhFuZR0502QC" class="gsc_a_at">High incidence of anti‐FVIII antibodies against non‐coagulant epitopes in haemophilia A patients: a possible role for the half‐life of transfused FVIII</a><div class="gs_gray">F Dazzi, T Tison, F Vianello, P Radossi, P Zerbinati, P Carraro, A Poletti, ...</div><div class="gs_gray">British journal of haematology 93 (3), 688-693<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7034425454404699924" class="gsc_a_ac gs_ibl">80</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:M3ejUd6NZC8C" class="gsc_a_at">Examination of HY response: T cell expansion, immunodominance, and cross-priming revealed by HY tetramer analysis</a><div class="gs_gray">M Millrain, P Chandler, F Dazzi, D Scott, E Simpson, PJ Dyson</div><div class="gs_gray">The Journal of Immunology 167 (7), 3756-3764<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12422586476223705455" class="gsc_a_ac gs_ibl">78</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:AHdEip9mkN0C" class="gsc_a_at">Hematopoietic stem cell transplantation in its 60s: A platform for cellular therapies</a><div class="gs_gray">C Chabannon, J Kuball, A Bondanza, F Dazzi, P Pedrazzoli, A Toubert, ...</div><div class="gs_gray">Science translational medicine 10 (436)<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13534696085450162669" class="gsc_a_ac gs_ibl">76</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:jgBuDB5drN8C" class="gsc_a_at">Challenges for mesenchymal stromal cell therapies</a><div class="gs_gray">I Martin, J Galipeau, C Kessler, K Le Blanc, F Dazzi</div><div class="gs_gray">Science translational medicine 11 (480)<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10289368603705748636" class="gsc_a_ac gs_ibl">74</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:9ZlFYXVOiuMC" class="gsc_a_at">Estimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes into account patients who relapse and are restored to complete remission</a><div class="gs_gray">C Craddock, RM Szydlo, JP Klein, F Dazzi, E Olavarria, F van Rhee, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 96 (1), 86-90<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11393427162817211130" class="gsc_a_ac gs_ibl">73</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:wMgC3FpKEyYC" class="gsc_a_at">Bi-directional cell-pericellular matrix interactions direct stem cell fate</a><div class="gs_gray">SA Ferreira, MS Motwani, PA Faull, AJ Seymour, TL Tracy, M Enayati, ...</div><div class="gs_gray">Nature communications 9 (1), 1-12<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4919463011457978865" class="gsc_a_ac gs_ibl">72</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:QIV2ME_5wuYC" class="gsc_a_at">Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse</a><div class="gs_gray">TI Mughal, A Yong, RM Szydlo, F Dazzi, E Olavarria, F Van Rhee, ...</div><div class="gs_gray">British journal of haematology 115 (3), 569-574<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3150812532415654175" class="gsc_a_ac gs_ibl">71</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:-f6ydRqryjwC" class="gsc_a_at">Increased frequencies of CD4+ CD25 high T regs correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia</a><div class="gs_gray">E Nadal, M Garin, J Kaeda, J Apperley, R Lechler, F Dazzi</div><div class="gs_gray">Leukemia 21 (3), 472-479<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4426209861051115530" class="gsc_a_ac gs_ibl">69</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:q3oQSFYPqjQC" class="gsc_a_at">Human cytotoxic T lymphocytes specific for Wilms’ tumor antigen-1 inhibit engraftment of leukemia-initiating stem cells in non-obese diabetic-severe combined immunodeficient&nbsp;…</a><div class="gs_gray">L Gao, S Xue, R Hasserjian, F Cotter, J Kaeda, JM Goldman, F Dazzi, ...</div><div class="gs_gray">Transplantation 75 (9), 1429-1436<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10317990522163852428" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:_OXeSy2IsFwC" class="gsc_a_at">Adoptive immunotherapy following allogeneic bone marrow transplantation</a><div class="gs_gray">F Dazzi, JM Goldman</div><div class="gs_gray">Annual review of medicine 49 (1), 329-340<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3056323844158472814" class="gsc_a_ac gs_ibl">67</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:F9fV5C73w3QC" class="gsc_a_at">Monomeric, porous type II collagen scaffolds promote chondrogenic differentiation of human bone marrow mesenchymal stem cells in vitro</a><div class="gs_gray">M Tamaddon, M Burrows, SA Ferreira, F Dazzi, JF Apperley, A Bradshaw, ...</div><div class="gs_gray">Scientific reports 7 (1), 1-10<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12541352368931002369" class="gsc_a_ac gs_ibl">65</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:eMMeJKvmdy0C" class="gsc_a_at">Minor H antigens: genes and peptides</a><div class="gs_gray">E Simpson, D Scott, E James, G Lombardi, K Cwynarski, F Dazzi, ...</div><div class="gs_gray">European Journal of Immunogenetics 28 (5), 505-513<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16699618885537697795" class="gsc_a_ac gs_ibl">61</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:2P1L_qKh6hAC" class="gsc_a_at">Efficacy of tyrosine kinase inhibitors (TKIs) as third-line therapy in patients with chronic myeloid leukemia in chronic phase who have failed 2 prior lines of TKI therapy</a><div class="gs_gray">AR Ibrahim, C Paliompeis, M Bua, D Milojkovic, R Szydlo, JS Khorashad, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 116 (25), 5497-5500<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16993375401348800645" class="gsc_a_ac gs_ibl">60</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:TFP_iSt0sucC" class="gsc_a_at">Chronic GVHD as an autoimmune disease</a><div class="gs_gray">A Tyndall, F Dazzi</div><div class="gs_gray">Best Practice &amp; Research Clinical Haematology 21 (2), 281-289<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11166861887008601386" class="gsc_a_ac gs_ibl">59</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:0CzhzZyukY4C" class="gsc_a_at">Multiparametric analysis of circulating exosomes and other small extracellular vesicles by advanced imaging flow cytometry</a><div class="gs_gray">S Mastoridis, GM Bertolino, G Whitehouse, F Dazzi, A Sanchez-Fueyo, ...</div><div class="gs_gray">Frontiers in immunology 9, 1583<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7414272318086673161" class="gsc_a_ac gs_ibl">58</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:HbR8gkJAVGIC" class="gsc_a_at">MSCs: science and trials</a><div class="gs_gray">WE Fibbe, F Dazzi, K LeBlanc</div><div class="gs_gray">Nature medicine 19 (7), 812-813<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2052039464054129037" class="gsc_a_ac gs_ibl">58</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:BqipwSGYUEgC" class="gsc_a_at">Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT</a><div class="gs_gray">Y Chalandon, JR Passweg, C Schmid, E Olavarria, F Dazzi, MP Simula, ...</div><div class="gs_gray">Bone marrow transplantation 45 (3), 558-564<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15078503228655031924" class="gsc_a_ac gs_ibl">57</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:mB3voiENLucC" class="gsc_a_at">Disease relapse after haematopoietic stem cell transplantation: risk factors and treatment</a><div class="gs_gray">F Dazzi, C Fozza</div><div class="gs_gray">Best Practice &amp; Research Clinical Haematology 20 (2), 311-327<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17843622755939312735" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:7PzlFSSx8tAC" class="gsc_a_at">Donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukaemia</a><div class="gs_gray">MH Gilleece, F Dazzi</div><div class="gs_gray">Leukemia &amp; lymphoma 44 (1), 23-28<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13709170364603122743" class="gsc_a_ac gs_ibl">55</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:Ug5p-4gJ2f0C" class="gsc_a_at">Combined inhibition of p97 and the proteasome causes lethal disruption of the secretory apparatus in multiple myeloma cells</a><div class="gs_gray">HW Auner, AM Moody, TH Ward, M Kraus, E Milan, P May, A Chaidos, ...</div><div class="gs_gray">PloS one 8 (9), e74415<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14983095318290843416" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:5ugPr518TE4C" class="gsc_a_at">Mesenchymal stem cells and innate tolerance: biology and clinical applications</a><div class="gs_gray">F Dazzi, C Trento</div><div class="gs_gray">Swiss medical weekly 140 (4748)<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10772274374023806011" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:4JMBOYKVnBMC" class="gsc_a_at">TCRζ<sup>dim</sup>lymphocytes define populations of circulating effector cells that migrate to inflamed tissues</a><div class="gs_gray">Z Zhang, CL Gorman, AC Vermi, C Monaco, A Foey, S Owen, P Amjadi, ...</div><div class="gs_gray">Blood 109 (10), 4328-4335<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17631477579586042292" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:R3hNpaxXUhUC" class="gsc_a_at">Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy</a><div class="gs_gray">MP Simula, S Marktel, C Fozza, J Kaeda, RM Szydlo, E Nadal, M Bua, ...</div><div class="gs_gray">Leukemia 21 (5), 943-948<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5086959221396901662" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:qUcmZB5y_30C" class="gsc_a_at">Donor lymphocyte infusions</a><div class="gs_gray">F Dazzi, J Goldman</div><div class="gs_gray">Current opinion in hematology 6 (6), 394<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10761907186627670573" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:TQgYirikUcIC" class="gsc_a_at">Adjuvant interleukin-2 therapy for patients refractory to donor lymphocyte infusions</a><div class="gs_gray">E Nadal, A Fowler, E Kanfer, J Apperley, J Goldman, F Dazzi</div><div class="gs_gray">Experimental hematology 32 (2), 218-223<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10464119405549164421" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:4xDN1ZYqzskC" class="gsc_a_at">Manufacturing mesenchymal stromal cells for the treatment of graft-versus-host disease: a survey among centers affiliated with the European Society for Blood and Marrow&nbsp;…</a><div class="gs_gray">C Trento, ME Bernardo, A Nagler, S Kuçi, M Bornhäuser, U Köhl, D Strunk, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 24 (11), 2365-2370<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3340625878436911671" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:HoB7MX3m0LUC" class="gsc_a_at">The therapeutic activity of low-dose irradiation on experimental arthritis depends on the induction of endogenous regulatory T cell activity</a><div class="gs_gray">L Weng, RO Williams, PL Vieira, G Screaton, M Feldmann, F Dazzi</div><div class="gs_gray">Annals of the rheumatic diseases 69 (8), 1519-1526<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18028425355300194686" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:HDshCWvjkbEC" class="gsc_a_at">Cell biology of CML cells</a><div class="gs_gray">MY Gordon, F Dazzi, SB Marley, JL Lewis, D Nguyen, FH Grand, ...</div><div class="gs_gray">Leukemia 13 (1), S65-S71<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7416680564045797142" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:iH-uZ7U-co4C" class="gsc_a_at">Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission</a><div class="gs_gray">G Pizzolo, L Trentin, F Vinante, C Agostini, R Zambello, M Masciarelli, ...</div><div class="gs_gray">British journal of cancer 58 (3), 368-372<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10510063101652881457" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:_Qo2XoVZTnwC" class="gsc_a_at">Mesenchymal stem cell therapy for degenerative inflammatory disorders</a><div class="gs_gray">I Müller, S Lymperi, F Dazzi</div><div class="gs_gray">Current opinion in organ transplantation 13 (6), 639-644<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7804355959284443712" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:RHpTSmoSYBkC" class="gsc_a_at">Mesenchymal stem cells for graft-versus-host disease: a double edged sword?</a><div class="gs_gray">F Vianello, F Dazzi</div><div class="gs_gray">Leukemia 22 (3), 463-465<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5701949445829576152" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:r0BpntZqJG4C" class="gsc_a_at">Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with&nbsp;…</a><div class="gs_gray">K Cwynarski, R Goulding, C Pocock, F Dazzi, C Craddock, J Kaeda, ...</div><div class="gs_gray">Bone marrow transplantation 28 (6), 581-586<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9001599567541923335" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:umqufdRvDiIC" class="gsc_a_at">Classification and biology of tumour associated stromal cells</a><div class="gs_gray">L Raffaghello, F Dazzi</div><div class="gs_gray">Immunology letters 168 (2), 175-182<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12775752986755421521" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:F1b5ZUV5XREC" class="gsc_a_at">Mesenchymal-myeloid interaction in the regulation of immunity</a><div class="gs_gray">TS Cheung, F Dazzi</div><div class="gs_gray">Seminars in immunology 35, 59-68<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1736587678205524366" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:u_35RYKgDlwC" class="gsc_a_at">Effects of MSC co-injection on the reconstitution of aplastic anemia patient following hematopoietic stem cell transplantation</a><div class="gs_gray">BG Jaganathan, V Tisato, T Vulliamy, I Dokal, J Marsh, F Dazzi, D Bonnet</div><div class="gs_gray">Leukemia 24 (10), 1791-1795<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6814245117351437019" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:bEWYMUwI8FkC" class="gsc_a_at">Normal and chronic phase CML hematopoietic cells repopulate NOD/SCID bone marrow with different kinetics and cell lineage representation</a><div class="gs_gray">F Dazzi, R Hasserjian, MY Gordon, F Boecklin, F Cotter, M Corbo, ...</div><div class="gs_gray">The Hematology Journal 1 (5), 307-315<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2608813698869581479" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:blknAaTinKkC" class="gsc_a_at">Factors for graft‐<i>versus</i>‐host disease after donor lymphocyte infusions with an escalating dose regimen: lack of association with cell dose</a><div class="gs_gray">C Fozza, RM Szydlo, MM Abdel‐Rehim, E Nadal, JM Goldman, ...</div><div class="gs_gray">British journal of haematology 136 (6), 833-836<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12283673049883036294" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:e5wmG9Sq2KIC" class="gsc_a_at">Detection of B-cell monoclonality in fine needle aspiration by PCR analysis</a><div class="gs_gray">F Vianello, T Tison, P Radossi, A Poletti, A Galligioni, C Giacon, ...</div><div class="gs_gray">Leukemia &amp; lymphoma 29 (1-2), 179-185<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5654049282447841435" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:Bg7qf7VwUHIC" class="gsc_a_at">Repurposing tin mesoporphyrin as an immune checkpoint inhibitor shows therapeutic efficacy in preclinical models of cancer</a><div class="gs_gray">T Muliaditan, JW Opzoomer, J Caron, M Okesola, P Kosti, S Lall, ...</div><div class="gs_gray">Clinical Cancer Research 24 (7), 1617-1628<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12068056246825633910" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:gVv57TyPmFsC" class="gsc_a_at">Preclinical imaging methods for assessing the safety and efficacy of regenerative medicine therapies</a><div class="gs_gray">L Scarfe, N Brillant, JD Kumar, N Ali, A Alrumayh, M Amali, S Barbellion, ...</div><div class="gs_gray">NPJ Regenerative medicine 2 (1), 1-13<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4447272786823638381" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:_FM0Bhl9EiAC" class="gsc_a_at">Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1+ subpopulation</a><div class="gs_gray">L Devito, H Badraiq, A Galleu, DK Taheem, S Codognotto, R Siow, ...</div><div class="gs_gray">Regenerative medicine 9 (6), 723-732<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10881132699599767349" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=7-4XHiUAAAAJ:pyW8ca7W8N0C" class="gsc_a_at">Regulatory T cell therapy for the induction of clinical organ transplantation tolerance</a><div class="gs_gray">H Fan, P Cao, DS Game, F Dazzi, Z Liu, S Jiang</div><div class="gs_gray">Seminars in immunology 23 (6), 453-461<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11488224255097640099" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:anf4URPfarAC" class="gsc_a_at">Hematopoietic mobilization: potential biomarker of response to natalizumab in multiple sclerosis</a><div class="gs_gray">M Mattoscio, R Nicholas, MP Sormani, O Malik, JS Lee, AD Waldman, ...</div><div class="gs_gray">Neurology 84 (14), 1473-1482<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6688922310735841446" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:NhqRSupF_l8C" class="gsc_a_at">EBMT risk score predicts outcome of allogeneic hematopoietic stem cell transplantation in patients who have failed a previous transplantation procedure</a><div class="gs_gray">K Rezvani, EJ Kanfer, D Marin, I Gabriel, A Rahemtulla, A Taylor, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 18 (2), 235-240<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7817977494122444971" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:Br1UauaknNIC" class="gsc_a_at">High-dose therapy in multiple myeloma</a><div class="gs_gray">JL Harousseau</div><div class="gs_gray">Multiple Myeloma, 209-222<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10984795534997412372" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:maZDTaKrznsC" class="gsc_a_at">Prevalence of anti‐FVIII antibodies in severe haemophilia A patients with inversion of intron 22</a><div class="gs_gray">F Vianello, P Radossi, T Tison, F Dazzi, G Tagariello, P Giorgio Davoli, ...</div><div class="gs_gray">British journal of haematology 97 (4), 807-809<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18362105959783479625" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:WHdLCjDvYFkC" class="gsc_a_at">Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa</a><div class="gs_gray">E Rashidghamat, T Kadiyirire, S Ayis, G Petrof, L Liu, V Pullabhatla, ...</div><div class="gs_gray">Journal of the American Academy of Dermatology 83 (2), 447-454<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1475260045817125312" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:GnPB-g6toBAC" class="gsc_a_at">Progress in characterization, preparation and clinical applications of non-hematopoietic stem cells, 29–30 September 2006, Tübingen, Germany</a><div class="gs_gray">R Schäfer, M Dominici, I Müller, F Dazzi, K Bieback, K Godthardt, ...</div><div class="gs_gray">Cytotherapy 9 (4), 397-405<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6299309023290891713" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:M3NEmzRMIkIC" class="gsc_a_at">Engraftment of Allogeneic Hematopoietic Stem Cells Requires Both Inhibition of Host-Versus-Graft Responses and ‘Space'for Homeostatic Expansion</a><div class="gs_gray">R Laylor, H Dewchand, E Simpson, F Dazzi</div><div class="gs_gray">Transplantation 79 (11), 1484-1491<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11514932128428346989" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:isC4tDSrTZIC" class="gsc_a_at">Immunologic abnormalities in angioimmunoblastic lymphadenopathy</a><div class="gs_gray">G Pizzolo, F Vinante, C Agostini, R Zambello, L Trentin, M Masciarelli, ...</div><div class="gs_gray">Cancer 60 (10), 2412-2418<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16225723541814992491" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:zCSUwVk65WsC" class="gsc_a_at">Apoptotic mesenchymal stromal cells induce prostaglandin E2 in monocytes: implications for the monitoring of mesenchymal stromal cell activity</a><div class="gs_gray">TS Cheung, A Galleu, M von Bonin, M Bornhäuser, F Dazzi</div><div class="gs_gray">Haematologica 104 (10), e438<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6584139669153627771" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:ALROH1vI_8AC" class="gsc_a_at">Mesenchymal stromal cells for acute graft‐versus‐host disease: response at 1 week predicts probability of survival</a><div class="gs_gray">A Galleu, D Milojkovic, S Deplano, R Szydlo, S Loaiza, R Wynn, DI Marks, ...</div><div class="gs_gray">British journal of haematology 185 (1), 89-92<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8118815915916693340" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:k_IJM867U9cC" class="gsc_a_at">Low-intensity transplant regimens facilitate recruitment of donor-specific regulatory T cells that promote hematopoietic engraftment</a><div class="gs_gray">L Weng, J Dyson, F Dazzi</div><div class="gs_gray">Proceedings of the National Academy of Sciences 104 (20), 8415-8420<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1267923302988570666" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:7H_MAutzIkAC" class="gsc_a_at">Persistence of drug-resistant leukemic stem cells and impaired NK cell immunity in CML patients depend on MIR300 antiproliferative and PP2A-activating functions</a><div class="gs_gray">G Silvestri, R Trotta, L Stramucci, JJ Ellis, JG Harb, P Neviani, S Wang, ...</div><div class="gs_gray">Blood cancer discovery 1 (1), 48<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3757488269756295268" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:WA5NYHcadZ8C" class="gsc_a_at">Clinical perspectives of mesenchymal stem cells</a><div class="gs_gray">J Kramer, F Dazzi, M Dominici, P Schlenke, W Wagner</div><div class="gs_gray">Stem cells international 2012<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2241413860999289232" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:XUvXOeBm_78C" class="gsc_a_at">Mesenchymal stromal cells for graft versus host disease: mechanism-based biomarkers</a><div class="gs_gray">TS Cheung, GM Bertolino, C Giacomini, M Bornhäuser, F Dazzi, A Galleu</div><div class="gs_gray">Frontiers in Immunology 11, 1338<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18034289078416984909" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:JV2RwH3_ST0C" class="gsc_a_at">Prognostic factors for acute graft-versus-host disease after donor lymphocyte infusions</a><div class="gs_gray">F Dazzi, RM Szydlo, JF Apperley, JM Goldman</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 100 (7), 2673-2673<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11099640965034967025" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:BrmTIyaxlBUC" class="gsc_a_at">The probability of long-term leukaemia free survival for patients in molecular remission 5 years after allogeneic stem cell transplantation for chronic myeloid leukaemia in&nbsp;…</a><div class="gs_gray">TI Mughal, A Yong, R Szydlo, F Dazzi, E Olavarria, F van Rhee, J Kaeda, ...</div><div class="gs_gray">Br J Haematol 115 (3), 569-574<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12110674847408354709" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:nVrZBo8bIpAC" class="gsc_a_at">Advances in mesenchymal stromal cell therapy in the management of Crohn’s disease</a><div class="gs_gray">H Ibraheim, C Giacomini, Z Kassam, F Dazzi, N Powell</div><div class="gs_gray">Expert review of gastroenterology &amp; hepatology 12 (2), 141-153<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16482164187271389332" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:dBIO0h50nwkC" class="gsc_a_at">Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo</a><div class="gs_gray">IM Michelozzi, A Pievani, F Pagni, L Antolini, M Verna, P Corti, A Rovelli, ...</div><div class="gs_gray">British journal of haematology<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11031876333948994679" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:HE397vMXCloC" class="gsc_a_at">Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation</a><div class="gs_gray">GW Basak, LC de Wreede, A van Biezen, W Wiktor-Jedrzejczak, ...</div><div class="gs_gray">Bone marrow transplantation 48 (6), 837-842<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7635162607926652527" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:eJXPG6dFmWUC" class="gsc_a_at">P103-Mesenchymal stem cells administered via novel selective mesenteric artery cannulation for the treatment of severe refractory Crohn's disease</a><div class="gs_gray">L Dinesen, A Wang, F Vianello, P Tait, E Leen, J Davis, F Dazzi, S Ghosh</div><div class="gs_gray">Journal of Crohn's and Colitis 3 (1), S51-S52<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17504646974479206928,8818003135136029572" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:M05iB0D1s5AC" class="gsc_a_at">Basic research and clinical applications of non-hematopoietic stem cells, 4–5 April 2008, Tübingen, Germany</a><div class="gs_gray">R Schäfer, M Dominici, I Müller, E Horwitz, T Asahara, JWM Bulte, ...</div><div class="gs_gray">Cytotherapy 11 (2), 245-255<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8600219672679806978" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:YFjsv_pBGBYC" class="gsc_a_at">Management of chronic myeloid leukaemia in relapse following donor lymphocyte infusion induced remission: a retrospective study of the Clinical Trials Committee of the British&nbsp;…</a><div class="gs_gray">M Cummins, K Cwynarski, S Marktel, F Dazzi, J Cavenagh, RE Clark, ...</div><div class="gs_gray">Bone marrow transplantation 36 (12), 1065-1069<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18369843507794789508" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:mNrWkgRL2YcC" class="gsc_a_at">Complement C3 exacerbates imiquimod-induced skin inflammation and psoriasiform dermatitis</a><div class="gs_gray">C Giacomassi, N Buang, GS Ling, G Crawford, HT Cook, D Scott, F Dazzi, ...</div><div class="gs_gray">The Journal of investigative dermatology 137 (3), 760<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13896336951181919433" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:LhH-TYMQEocC" class="gsc_a_at">Bone marrow mesenchymal stromal cells induce nitric oxide synthase-dependent differentiation of CD11b+ cells that expedite hematopoietic recovery</a><div class="gs_gray">C Trento, I Marigo, A Pievani, A Galleu, L Dolcetti, CY Wang, M Serafini, ...</div><div class="gs_gray">haematologica 102 (5), 818<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5620319129041150690" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:9c2xU6iGI7YC" class="gsc_a_at">Rapid and efficient stable gene transfer to mesenchymal stromal cells using a modified foamy virus vector</a><div class="gs_gray">NP Sweeney, C Regan, J Liu, A Galleu, F Dazzi, D Lindemann, CA Rupar, ...</div><div class="gs_gray">Molecular Therapy 24 (7), 1227-1236<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10645803197097957007" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:4OULZ7Gr8RgC" class="gsc_a_at">Haemopoietic stem cell transplantation induces tolerance to donor antigens but not to foreign FVIII peptides</a><div class="gs_gray">J Uprichard, F Dazzi, JF Apperley, MA Laffan</div><div class="gs_gray">Haemophilia 16 (1), 143-147<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10842852643838042349" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:lmc2jWPfTJgC" class="gsc_a_at">Prediction of cytogenetic response to second generation TKI therapy in CML chronic phase patients who have failed imatinib therapy and early identification of factors that&nbsp;…</a><div class="gs_gray">D Milojkovic, M Bua, JF Apperley, K Kozlowski, J Sorori, L Foroni, A Reid, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 332-332<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3793367252360157082" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:hMod-77fHWUC" class="gsc_a_at">T-cell receptor repertoire usage after allografting differs between CD4+ CD25+ regulatory T cells and their CD4+ CD25− counterpart</a><div class="gs_gray">C Fozza, E Nadal, M Longinotti, F Dazzi</div><div class="gs_gray">Haematologica 92 (2), 206-214<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2119026082582538978" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:J_g5lzvAfSwC" class="gsc_a_at">Serum neopterin levels in haematological malignancies.</a><div class="gs_gray">A Caenazzo, F Pietrogrande, D Sgarabotto, F Dazzi, D Sartori, ...</div><div class="gs_gray">Haematologica 78 (4), 225-229<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=228117050777652393" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:O3NaXMp0MMsC" class="gsc_a_at">Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors.</a><div class="gs_gray">G Biasi, L Saggin, F Dazzi, A De Rossi, D Collavo</div><div class="gs_gray">The Journal of Immunology 130 (3), 1447-1450<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8453290098437137432" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:v1_lew4L6wgC" class="gsc_a_at">Acute myeloid leukaemia niche regulates response to L‐asparaginase</a><div class="gs_gray">IM Michelozzi, V Granata, G De Ponti, G Alberti, C Tomasoni, L Antolini, ...</div><div class="gs_gray">British journal of haematology 186 (3), 420-430<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4761983269445933831" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:kVjdVfd2voEC" class="gsc_a_at">Bone marrow transplantation 1957-2019</a><div class="gs_gray">E Simpson, F Dazzi</div><div class="gs_gray">Frontiers in immunology 10, 1246<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16378456382588558408" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:43bX7VzcjpAC" class="gsc_a_at">Comparison of human isogeneic Wharton’s jelly MSCs and iPSC-derived MSCs reveals differentiation-dependent metabolic responses to IFNG stimulation</a><div class="gs_gray">L Devito, ME Klontzas, A Cvoro, A Galleu, M Simon, C Hobbs, F Dazzi, ...</div><div class="gs_gray">Cell death &amp; disease 10 (4), 1-13<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=585150501566533552" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:35N4QoGY0k4C" class="gsc_a_at">A role for platelet-derived growth factor in drug-induced chronic ergotism? A case report</a><div class="gs_gray">F Pietrogrande, A Caenazzo, F Dazzi, G Polato, A Girolami</div><div class="gs_gray">Angiology 46 (7), 633-636<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10275315816170980466" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:U4n9YNQMCAIC" class="gsc_a_at">Human mesenchymal stromal cells engineered to express collagen VII can restore anchoring fibrils in recessive dystrophic epidermolysis bullosa skin graft chimeras</a><div class="gs_gray">A Petrova, C Georgiadis, RA Fleck, L Allison, JA McGrath, F Dazzi, WL Di, ...</div><div class="gs_gray">Journal of Investigative Dermatology 140 (1), 121-131. e6<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=572377190994360865" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:ZuybSZzF8UAC" class="gsc_a_at">Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT</a><div class="gs_gray">AJ Innes, R Beattie, R Sergeant, G Damaj, L Foroni, D Marin, E Kanfer, ...</div><div class="gs_gray">Bone marrow transplantation 48 (10), 1324-1328<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7864059109870374085" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:bFI3QPDXJZMC" class="gsc_a_at">Dasatinib may not suppress the GVL effect of donor lymphocyte infusions for CML</a><div class="gs_gray">P Garland, F Dazzi, D Marin</div><div class="gs_gray">Bone marrow transplantation 45 (2), 395-396<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9602889316666840983" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:NaGl4SEjCO4C" class="gsc_a_at">Minor antigen solves major problem</a><div class="gs_gray">F Dazzi, E Simpson, JM Goldman</div><div class="gs_gray">Nature medicine 7 (7), 769-770<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10022991464171486817" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:RYcK_YlVTxYC" class="gsc_a_at">Immunotherapy for chronic myeloid leukaemia</a><div class="gs_gray">JF Apperley, F Dazzi, C Craddock, JM Goldman</div><div class="gs_gray">Hematology and cell therapy (Print) 40 (5), 229-232<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6579839852941961935" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:PYBJJbyH-FwC" class="gsc_a_at">Early detection of BCR-ABL transcripts by quantitative RT-PCR predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia</a><div class="gs_gray">E Olavarria, E Kanfer, R Szydlo, J Kaeda, K Rezvani, K Cwynarski, ...</div><div class="gs_gray">Blood 97 (6), 1560-1565<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3964466595802592452" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:foquWX3nUaYC" class="gsc_a_at">Enhanced and aberrant T cell trafficking following total body irradiation: a gateway to graft‐versus‐host disease?</a><div class="gs_gray">F Vianello, L Cannella, D Coe, JG Chai, D Golshayan, FM Marelli‐Berg, ...</div><div class="gs_gray">British journal of haematology 162 (6), 808-818<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12934000366609770793" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:lSLTfruPkqcC" class="gsc_a_at">Minor histocompatibility antigens and stem cell transplantation</a><div class="gs_gray">R Laylor, L Cannella, E Simpson, F Dazzi</div><div class="gs_gray">Vox sanguinis 87, 11-14<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2382231574295241120" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:3s1wT3WcHBgC" class="gsc_a_at">Intractable pruritus in non-Hodgkin lymphoma/CLL: rapid response to IFN alpha.</a><div class="gs_gray">P Radossi, T Tison, F Vianello, F Dazzi</div><div class="gs_gray">British journal of haematology 94 (3), 579-579<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10963830580967722387" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:g5m5HwL7SMYC" class="gsc_a_at">Biased TCR gene usage in alloreactive T cells specific for a structurally dissimilar MHC alloantigen</a><div class="gs_gray">A George, F Dazzi, J Lynch, S Sidhu, F Marelli, RJ Batchelor, G Lombardi, ...</div><div class="gs_gray">International immunology 6 (11), 1785-1790<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9117360392423903575" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:BJbdYPG6LGMC" class="gsc_a_at">Effects of maternal obesity on Wharton’s Jelly mesenchymal stromal cells</a><div class="gs_gray">H Badraiq, A Cvoro, A Galleu, M Simon, C Miere, C Hobbs, R Schulz, ...</div><div class="gs_gray">Scientific reports 7 (1), 1-13<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18307248922662098041" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:08ZZubdj9fEC" class="gsc_a_at">Regulatory T cells in stem cell transplantation: main characters or walk-on actors?</a><div class="gs_gray">C Fozza, F Dazzi</div><div class="gs_gray">Critical reviews in oncology/hematology 84 (1), 18-25<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11136321980746167360" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:CdxZDUztZiMC" class="gsc_a_at">Prolonged duodenal paralysis after PEG placement in a patient with traumatic brain injury: a case report.</a><div class="gs_gray">P Mammi, B Zaccaria, F Dazzi, M Saccavini</div><div class="gs_gray">European journal of physical and rehabilitation medicine 47 (1), 49-51<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5882979696040966629" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:GFxP56DSvIMC" class="gsc_a_at">Mesenchymal stem cells</a><div class="gs_gray">S Brenton, B Nathalie, OS Teresa</div><div class="gs_gray">Arch Med Res 34 (6), 565N571<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6226394689120609306" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:LI9QrySNdTsC" class="gsc_a_at">Response to donor lymphocyte infusions (DLI) of patients with CML in relapse after allografting: A long-term follow-up study using RT-PCR.</a><div class="gs_gray">K Cwynarski, F Dazzi, NCP Cross, A Yong, C Craddock, J Kaeda, ...</div><div class="gs_gray">Blood 94 (10), 669A-669A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6381864729941524477" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:b1wdh0AR-JQC" class="gsc_a_at">Adoptive immunotherapy for patients who relapse after allografting for chronic myeloid leukemia: A comparison of two regimens for donor lymphocyte infusion.</a><div class="gs_gray">F Dazzi, RM Szydlo, C Craddock, E Olavarria, J Kaeda, F van Rhee, ...</div><div class="gs_gray">Blood 92 (10), 653A-653A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10210950262254615805" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:mvPsJ3kp5DgC" class="gsc_a_at">Leukemia free survival after allogeneic transplantation for chronic myeloid leukemia: Effect of reclassifying responders to donor lymphocyte infusion as''currently free of&nbsp;…</a><div class="gs_gray">C Craddock, R Szydlo, E Olavarria, F Dazzi, F VanRhee, J Apperley, ...</div><div class="gs_gray">Blood 90 (10), 4449-4449<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1477797330690898265" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:vV6vV6tmYwMC" class="gsc_a_at">Rearrangement for the T‐cell receptor gene and co‐expression of immature T‐cell markers and natural killer cell phenotype, in a patient with acute lymphoblastic leukaemia</a><div class="gs_gray">G Pizzolo, L Trentin, F Vinante, C Agostini, R Zambello, A Ranucci, ...</div><div class="gs_gray">British journal of haematology 65 (1), 17-22<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6887279376456919125" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:2tRrZ1ZAMYUC" class="gsc_a_at">Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP</a><div class="gs_gray">R Greco, F Ciceri, M Noviello, A Bondanza, L Vago, G Oliveira, ...</div><div class="gs_gray">Bone marrow transplantation 53 (9), 1201-1205<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3206248342666247742" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:kuK5TVdYjLIC" class="gsc_a_at">AN ANIMAL-MODEL TO EXPLORE THE MOLECULAR-BASIS OF FACTOR-VIII (FVIII) INHIBITOR FORMATION-EVIDENCE OF ANTI-FVIII T-CELL RESPONSE AND IMPORTANCE OF ADMINISTRATION ROUTE</a><div class="gs_gray">F Dazzi, A Rosato, T Tison, F Vianello, P Radossi, A Girolami</div><div class="gs_gray">Thrombosis and Haemostasis 73 (6), 1026-1026<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6610245929782791636" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:hsZV8lGYWTMC" class="gsc_a_at">Immunomodulatory properties of mesenchymal stromal cells: An update</a><div class="gs_gray">L Müller, A Tunger, M Wobus, M Von Bonin, R Towers, M Bornhäuser, ...</div><div class="gs_gray">Frontiers in Cell and Developmental Biology 9<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8530170714363495889" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:wKETBy42zhYC" class="gsc_a_at">The emergence of regenerative medicine in organ transplantation: 1st European Cell Therapy and Organ Regeneration Section meeting</a><div class="gs_gray">MJ Hoogduijn, N Montserrat, LJW van der Laan, F Dazzi, N Perico, ...</div><div class="gs_gray">Transplant International 33 (8), 833-840<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3909309387220032802" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:GtLg2Ama23sC" class="gsc_a_at">Unique regulatory properties of mesangial cells are genetically determined in the rat</a><div class="gs_gray">PC Lai, LY Chiu, P Srivastava, C Trento, F Dazzi, E Petretto, HT Cook, ...</div><div class="gs_gray">Plos one 9 (10), e111452<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16532347175113834356" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:q3CdL3IzO_QC" class="gsc_a_at">Cancer makes new friends with old tricks</a><div class="gs_gray">F Dazzi</div><div class="gs_gray">Blood 122 (7), 1093-1094<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16440584478216568538" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:SeFeTyx0c_EC" class="gsc_a_at">Immunotherapy by non-myeloablative stem cell transplantation: study of the immune reconstitution. Arguments for distinct cell subsets in skin and blood</a><div class="gs_gray">F Garban, M Gallagher, E Jouvin-Marche, MC Jacob, A Moine, ...</div><div class="gs_gray">The Hematology Journal 1 (4), 274-281<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2620930598891579485" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:MLfJN-KU85MC" class="gsc_a_at">Donor lymphocyte infusions (dli) for cml: Factors influencing the effective cell dose and implications for the definition of refractoriness</a><div class="gs_gray">K Rezvani, A Rahemtulla, M Cummins, K Cwynarski, M Gilleece, R Szydlo, ...</div><div class="gs_gray">Blood 96 (11 PART I), 195a<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18394673571905295857" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:gsN89kCJA0AC" class="gsc_a_at">Interleukin-2 may induce complete remission in patients who respond only partially to donor lymphocyte infusion (DLI) for relapse following allogeneic bone marrow transplantation</a><div class="gs_gray">F Dazzi, J Kaeda, E Kanfer, JF Apperley, JM Goldman</div><div class="gs_gray">British Journal of Haematology 102 (1-I)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5077122557076415210" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:ldfaerwXgEUC" class="gsc_a_at">CD25‐negative hairy cell leukaemia: Intracytoplasmic detection of Tac antigen and interferon‐induced surface expression</a><div class="gs_gray">T Tison, F Dazzi, C Giacon, F Vianello, ML Valente, P Radossi, ...</div><div class="gs_gray">The Journal of pathology 177 (1), 41-47<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1282185813788610826" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:owLR8QvbtFgC" class="gsc_a_at">Acute myeloid leukemia shapes the bone marrow stromal niche in vivo</a><div class="gs_gray">A Pievani, S Donsante, C Tomasoni, A Corsi, F Dazzi, A Biondi, ...</div><div class="gs_gray">haematologica 106 (3), 865<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7331832875300302553" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:kRWSkSYxWN8C" class="gsc_a_at">Mesenchymal stromal cells (MSC) for treating immune‐mediated inflammation post‐transplantation and in autoimmunity</a><div class="gs_gray">A Cutler, J Girdlestone, S Hopewell, S Stanworth, C Doree, F Dazzi, ...</div><div class="gs_gray">Cochrane Database of Systematic Reviews<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17242371415352247595" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:a0OBvERweLwC" class="gsc_a_at">Mechanisms of graft-versus-malignancy in humans</a><div class="gs_gray">F Dazzi, E Macchiarulo, S Marktel, E Simpson</div><div class="gs_gray">Haematologica 87 (8 Suppl), 21-4<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7591617628281744386" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:VaXvl8Fpj5cC" class="gsc_a_at">Adoptive immunotherapy with donor lymphocytes for relapse of chronic myeloid leukemia (CML) after allogeneic stem cell transplant (SCT): Factor influencing the effective cell&nbsp;…</a><div class="gs_gray">F Dazzi, C Craddock, R Szydlo, J Kaeda, V Montefusco, E Kanfer, ...</div><div class="gs_gray">Blood 92 (10), 494A-494A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13799382489567440062" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:tuHXwOkdijsC" class="gsc_a_at">Donor lymphocyte infusion (DLI) for relapse of CML after allo-BMT: Comparison of two regimens.</a><div class="gs_gray">F Dazzi, P Raanani, F van Rhee, R Szydlo, E Olavarria, J Kaeda, ...</div><div class="gs_gray">Bone Marrow Transplantation 21, S70-S70<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10374097412944062703" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:ZHo1McVdvXMC" class="gsc_a_at">The kinetics and extent of engraftment of chronic myelogenous leukemia (CML) cells in NOD/SCID mice reflect the phase of the donor’s disease: An in vivo model of CML biology.</a><div class="gs_gray">F Dazzi, D Capelli, R Hasserjian, M Corbo, A Poletti, ...</div><div class="gs_gray">Blood 92, 1390<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10484321885887524857" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:k8Z6L05lTy4C" class="gsc_a_at">Responses to donor lymphocyte infusion (DLI) in CML patients in relapse after BMT may be partial and transient: Further evidence for a dose-reponse effect.</a><div class="gs_gray">F Dazzi, P Raanani, F vanRhee, E Olavarria, KM Murphy, NJ Philpott, ...</div><div class="gs_gray">Blood 90 (10), 2307-2307<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3188642384138566390" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:dfsIfKJdRG4C" class="gsc_a_at">The failure of female cells to present in vitro the male HY antigen for secondary cytotoxic T-cell responses</a><div class="gs_gray">G Biasi, F Dazzi, B Loveland, R Rivarollo, G Asherson</div><div class="gs_gray">Immunogenetics 22 (2), 177-181<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13497668008072599635" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:XvxMoLDsR5gC" class="gsc_a_at">Therapeutic immunomodulation with mesenchymal stromal cells: the need for in vivo clues</a><div class="gs_gray">L Dolcetti, F Dazzi</div><div class="gs_gray">International Journal of Translational Science 2016 (1), 1-17<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9917901750556820951" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:t7zJ5fGR-2UC" class="gsc_a_at">The majority of patients receiving donor lymphocyte infusions for relapsed chronic myeloid leukemia remain PCR positive despite maintaining long-term remission</a><div class="gs_gray">AJ Innes, J Lurkins, RM Szydlo, A Guerra, D Milojkovic, J Pavlu, EJ Kanfer, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 4103-4103<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2372863857065950136" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:cFHS6HbyZ2cC" class="gsc_a_at">115: Mesenchymal stem cells are effective at preventing but not at treating GVJD</a><div class="gs_gray">V Tisato, K Naresh, C Navarrete, F Dazzi</div><div class="gs_gray">Biology of blood and marrow transplantation 13 (2), 44-45<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1767760956109041996" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:Tiz5es2fbqcC" class="gsc_a_at">Correction of severe anaemia using immuno‐regulated gene therapy is achieved by restoring the early erythroblast compartment</a><div class="gs_gray">C Du Roure, K Takács, PH Maxwell, I Roberts, F Dazzi, L Cannella, ...</div><div class="gs_gray">British journal of haematology 132 (5), 608-614<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8420934253053933352" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:zA6iFVUQeVQC" class="gsc_a_at">Monitoring of minimal residual disease after allografting: a requirement to guide DLI treatment?</a><div class="gs_gray">F Dazzi</div><div class="gs_gray">Annals of hematology 81, S29-S30<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17553441309265060127" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:ye4kPcJQO24C" class="gsc_a_at">Engraftment of CML cells in NOD/SCID mice: Potential for characterizing phase of disease.</a><div class="gs_gray">F Dazzi, M Gordon, W Chinswangwatanakul, F Cotter, M Evans, ...</div><div class="gs_gray">Blood 90 (10), 362-362<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1099614729756894940" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:5Ul4iDaHHb8C" class="gsc_a_at">Marked but transitory elevation of hepatic transaminases after subcutaneous calcium heparin administration</a><div class="gs_gray">T Tison, F Dazzi, F Vianello, P Radossi, A Girolami</div><div class="gs_gray">Acta haematologica 92 (1), 54-54<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14740512756064065087" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:fPk4N6BV_jEC" class="gsc_a_at">Alpha-interferon treatment of hairy cell leukemia and associated monoclonal large granular lymphocyte proliferation</a><div class="gs_gray">D Sgarabotto, P Zerbinati, F Vianello, P Valeri, A Girolami, F Dazzi</div><div class="gs_gray">Haematologica 77 (4), 367-368<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7927602302811597012" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:SjuI4pbJlxcC" class="gsc_a_at">Mixed T cell lineage chimerism in acute leukemia/MDS using pre-emptive donor lymphocyte infusion strategy—Is it prognostic?—a single-center retrospective study</a><div class="gs_gray">V Sheth, V Potter, H de Lavallade, S Gandhi, A Kulasekararaj, ...</div><div class="gs_gray">Blood Cancer Journal 11 (7), 1-6<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11286565287913025703" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:1taIhTC69MYC" class="gsc_a_at">A 14q32.31 Genomic-Imprinted <i>DLK1-DIO3</i> microrna promotes Leukemogenesis By Inducing Stem Cell Quiescence and Inhibiting NK Cell Anti-Cancer Immunity</a><div class="gs_gray">G Silvestri, R Trotta, L Stramucci, S Wang, AK Eisfeld, B Zhang, K Srutova, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15090020642477607277" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:p2g8aNsByqUC" class="gsc_a_at">Molecular basis of transplantation</a><div class="gs_gray">F Dazzi, A Galleu</div><div class="gs_gray">Molecular Hematology, 373-388<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14125935476357366148" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:vDZJ-YLwNdEC" class="gsc_a_at">Roadmap to clinical translation: insights from a UK regenerative medicine platform workshop on mesenchymal stromal cells</a><div class="gs_gray">CO Asante, F Dazzi</div><div class="gs_gray">Regenerative medicine 12 (8), 895-897<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13112068348854001898" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:ZzlSgRqYykMC" class="gsc_a_at">Mesenchymal stromal cells for the treatment of steroid-resistant acute graft versus host disease: factors influencing clinical responses.</a><div class="gs_gray">A Galleu, S Deplano, R Szydlo, D Milojkovic, A Bradshaw, R Wynn, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2460427971700369636" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:WJVC3Jt7v1AC" class="gsc_a_at">Preliminary results of a phase 2 trial of autologous mesenchymal cell therapy in MS (STREAMS)</a><div class="gs_gray">R Ali, R Nicholas, S Marley, S Mallik, R Palanicawandar, B Zamarreno, ...</div><div class="gs_gray">MULTIPLE SCLEROSIS JOURNAL 21, 556-556<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4983246367040788628" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:mlAyqtXpCwEC" class="gsc_a_at">Interview with Professor Francesco Dazzi: The UKRMP Immunomodulation hub</a><div class="gs_gray">F Dazzi</div><div class="gs_gray">Regenerative medicine 10 (3), 255-257<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15864411242564972726" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:gKiMpY-AVTkC" class="gsc_a_at">Umbilical Cord as a Source of Immunomodulatory Reagents</a><div class="gs_gray">A Galleu, F Dazzi</div><div class="gs_gray">Cord Blood Stem Cells and Regenerative Medicine, 125-140<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8177419675581055656" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:J-pR_7NvFogC" class="gsc_a_at">Mesenchymal stem cells: application for immunomodulation and tissue repair</a><div class="gs_gray">NJ Horwood, F Dazzi, W Zaher, M Kassem</div><div class="gs_gray">Tissue and Cell Clinical Use: An Essential Guide, 332-357<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16750330755499642151" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:tzM49s52ZIMC" class="gsc_a_at">Differential increase of circulating haematopoietic stem cells (HSC) following therapeutic alpha 4-integrin blockade in multiple sclerosis: correlation between HSC mobilization&nbsp;…</a><div class="gs_gray">M Mattoscio, R Nicholas, O Malik, F Dazzi, J Lee, A Waldman, P Muraro</div><div class="gs_gray">Neurology 78 (1 Supplement), IN8-1.006-IN8-1.006<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6469804226692407128" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:tOudhMTPpwUC" class="gsc_a_at">Risk score predicts outcome of second allogeneic hematopoietic stem cell transplantation</a><div class="gs_gray">K Rezvani, D Marin, JM Goldman, E Kanfer, D MacDonald, F Dazzi, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 17 (2), S155<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9568550831011413918" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:BUYA1_V_uYcC" class="gsc_a_at">High Frequency and Cell Dose of Invariant NKT Cells In the Graft Are Associated with Lack of Clinically Significant Acute Gvhd In T Cell-Replete Sibling Allografts</a><div class="gs_gray">A Chaidos, RM Szydlo, EJ Kanfer, F Dazzi, DH MacDonald, D Marin, ...</div><div class="gs_gray">Blood 116 (21), 2539<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12956081172134996914" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:tkaPQYYpVKoC" class="gsc_a_at">Response to Tyrosine Kinase Inhibitor Therapy In Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Phase Chronic Myeloid Leukemia</a><div class="gs_gray">A Holroyd, E Phillips, R Szydlo, D Marin, L Foroni, J Khorashad, ...</div><div class="gs_gray">Blood 116 (21), 3515<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15265425582470567203" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:_Re3VWB3Y0AC" class="gsc_a_at">Allogeneic Myeloablative Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia in the Imatinib Era.</a><div class="gs_gray">J Pavlu, M Klammer, I Gabriel, R Szydlo, E Olavarria, D Milojkovic, A Kew, ...</div><div class="gs_gray">Blood 112 (11), 970<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16053751741106615250" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:6bLC7aUMtPcC" class="gsc_a_at">The role of mesenchymal stem cells in haemopoiesis.</a><div class="gs_gray">S Glennie, F Dazzi, R Ramasamy, S Glennie, SP Jones, I Roberts</div><div class="gs_gray">Blood Reviews 20 (3)<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5683461643081212118" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:D_sINldO8mEC" class="gsc_a_at">Sustained downregulation of the TCRζ chain defines a transition from antigen mode to inflammation mode during terminal T-cell differentiation</a><div class="gs_gray">Z Zhang, M Panesar, P Amjadi, A Foey, S Owen, F Dazzi, FM Brennan, ...</div><div class="gs_gray">Arthritis Research &amp; Therapy 7 (1), 1-1<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17634833309579663322" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:b0M2c_1WBrUC" class="gsc_a_at">Mesenchymal stem cells induce division arrest anergy of activated T cells</a><div class="gs_gray">SJ Glennie, I Soeiro, J Dyson, E Lam, F Dazzi</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 11 (2), 1<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=852343096958680589" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:f2IySw72cVMC" class="gsc_a_at">Irradiation influences endothelial cell function in vitro and in vivo: A possible role for IP10</a><div class="gs_gray">L Cannella, R Laylor, F Marelli-Berg, F Dazzi</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 11 (2), 45<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16381793554072067894" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:tKAzc9rXhukC" class="gsc_a_at">Donor lymphocyte infusions for chronic myeloid leukemia: factors influencing the effective cell dose</a><div class="gs_gray">F Dazzi, S Marktel, R Szydlo, C Crawley, E Olavarria, E Kanfer, ...</div><div class="gs_gray">Bone Marrow Transplantation 31<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16685287173785916741" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:BwyfMAYsbu0C" class="gsc_a_at">STI571 inhibits the activation and proliferation of normal T lymphocytes</a><div class="gs_gray">K Cwynarski, R Laylor, J Goldman, J Melo, F Dazzi</div><div class="gs_gray">British Journal of Haematology-Supplement 117<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3535263068965068993" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:uWiczbcajpAC" class="gsc_a_at">Donor Lymphocyte Infusion for relapsed chronic myelogenous leukemia-The effect of its method of administration In separate risk groups</a><div class="gs_gray">C Guglielmi, W Arcese, F Dazzi, D Bunjes, L Verdonck, A Schattenberg, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 29, S30-S31<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16573392726391488948" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:zLWjf1WUPmwC" class="gsc_a_at">Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: The first dose decides outcome.</a><div class="gs_gray">C Guglielmi, W Arcese, F Dazzi, D Bunjes, LF Verdonck, A Schattenberg, ...</div><div class="gs_gray">Blood 98 (11), 727A-727A<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4175388904361863515" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:j8SEvjWlNXcC" class="gsc_a_at">Myeloid and lymphoid chimerism in long-term survivors post SCT for CML-CP: the presence of recipient hematopoiesis is not predictive of relapse and correlates with lower GVHD risk</a><div class="gs_gray">K Rezvani, M Lawler, R Goulding, J Kaedar, F Dazzi, E Domingo, ...</div><div class="gs_gray">Bone Marrow Transplantation 27, S28-S28<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3133847145557921092" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:FiytvqdAVhgC" class="gsc_a_at">Donor lymphocyte infusions for CML: possible effects of age and mobilization</a><div class="gs_gray">V Reddy, J Moreb, P Mehta, F Dazzi, RM Szydlo, JM Goldman</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 95 (9), 2994-2995<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15506252396624229271" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:VL0QpB8kHFEC" class="gsc_a_at">Factors influencing acute GVHD after donor lymphocyte infusion.</a><div class="gs_gray">F Dazzi, K Cwynarski, C Craddock, R Szydlo, E Kanfer, E Olavarria, ...</div><div class="gs_gray">Blood 94 (10), 669A-669A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11353941805130213811" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:Fu2w8maKXqMC" class="gsc_a_at">Normal and chronic phase CML hematopoietic cells repopulate NOD/SCID bone marrow with different kinetics and differentiation pattern.</a><div class="gs_gray">F Dazzi, F Boecklin, R Hasserjian, F Cotter, M Corbo, D Capelli, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 23, S58-S58<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7794231058697306852" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:_B80troHkn4C" class="gsc_a_at">Donor lymphocyte infusions produce durable molecular remission in patients who relapse after allografting for CML in chronic phase: The consequent need to reassess the&nbsp;…</a><div class="gs_gray">C Craddock, F Dazzi, RM Szydlo, E Olavarria, NCP Cross, F Van Rhee, ...</div><div class="gs_gray">Blood 92 (10), 654A-654A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18428651410719646349" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:ipzZ9siozwsC" class="gsc_a_at">HIGH-INCIDENCE OF NONINHIBITORY ANTI-FACTOR-VIII (FVII) ANTIBODIES IN HEMOPHILIA-A PATIENTS-RELEVANCE ON FVIII HALF-LIFE</a><div class="gs_gray">T Tison, F Vianello, P Carraro, P Radossi, A Rosato, F Dazzi, A Girolami</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS 73 (6), 1012-1012<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6605197267414420619" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:yD5IFk8b50cC" class="gsc_a_at">Myelodysplastic syndrome and thrombocytosis: a random association?</a><div class="gs_gray">T Tison, F Vianello, P Radossi, A Girolami, D Sgarabotto, F Dazzi</div><div class="gs_gray">Haematologica 79 (6), 534-535<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4423693917495925107" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:_xSYboBqXhAC" class="gsc_a_at">Lithium carbonate failed to modify the neutropenia associated with large granular lymphocyte proliferation</a><div class="gs_gray">D Sgarabotto, F Dazzi, A Girolami</div><div class="gs_gray">Acta haematologica 81 (2), 114-115<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=467927562840315170" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:nb7KW1ujOQ8C" class="gsc_a_at">Persistence and specificity of accessory cell impairment in M-MuLV neonatally injected mice</a><div class="gs_gray">G Biasi, L Saggin, F Dazzi, D Collavo</div><div class="gs_gray">Transplantation proceedings 15 (4), 2125-2127<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3965779708706855833" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:DBa1UEJaJKAC" class="gsc_a_at">Mixed T cell lineage chimerism in acute leukemia/MDS using pre-emptive donor lymphocyte infusion strategy—Is it prognostic?—a single-center retrospective study</a><div class="gs_gray">S Vipul, V Potter, G Shreyans, K Austin, K Pramila, M Varun, F Dazzi, ...</div><div class="gs_gray">Blood Cancer Journal 11 (7)<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:Ade32sEp0pkC" class="gsc_a_at">Apoptosis in the Pancreatic Cancer Tumor Microenvironment—The Double-Edged Sword of Cancer-Associated Fibroblasts</a><div class="gs_gray">E Pfeifer, JM Burchell, F Dazzi, D Sarker, R Beatson</div><div class="gs_gray">Cells 10 (7), 1653<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:WC9gN4BGCRcC" class="gsc_a_at">Lyve-1 expressing macrophages direct the expansion of pericytes within the perivascular niche to support angiogenesis in cancer</a><div class="gs_gray">JW Opzoomer, JE Anstee, I Dean, EJ Hill, I Bouybayoune, J Caron, ...</div><div class="gs_gray">Cancer Research 81 (13 Supplement), 113-113<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:prdVHNxh-e8C" class="gsc_a_at">On minor histocompatibility antigens, mixed chimerism, and transplantation tolerance</a><div class="gs_gray">A Sánchez‐Fueyo, F Dazzi</div><div class="gs_gray">American Journal of Transplantation 21 (3), 919-920<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:LPtt_HFRSbwC" class="gsc_a_at">Macrophages orchestrate the expansion of a pro-angiogenic perivascular niche during cancer progression</a><div class="gs_gray">JW Opzoomer, JE Anstee, I Dean, EJ Hill, I Bouybayoune, J Caron, ...</div><div class="gs_gray">bioRxiv, 2020.10. 30.361907<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:-mN3Mh-tlDkC" class="gsc_a_at">Macrophages orchestrate the expansion of a pro-angiogenic perivascular niche during cancer progression</a><div class="gs_gray">JW Opzoomer, JE Anstee, I Dean, EJ Hill, I Bouybayoune, J Caron, ...</div><div class="gs_gray">bioRxiv, 2020.10. 30.361907<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:3NQIlFlcGxIC" class="gsc_a_at">Differential Alemtuzumab Dosages in T-cell Deplete Allogeneic Haematopoietic Stem Cell Transplants for Myeloid Malignancies</a><div class="gs_gray">V Mehra, D Avenoso, XC Castellano, A Choy, S Widya, M Shah, S Inam, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 55 (SUPPL 1), 287-287<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:1yWc8FF-_SYC" class="gsc_a_at">Comparing Outcomes of Patients Having Mixed T Chimerism and Unrelated Donor Allografts for Acute Leukaemia/MDS to Patients with Complete Chimerism-Single Centre Retrospective Study</a><div class="gs_gray">V Sheth, V Potter, D McLornan, H Delavallade, S Gandhi, A Kulasekararaj, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 55 (SUPPL 1), 123-124<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:L1USKYWJimsC" class="gsc_a_at">Immunoregulation in the Hematopoietic Stem Cell Niche</a><div class="gs_gray">C Giacomini, F Dazzi</div><div class="gs_gray">Academic Press<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:kw52XkFRtyQC" class="gsc_a_at">Differential Alemtuzumab Dosage Effects in T-Cell Deplete Allogeneic Haematopoietic Stem Cell Transplants for Myeloid Malignancies-King's College Hospital London Experience</a><div class="gs_gray">V Mehra, D Avenoso, XC Castellano, A Choy, S Widya, M Shah, S Inam, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:MhiOAD_qIWkC" class="gsc_a_at">CML PSYCHOEDUCATIONAL GROUP THERAPY</a><div class="gs_gray">F Dazzi, F Simonetti, A Stefanelli, P Scarsini, E Capochiani</div><div class="gs_gray">HAEMATOLOGICA 104, 157-157<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:j7_hQOaDUrUC" class="gsc_a_at">Immunological change after MSC infusion in MS patients results from a Phase 2 trial of autologous mesenchymal cell therapy in MS (STREAMS)</a><div class="gs_gray">R Ali, MT Cencioni, R Nicholas, F Dazzi, P Muraro</div><div class="gs_gray">MULTIPLE SCLEROSIS JOURNAL 25, 297-298<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:7BrZ7Jt4UNcC" class="gsc_a_at">Identifying chimeric antigen receptor (CAR) centers and CAR activity in Europe, a survey on behalf of the cellular therapy &amp; immunobiology working-party (CTIWP) of EBMT</a><div class="gs_gray">A Urbano, M Hudecek, F Dazzi, R Ellard, K Fleischhauer, U Koehl, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 54, 44-45<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:jU7OWUQzBzMC" class="gsc_a_at">PB1987 SELECTIVE ACTIVATION OF TOLEROGENIC CELL DEATH PATHWAYS IN MESENCHYMAL STROMAL CELLS</a><div class="gs_gray">R Savoldelli, A Galleu, F Dazzi</div><div class="gs_gray">HemaSphere 3 (S1), 901<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:LdasjJ6CEcoC" class="gsc_a_at">The 14q32. 31 DLK1-DIO3 MIR300 tumor suppressor promotes leukemogenesis by inducing cancer stem cell quiescence and inhibiting NK cell anti-cancer immunity</a><div class="gs_gray">G Silvestri, R Trotta, L Stramucci, JJ Ellis, JG Harb, P Neviani, S Wang, ...</div><div class="gs_gray">bioRxiv, 680108<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:lgwcVrK6X84C" class="gsc_a_at">Mechanisms of Immune Resistance</a><div class="gs_gray">L Vago, F Dazzi</div><div class="gs_gray">The EBMT Handbook, 457-460<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:yxmsSjX2EkcC" class="gsc_a_at">Author Correction: Bi-directional cell-pericellular matrix interactions direct stem cell fate</a><div class="gs_gray">SA Ferreira, MS Motwani, PA Faull, AJ Seymour, TL Tracy, M Enayati, ...</div><div class="gs_gray">Nature communications 9 (1), 1-1<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:PVgj2kMGcgYC" class="gsc_a_at">The tumor suppressor activity of miR-300 is detrimental for leukemia development but required for leukemia stem cell maintenance</a><div class="gs_gray">G Silvestri, L Stramucci, J Ellis, J Harb, P Neviani, B Zhang, K Srutova, ...</div><div class="gs_gray">Cancer Research 78 (13 Supplement), 1134-1134<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:4X0JR2_MtJMC" class="gsc_a_at">Fludarabine as a cost-effective adjuvant to enhance engraftment of human normal and malignant hematopoiesis in immunodeficient mice</a><div class="gs_gray">A Pievani, IM Michelozzi, B Rambaldi, V Granata, A Corsi, F Dazzi, ...</div><div class="gs_gray">Scientific reports 8 (1), 1-8<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:CB2v5VPnA5kC" class="gsc_a_at">Repurposing tin mesoporphyrin as a novel immune checkpoint therapy in the treatment of cancer: A preclinical evaluation.</a><div class="gs_gray">JN Arnold, T Muliaditan, JW Opzoomer, J Caron, M Okesola, P Kosti, ...</div><div class="gs_gray">Journal of Clinical Oncology 36 (15_suppl), e15129-e15129<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:uDGL6kOW6j0C" class="gsc_a_at">Lentiviral Mediated Collagen VII Expression in Allogeneic MSCS Restores Anchoring Fibrils in a Recessive Dystrophic Epidermolysis Bullosa Skin Graft Model</a><div class="gs_gray">A Petrova, F Syed, G Naso, R Fleck, L Allison, F Dazzi, J McGrath, WL Di, ...</div><div class="gs_gray">MOLECULAR THERAPY 26 (5), 123-124<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:artPoR2Yc-kC" class="gsc_a_at">The Bone Marrow Niche Uses Mir-300 As a Biological Rheostat to Selectively Control Stem Cell-Driven Malignant Hematopoiesis and Innate Anti-Cancer Immunity</a><div class="gs_gray">G Silvestri, L Stramucci, J Ellis, J Harb, P Neviani, B Zhang, K Srutova, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 45-45<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:lvd772isFD0C" class="gsc_a_at">INVESTIGATION OF MESENCHYMAL STEM CELLS FOR PRECONDITIONING OF KIDNEY GRAFTS IN AN EX-VIVO PORCINE MODEL OF HYPOTHERMIC MACHINE PERFUSION</a><div class="gs_gray">N Vallant, B Sandhu, C Trento, F Dazzi, C Pusey, V Papalois</div><div class="gs_gray">TRANSPLANT INTERNATIONAL 30, 501-501<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:5MTHONV0fEkC" class="gsc_a_at">British Society for Gene and Cell Therapy Annual Conference and Joint UK Regenerative Medicine Platform Meeting Royal Welsh College of Music &amp; Drama Cardiff, Wales, United&nbsp;…</a><div class="gs_gray">W Qasim, A Nathwani, M Cavazzana, R Buckle, S Harding, A Baker, ...</div><div class="gs_gray">Human Gene Therapy 28 (8), A1-A36<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:fbc8zXXH2BUC" class="gsc_a_at">Mesenchymal cells engineered to express Collagen VII in a human: murine Recessive dystrophic epidermolysis bullosa model</a><div class="gs_gray">A Petrova, WL Di, F Syed, C Georgiadis, F Dazzi, S Marley, L Glover, ...</div><div class="gs_gray">Annual Conference of the British-Society-for-Gene-and-Cell-Therapy/Joint UK&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:u-coK7KVo8oC" class="gsc_a_at">Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-Cellular Therapy &amp; Immunobiology Working Party: O108</a><div class="gs_gray">R Greco, F Ciceri, M Noviello, A Bondanza, L Vago, G Oliveira, ...</div><div class="gs_gray">Bone Marrow Transplantation 52<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:nZcligLrVowC" class="gsc_a_at">239-Maternal obesity alters characteristics of Wharton's Jelly mesenchymal stromal cells: ISCT 2017 Annual Meeting</a><div class="gs_gray">H Badraiq, A Cvoro, A Galleu, M Simon, F Dazzi, D Ilic</div><div class="gs_gray">Cytotherapy 19 (5, Supplement), S160<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:DJbcl8HfkQkC" class="gsc_a_at">How to Monitor Immune Reconstitution Following Allogeneic Hematopoietic Stem Cell Transplantation: A Survey from the EBMT-Cellular Therapy &amp; Immunobiology Working Party</a><div class="gs_gray">R Greco, F Ciceri, M Noviello, A Bondanza, L Vago, G Oliveira, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 128 (22), 4581-4581<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:jL-93Qbq4QoC" class="gsc_a_at">HUMAN APLASTIC ANEMIA DERIVED MESENCHYMAL STROMAL CELLS FORM FUNCTIONAL HEMATOPOIETIC STEM CELL NICHE IN VIVO</a><div class="gs_gray">A Pievani, IM Michelozzi, F Pagni, L Antolini, M Verna, P Corti, A Rovelli, ...</div><div class="gs_gray">HAEMATOLOGICA 101, S13-S13<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:yFnVuubrUp4C" class="gsc_a_at">Mesenchymal stem cells enhance bacterial clearance of streptococcal pneumoniae and pseudomonas aeruginosa in the lung</a><div class="gs_gray">RJ Boyton, J Stowell, C Reynolds, K Quigley, D Altmann, F Dazzi</div><div class="gs_gray">European Respiratory Journal 48 (suppl 60)<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:HIFyuExEbWQC" class="gsc_a_at">DISSECTING THE ROLE OF THE MICROENVIRONMENT IN APLASTIC ANEMIA USING AN IN VIVO HAEMATOPOIETIC STEM CELL NICHE MODEL</a><div class="gs_gray">IM Michelozzi, AS Pievani, F Pagni, L Antolini, M Verna, P Corti, A Rovelli, ...</div><div class="gs_gray">HAEMATOLOGICA 101, 294-294<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:tH6gc1N1XXoC" class="gsc_a_at">Immune Tolerance in Hemopoietic Stem Cell Transplantation</a><div class="gs_gray">F Dazzi, J Clay, A Galleu</div><div class="gs_gray">Physiology and Immune System Dysfunction, 241-247<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:LgRImbQfgY4C" class="gsc_a_at">Rapid and efficient stable gene transfer to mesenchymal stromal cells using a modified foamy virus vector virus vector</a><div class="gs_gray">NP Sweeney, C Regan, J Liu, A Galleu, F Dazzi, D Lindemann, CA Rupar, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:HtS1dXgVpQUC" class="gsc_a_at">Manufacturing of Mesenchymal Stromal Cells for the Treatment of Graft-Versus-Host Disease: A Survey within the European Society of Blood and Marrow Transplantation</a><div class="gs_gray">T Cristina, ME Bernardo, A Nagler, S Kuci, M Bornhäuser, U Köhl, ...</div><div class="gs_gray">Blood 128 (22), 3374<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:IUKN3-7HHlwC" class="gsc_a_at">Immunological barriers to regenerative medicine: do they matter?</a><div class="gs_gray">C Trento, F Dazzi</div><div class="gs_gray">Stem Cells in Regenerative Medicine: Science, regulation and business&nbsp;…<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:OTTXONDVkokC" class="gsc_a_at">Interview with Professor Francesco Dazzi: The UKRMP Immunomodulation hub (vol 10, pg 305, 2015)</a><div class="gs_gray">E Conroy, F Dazzi</div><div class="gs_gray">REGENERATIVE MEDICINE 10 (5), 680-680<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:XD-gHx7UXLsC" class="gsc_a_at">Haematopoietic stem cell mobilization and re-arrangement of immune cell subsets following therapeutic alpha 4-integrin blockade in multiple sclerosis: functional relevance&nbsp;…</a><div class="gs_gray">M Mattoscio</div><div class="gs_gray">Imperial College London<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:cWzG1nlazyYC" class="gsc_a_at">Complement C3 exacerbates skin inflammation in a murine model of imiquimod-induced psoriasis: 622</a><div class="gs_gray">C Giacomassi, G Ling, J Strid, F Dazzi, M Botto</div><div class="gs_gray">Immunology 143<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:LO7wyVUgiFcC" class="gsc_a_at">The immunobiology of mesenchymal stromal cells: 63</a><div class="gs_gray">F Dazzi</div><div class="gs_gray">Immunology 143<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:9pM33mqn1YgC" class="gsc_a_at">STREAMS: PRELIMINARY RESULTS FROM A PHASE II TRIAL</a><div class="gs_gray">R Ali, R Nicolas, S Marley, R Palanicawandar, F Dazzi, P Muraro</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 85 (10), e4-e4<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:YohjEiUPhakC" class="gsc_a_at">STREAMS: A Phase 2 Clinical Trial Of Autologous Mesenchymal Stem Cells In Active Multiple Sclerosis (S23. 005)</a><div class="gs_gray">R Ali, S Marley, R Palanicawandar, F Dazzi, R Nicholas, P Muraro</div><div class="gs_gray">Neurology 82 (10 Supplement)<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:DUooU5lO8OsC" class="gsc_a_at">MESENCHYMAL STROMAL CELLS FOR THE TREATMENT OF GRAFT VERSUS HOST DISEASE IN PATIENTS WITH CONCOMITANT INFECTION: PH-AB228</a><div class="gs_gray">A Bradshaw, F Dazzi, S Marley, S Loaiza, SA Finn, E Bray, A Saleem, ...</div><div class="gs_gray">Bone Marrow Transplantation 49<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:yMeIxYmEMEAC" class="gsc_a_at">Terminal Disruption of Secretory Homeostasis by Inhibition of p97 and Proteasome-mediated Protein Degradation in Myeloma: P-308</a><div class="gs_gray">H AUNER, A MOODY, T WARD, M KRAUS, E MILAN, P MAY, A CHAIDOS, ...</div><div class="gs_gray">Clinical Lymphoma, Myeloma &amp; Leukemia 13<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:ClCfbGk0d_YC" class="gsc_a_at">Prophylaxis and treatment of graft-versus-host disease: EBMT-ELN working group recommendations for a standardized practice: 296</a><div class="gs_gray">T Ruutu, A Gratwohl, T de Witte, J Apperley, A Bacigalupo, F Dazzi, ...</div><div class="gs_gray">Bone Marrow Transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:xtoqd-5pKcoC" class="gsc_a_at">Natural killer T-cells control the expansion of myeloid-derived suppressor cells during the haematopoietic reconstitution: a novel immunoregulatory network post-transplant: P567</a><div class="gs_gray">L Weng, I Marigo, A Karadimitris, V Bronte, F Dazzi</div><div class="gs_gray">Bone Marrow Transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:Dip1O2bNi0gC" class="gsc_a_at">microRNA regulates mesenchymal stromal cell-mediated anti-inflammatory activity in vitro and in vivo: O285</a><div class="gs_gray">M Coelho, L Lopes, B Graham, M Merkenschlager, F Dazzi</div><div class="gs_gray">Bone Marrow Transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:PoWvk5oyLR8C" class="gsc_a_at">Mesenchymal stromal cells differently regulate acute and chronic inflammatory responses: P828</a><div class="gs_gray">L Lopes, M Coelho, F Dazzi</div><div class="gs_gray">Bone Marrow Transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:SpbeaW3--B0C" class="gsc_a_at">Clinical scale production of mesenchymal stromal cells: the Hammersmith experience: P450</a><div class="gs_gray">S Marley, S Loaiza, A Bradshaw, SA Finn, E Bray, M Cook, L Matthews, ...</div><div class="gs_gray">Bone Marrow Transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:S16KYo8Pm5AC" class="gsc_a_at">Mesenchymal stromal cell-mediated immunosuppression is activated by TNF-α dependent and independent pathways: P829</a><div class="gs_gray">C Wang, C Trento, I Marigo, F Dazzi</div><div class="gs_gray">Bone Marrow Transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:e_rmSamDkqQC" class="gsc_a_at">NF-κ B pathway plays a key role in mesenchymal stromal cell-mediated immunomodulation: P830</a><div class="gs_gray">Y Li, L Weng, L Lopes, F Dazzi</div><div class="gs_gray">Bone Marrow Transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:-FonjvnnhkoC" class="gsc_a_at">HLA-mismatched donor lymphocyte infusion is safe for the treatment of leukaemia relapse following alemtuzumabbased myeloablative allogeneic stem cell transplantation: P463</a><div class="gs_gray">A Innes, R Beattie, R Sergeant, D Ghandi, L Foroni, D Marin, E Kanfer, ...</div><div class="gs_gray">Bone Marrow Transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:WZBGuue-350C" class="gsc_a_at">Mesenchymal stromal cells protect from complement activation in graft-versus-host disease: P462</a><div class="gs_gray">A Innes, B Uttenthal, S Marley, A Hall, M Botto, M Pickering, F Dazzi</div><div class="gs_gray">Bone Marrow Transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:oNZyr7d5Mn4C" class="gsc_a_at">Long-term leukaemia control following DLI is independent of disease eradication: P809</a><div class="gs_gray">A Innes, J Lurkins, R Szydlo, L Foroni, D Milojkovic, J Pavlu, D Marin, ...</div><div class="gs_gray">Bone Marrow Transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:M7yex6snE4oC" class="gsc_a_at">A potency assay for clinical grade mesenchymal stromal cells: P833</a><div class="gs_gray">A Galleu, L Weng, I Marigo, F Dazzi</div><div class="gs_gray">Bone Marrow Transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:kz9GbA2Ns4gC" class="gsc_a_at">Mesenchymal stromal cells drive haematopoietic precursors to differentiate into myeloid lineage in vitro: P826</a><div class="gs_gray">C Trento, I Marigo, C Wang, V Bronte, F Dazzi</div><div class="gs_gray">Bone Marrow Transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:3htObqc8RwsC" class="gsc_a_at">Do titanium implant surfaces induce immunosuppressive properties of human mesenchymal stromal cellsin vitro?: PP-074</a><div class="gs_gray">T Oliver, B Way, A Galleu, P Ferretti, P Butler, F Dazzi, P Brett</div><div class="gs_gray">Regenerative Medicine 8 (6)<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:olpn-zPbct0C" class="gsc_a_at">The Immunosuppressive Properties of Adult Stem Cells: Mesenchymal Stem Cells as a Case Study</a><div class="gs_gray">F Dazzi, I Marigo</div><div class="gs_gray">The Immunological Barriers to Regenerative Medicine, 175-197<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:L7CI7m0gUJcC" class="gsc_a_at">Can Targeted Therapy for CML Still Learn From Transplant? Using Post-transplant RQ-PCR monitoring to Clarify the Importance of the Depth of Molecular Remission On the Risk of&nbsp;…</a><div class="gs_gray">F Pimm, R Szydlo, L Foroni, F Dazzi, JS Kaeda, G Gerrard, A Reid, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 2789-2789<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:g3aElNc5_aQC" class="gsc_a_at">Optimising patient selection for allogeneic stem cell transplantation: prediction of non-relapse mortality and survival: O149</a><div class="gs_gray">J Pavlu, K Rezvani, B Kishore, J Chakrabartty, R Shah, H Auner, ...</div><div class="gs_gray">Bone Marrow Transplantation 47<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:FAceZFleit8C" class="gsc_a_at">Differential increase of circulating haematopoietic stem cells following therapeutic alpha 4-integrin blockade in multiple sclerosis: definition of mobilisers versus non&nbsp;…</a><div class="gs_gray">M Mattoscio, R Nicholas, O Malik, F Dazzi, PA Muraro</div><div class="gs_gray">MULTIPLE SCLEROSIS JOURNAL 17, S191-S191<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:vRqMK49ujn8C" class="gsc_a_at">Osteoclast activity regulates the size of the haematopoietic stem cell pool</a><div class="gs_gray">A Ersek, S Lymperi, F Dazzi, N Horwood</div><div class="gs_gray">3rd Joint Meeting of the European-Calcified-Tissue-Society/International&nbsp;…<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:URolC5Kub84C" class="gsc_a_at">Massive expansion of umbilical cord derived mesenchymal stromal cells (MSC): an innovative and unlimited source of MSC with potent immunosuppressive activity for the treatment&nbsp;…</a><div class="gs_gray">C Capelli, E Gotti, M Morigi, C Rota, L Weng, F Dazzi, O Spinelli, ...</div><div class="gs_gray">Bone Marrow Transplantation 46<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:ns9cj8rnVeAC" class="gsc_a_at">Mesenchymal stem cells and innate tolerance: biology and clinical applications</a><div class="gs_gray">C Trento, F Dazzi</div><div class="gs_gray">Swiss Medical Weekly 141, 24-27<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:AvfA0Oy_GE0C" class="gsc_a_at">Preconditioning Level of C-Reactive Protein and Disease Stage Are Key Prognostic Factors In Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation.</a><div class="gs_gray">J Pavlu, R Shah, HW Auner, D Milojkovic, D Marin, J Sargent, ...</div><div class="gs_gray">Blood 116 (21), 3488<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:OP4eGU-M3BUC" class="gsc_a_at">Stem Cell Therapies–The Underlying Biology and Impact on Clinical Trials</a><div class="gs_gray">F Dazzi</div><div class="gs_gray">Med J Malaysia 65<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:uLbwQdceFCQC" class="gsc_a_at">Functional relevance of haematopoietic stem cell mobilization following therapeutic alpha 4-integrin blockade in multiple sclerosis: preliminary data</a><div class="gs_gray">M Mattoscio, R Nicholas, O Malik, C Mc Guigan, F Dazzi, PA Muraro</div><div class="gs_gray">JOURNAL OF NEUROLOGY 257, S221-S221<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:N5tVd3kTz84C" class="gsc_a_at">Allogeneic myeloablative haematopoietic stem cell transplantation for chronic myeloid leukaemia in the imatinib era</a><div class="gs_gray">J Pavlu, H Auner, R Szydlo, E Olavarria, C Giles, M Klammer, A Kew, ...</div><div class="gs_gray">Bone Marrow Transplantation 43 (S1), S49-S49<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:VOx2b1Wkg3QC" class="gsc_a_at">Критерии неудачи лечения или субоптимального ответа, разработанные European LeukemiaNet, позволяют надежно выявлять пациентов с ранней хронической фазой ХМЛ, леченных&nbsp;…</a><div class="gs_gray">D Marin, D Milojkovic, E Olavarria, JS Khorashad, H de Lavallade, ...</div><div class="gs_gray">BLOOD 112 (12)<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:hMsQuOkrut0C" class="gsc_a_at">Osteoclast Function Is Essential in the Hematopoietic Stem Cell Niche</a><div class="gs_gray">S Lymperi, N Horwood, F Dazzi</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 112 (11), 547-547<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:LPZeul_q3PIC" class="gsc_a_at">Dissection of effector pathways in the host-versus-graft response to bone marrow transplantation</a><div class="gs_gray">L Weng, C Addey, AN Warrens, J Dyson, JG Chai, F Dazzi</div><div class="gs_gray">Transplantation 86 (9), 1311-1314<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:uc_IGeMz5qoC" class="gsc_a_at">Multipotent mesenchymal stromal cells in the treatment of autoimmune diseases</a><div class="gs_gray">A Tyndall, F Dazzi, A Uccelli</div><div class="gs_gray">Bone Marrow Transplantation 41<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:l7t_Zn2s7bgC" class="gsc_a_at">127: Mesenchymal Stem Cells Exert Differential Effects on Alloantigen-and Virus-Specific T Cells</a><div class="gs_gray">H Karlsson, S Samarasinghe, L Ball, B Sundberg, AC Lankester, F Dazzi, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 14 (2), 48-49<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:vbGhcppDl1QC" class="gsc_a_at">Increasing osteoblast number is not sufficient to enhance the function of the hematopoietic stem cell niche.</a><div class="gs_gray">S Lymperi, A Cope, F Dazzi, N Horwood</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:P5F9QuxV20EC" class="gsc_a_at">Reply to ‘Splenectomy status of the patient may have impact on response to donor lymphocyte infusions’ by Duygu Uckan-Cetinkaya et al.</a><div class="gs_gray">F Dazzi, C Fozza</div><div class="gs_gray">Leukemia 21 (9), 2050-2051<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:p__nRnzSRKYC" class="gsc_a_at">Mesenchymal stem cell mediated immunosuppression is not confined to progenitor status</a><div class="gs_gray">F Jones, N Horwood, A Cope, F Dazzi</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:5awf1xo2G04C" class="gsc_a_at">The anabolic effects of strontium increase the number of progenitor but not primitive haemopoietic stem cells</a><div class="gs_gray">S Lymperi, N Horwood, A Cope, F Dazzi</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:uJ-U7cs_P_0C" class="gsc_a_at">Cord blood derived mesenchymal stem cells are effective at preventing graft-versus-host disease</a><div class="gs_gray">V Tisato, K Naresh, J Girdlestone, C Navarrete, F Dazzi</div><div class="gs_gray">HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 92, 317-317<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:NJ774b8OgUMC" class="gsc_a_at">Low intensity transplantat regimens facilitate recruitment of donor apecific regulatory T cell which promote heamatopoietic engraftment</a><div class="gs_gray">L Weng, J Dyson, F Dazzi</div><div class="gs_gray">HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 92, 379-379<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:evX43VCCuoAC" class="gsc_a_at">CD4+ CD25+ regulatory T-cells exhibit a higher T-cell receptor diversity than CD4+ CD25− conventional T-cells after allogeneic stem cell transplantation</a><div class="gs_gray">C Fozza, E Nadal, M Longinotti, F Dazzi</div><div class="gs_gray">Bone Marrow Transplantation 39<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:tS2w5q8j5-wC" class="gsc_a_at">The Immunoregulatory Role of Mesenchymal Stem Cells</a><div class="gs_gray">F Dazzi, J Timoshanko</div><div class="gs_gray">Stem Cell Repair and Regeneration, 35<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:dQ2og3OwTAUC" class="gsc_a_at">038 TCR-ZETA DIM T CELLS DEFINE A POPULATION OF CIRCULATING EFFECTOR CELLS THAT MIGRATE TO INFLAMED TISSUES</a><div class="gs_gray">CL Gorman, Z Zhang, AC Vermi, C Monaco, F Marelli-Berg, F Dazzi, ...</div><div class="gs_gray">Annals Of The Rheumatic Diseases 66<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:8AbLer7MMksC" class="gsc_a_at">33: Increased CD4+ CD25high+ regulatory T-cell are associated with disease relapse after allogeneic stem cell transplantation (SCT) for chronic myeloid leukaemia (CML)</a><div class="gs_gray">E Nadal, J Kaeda, JF Apperley, R Lechler, F Dazzi</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 13 (2), 15<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:B3FOqHPlNUQC" class="gsc_a_at">287: Reduced intensity conditioning allografting induces the generation of antigen-specific regulatory T cells necessary for graft tolerance</a><div class="gs_gray">L Weng, J Dyson, F Dazzi</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 13 (2), 104<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:1lhNe0rCu4AC" class="gsc_a_at">Stem Cell Transplantation-T-cell receptor repertoire usage after allografting differs between CD4+ CD25+ regulatory T-cells and their CD4+ CD25+ counterpart</a><div class="gs_gray">C Fozza, E Nadal, M Longinotti, F Dazzi</div><div class="gs_gray">Haematologica 92 (2), 206<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:86PQX7AUzd4C" class="gsc_a_at">Defining Progenitors Based on Their Expression of Aldehyde Dehydrogenase</a><div class="gs_gray">RW Storms</div><div class="gs_gray">Stem Cell Repair And Regeneration: Volume 2, 1-15<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:r_AWSJRzSzQC" class="gsc_a_at">REGENERATION OF CHRONICALLY DAMAGED LIVER BY STEM CELL THERAPY: P25. 20</a><div class="gs_gray">M Pai, N Levicar, F Al-Allaf, I Dimarakis, J Welsh, F Dazzi, J Nicholls, ...</div><div class="gs_gray">The Official Journal of The International Hepato Pancreato Biliary&nbsp;…<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:4fKUyHm3Qg0C" class="gsc_a_at">Hematopoietic and mesenchymal stem cell transplantation in autoimmune diseases</a><div class="gs_gray">A Tyndall, F Dazzi</div><div class="gs_gray">International Journal of Clinical Rheumatology 1 (2), 179<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:kzcrU_BdoSEC" class="gsc_a_at">Outcome of patients developing GVHD after DLI for CML relapse post HSCT: a retrospective study from the CLWP of the EBMT</a><div class="gs_gray">Y Chalandon, C Schmid, K Porkka, A Urbano-Ispizua, B Hertenstein, ...</div><div class="gs_gray">Bone Marrow Transplantation 37<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:EUQCXRtRnyEC" class="gsc_a_at">Outcome of Patients Developing GVHD after DLI for CML Relapse from HLA-Identical Sibling or VUD HSCT.</a><div class="gs_gray">Y Chalandon, C Schmid, K Porkka, A Urbano-Ispizua, B Hertenstein, ...</div><div class="gs_gray">Blood 106 (11), 1817<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:KUbvn5osdkgC" class="gsc_a_at">Low level BCR-ABL transcript positivity in long term survivors of allogeneic stem cell transplantation for CML: 234</a><div class="gs_gray">K PATEL, J Kaeda, F Dazzi, J GOLDMAN, E KANFER, E OLAVARRIA, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 129<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:4MWp96NkSFoC" class="gsc_a_at">Variable significance of low levels of Bcr-Abl transcripts in the peripheral blood after allogeneic stem cell transplant for chronic myeloid leukaemia in chronic phase</a><div class="gs_gray">D Shea, J Kaeda, R Szydlo, E Olavarria, D Marin, F Dazzi, J Perz, ...</div><div class="gs_gray">Bone Marrow Transplantation 35<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:dshw04ExmUIC" class="gsc_a_at">Reply to ‘Does post-transplant treatment with imatinib mesylate inhibit graft-versus-leukemia?’by Chunduri et al</a><div class="gs_gray">K Cwynarski, JV Melo, F Dazzi</div><div class="gs_gray">Leukemia 19 (3), 457-457<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:xtRiw3GOFMkC" class="gsc_a_at">REVIEW IN TRANSLATIONAL HEMATOLOGY-HEMATOPOIESIS-HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: Inducing cell expansion and reversibly preventing multilineage&nbsp;…</a><div class="gs_gray">M Krampera, A Pasini, A Rigo, MT Scupoli, C Tecchio, G Malpeli, ...</div><div class="gs_gray">Blood 106 (1), 59-66<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:KbBQZpvPDL4C" class="gsc_a_at">Does sustained downregulation of TCRζ define a transition from antigen mode to inflammation mode during T cell differentiation?: OP59</a><div class="gs_gray">Z Zhang, M Panesar, P Amjadi, A Foey, J Clark, P Isomaki, F Dazzi, ...</div><div class="gs_gray">Immunology-Supplement 113<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:ILKRHgRFtOwC" class="gsc_a_at">CD4+ CD25+ regulatory T-cells favours leukaemia relapse after allogeneic stem cell transplantation</a><div class="gs_gray">E Nadal, M Macchiarulo, L Lim, R Lechler, F Dazzi</div><div class="gs_gray">Bone Marrow Transplantation 33<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:Z5m8FVwuT1cC" class="gsc_a_at">Impact of GvHD in long-term remission after escalated donor lymphocyte infusions</a><div class="gs_gray">E Nadal, S Marktel, R Szydlo, E Olavarria, E Kanfer, A Rahemtulla, ...</div><div class="gs_gray">Bone Marrow Transplantation 33<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:vDijr-p_gm4C" class="gsc_a_at">Mesenchymal stem cells inhibit immune responses by arresting T-cell proliferation in the G1 phase of the cell cycle</a><div class="gs_gray">S Glennie, I Soeiro, E Lam, F Dazzi</div><div class="gs_gray">Bone Marrow Transplantation 33<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:VLnqNzywnoUC" class="gsc_a_at">The conditioning regimen influences migration of donor T-cells in recipient tissues</a><div class="gs_gray">L Cannella, R Laylor, H Dewchand, E Simpson, F Marelli-Berg, F Dazzi</div><div class="gs_gray">Bone Marrow Transplantation 33<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:2KloaMYe4IUC" class="gsc_a_at">Adjuvant IL-2 in the treatment of relapse after allogeneic transplant refractory to donor lymphocyte infusions: clinical and biological effects</a><div class="gs_gray">E Nadal, A Fowler, S Avery, E Kanfer, J Apperley, J Goldman, F Dazzi</div><div class="gs_gray">Bone Marrow Transplantation 33<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:PR6Y55bgFSsC" class="gsc_a_at">Transplantation tolerance in allogeneic stem cell transplantation with reduced-intensity conditioning</a><div class="gs_gray">R Laylor, P Dyson, H Dewchand, E Simpson, F Dazzi</div><div class="gs_gray">Bone Marrow Transplantation 33<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:JoZmwDi-zQgC" class="gsc_a_at">Survival beyond 10 years after allogeneic stem cell transplantation (SCT) for CML in chronic phase using HLA-identical sibling or HLA-matched unrelated donors</a><div class="gs_gray">S Avery, E Nadal, JF Apperley, E Olavarria, E Kanfer, A Rahemtulla, ...</div><div class="gs_gray">BLOOD 102 (11), 980A-980A<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:8xutWZnSdmoC" class="gsc_a_at">hhaem</a><div class="gs_gray">M O’Dwyer, A Fassas, A Urbano-Ispìzua, C Anasetti, A Salvioni, R Mariani, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:EkHepimYqZsC" class="gsc_a_at">Patient with leukemia relapse after allogeneic stem cell transplantation show increased numbers of CD4+ CD25+ immunoregulatory T-cells in peripheral blood</a><div class="gs_gray">E Macchiarulo, L Lim, R Lechler, F Dazzi</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 31, S121-S121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:0KyAp5RtaNEC" class="gsc_a_at">Mesenchymal stem cell inhibitory effect on T-cell responses is mediated by non-cognate physical interaction</a><div class="gs_gray">S Glennie, M Krampera, P Dyson, D Scott, R Laylor, E Simpson, F Dazzi</div><div class="gs_gray">Bone Marrow Transplantation 31<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:7T2F9Uy0os0C" class="gsc_a_at">Factors influencing the incidence of GVHD after donor lymphocyte infusions in escalating doses for chronic myeloid leukemia</a><div class="gs_gray">F Dazzi, S Marktel, E Nadal, R Szydlo, E Olavarria, A Rahemtulla, ...</div><div class="gs_gray">Bone Marrow Transplantation 31<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:HeT0ZceujKMC" class="gsc_a_at">Host-versus-graft tolerance following non-myeloablative allogeneic bone marrow (BM) transplantation</a><div class="gs_gray">R Laylor, H Dewchand, E Simpson, F Dazzi</div><div class="gs_gray">Immunology-Supplement 107<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:OR75R8vi5nAC" class="gsc_a_at">Dendritic cells from CML patients have altered actin organization, reduced antigen processing and impaired migration</a><div class="gs_gray">K Cwynarski, R Dong, A Entwistle, F Marelli-Berg, F Dazzi, E Simpson, ...</div><div class="gs_gray">Immunology-Supplement 107, 51-52<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:ODE9OILHJdcC" class="gsc_a_at">Mesenchymal stem cells (MSC) inhibit response of antigen-specific T cells to their cognate peptide</a><div class="gs_gray">S Glennie, M Krampera, J Dyson, D Scott, R Laylor, E Simpson, F Dazzi</div><div class="gs_gray">Immunology-Supplement 107<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:dTyEYWd-f8wC" class="gsc_a_at">Low initial cell dose and escalating dose regimen is the best method of administering unmanipulated donor lymphocytes for relapsed chronic myelogenous leukemia.</a><div class="gs_gray">C Guglielmi, W Arcese, F Dazzi, R Brand, D Bunjes, LF Verdonck, ...</div><div class="gs_gray">BLOOD 100 (11), 635A-635A<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:fFSKOagxvKUC" class="gsc_a_at">Mechanisms of graft-versus-malignancy in humans: 997</a><div class="gs_gray">E Simpson, F Dazzi</div><div class="gs_gray">Onkologie 25<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:7Hz3ACDFbsoC" class="gsc_a_at">Dendritic cells from CML patients display abnormalities in antigen processing, migration and function</a><div class="gs_gray">K Cwynarski, R Dong, F Dazzi, E Simpson, I Bellantuono, G Lombardi</div><div class="gs_gray">British Journal of Haematology-Supplement 117, 12-13<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:CHSYGLWDkRkC" class="gsc_a_at">CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS-Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: Prognostic relevance of the initial cell dose</a><div class="gs_gray">C Guglielmi, W Arcese, F Dazzi, R Brand, D Bunjes, LF Verdonck, ...</div><div class="gs_gray">Blood 100 (2), 397-405<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:1sJd4Hv_s6UC" class="gsc_a_at">CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS-Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts&nbsp;…</a><div class="gs_gray">E Olavarria, E Kanfer, R Szydlo, J Kaeda, K Rezvani, K Cwynarski, ...</div><div class="gs_gray">Blood 97 (6), 1560-1564<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:D03iK_w7-QYC" class="gsc_a_at">CELLULAR IMMUNOLOGY AND IMMUNE REGULATION-Examination of HY Response: T Cell Expansion, Immunodominance, and Cross-Priming Revealed by HY Tetramer Analysis</a><div class="gs_gray">M Millrain, P Chandler, F Dazzi, D Scott, E Simpson, PJ Dyson</div><div class="gs_gray">Journal of Immunology 167 (7), 3756-3764<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:yB1At4FlUx8C" class="gsc_a_at">Myeloid and lymphoid chimerism in long-term survivors post SCT for CML-CP: The presence of recipient hematopoiesis is not predictive of relapse and correlates with lower GVHD risk.</a><div class="gs_gray">K Rezvani, M Lawler, R Goulding, J Kaedar, F Dazzi, E Domingo, ...</div><div class="gs_gray">BLOOD 96 (11), 479A-479A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:SdhP9T11ey4C" class="gsc_a_at">Risk assessment in patients with Ph plus CML treated with donor lymphocyte transfusion at relapse after allogeneic stem cell transplant.</a><div class="gs_gray">C Guglielmi, J Apperley, W Arcese, D Bunjes, F Dazzi, A Schattenberg, ...</div><div class="gs_gray">BLOOD 96 (11), 545A-545A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:XiVPGOgt02cC" class="gsc_a_at">The host-versus-graft (HvG) reaction in allogeneic stem cell transplantation (SCT): Donor-recipient chimerism is not associated with clonal deletion of HvG effector T cells.</a><div class="gs_gray">F Dazzi, P Chandler, H Dewchand, M Millrain, R Laylor, J Picard, ...</div><div class="gs_gray">BLOOD 96 (11), 374A-374A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:fQNAKQ3IYiAC" class="gsc_a_at">Immunoresponse to Wilms Tumor antigen-1 (WT-1) in CML patients.</a><div class="gs_gray">I Bellantuono, E Macchiarulo, LQ Gao, F Dazzi, V Cerundolo, SB Marley, ...</div><div class="gs_gray">BLOOD 96 (11)<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:kh2fBNsKQNwC" class="gsc_a_at">Is there a limit to the normality of blood products?</a><div class="gs_gray">L Degos</div><div class="gs_gray">The hematology journal: the official journal of the European Haematology&nbsp;…<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:eflP2zaiRacC" class="gsc_a_at">CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS-Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting&nbsp;…</a><div class="gs_gray">F Dazzi, RM Szydlo, C Craddock, NCP Cross, J Kaeda, A Chase, ...</div><div class="gs_gray">Blood 95 (1), 67-71<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:WbkHhVStYXYC" class="gsc_a_at">CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS-Estimating leukemia-free survival after allografting for chronic myeloid leukemia: A new method that takes into&nbsp;…</a><div class="gs_gray">C Craddock, RM Szydlo, JP Klein, F Dazzi, E Olavarria, F Rhee, C Pocock, ...</div><div class="gs_gray">Blood 96 (1), 86-90<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:OU6Ihb5iCvQC" class="gsc_a_at">CORRESPONDENCE-Response: Neither age nor mobilization likely to have effect</a><div class="gs_gray">F Dazzi, RM Szydlo, JM Goldman</div><div class="gs_gray">Blood 95 (9), 2995<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:epqYDVWIO7EC" class="gsc_a_at">Early detection of BCR/ABL transcripts by RT-PCR predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia.</a><div class="gs_gray">E Olavarria, J Kaeda, F Carnicero, R Szydlo, N Cross, F Dazzi, K Rezvani, ...</div><div class="gs_gray">Blood 94 (10), 632A-632A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:nrtMV_XWKgEC" class="gsc_a_at">'Current leukemia free survival': A novel method for assessing results of allogeneic stem cell transplantation for CML that takes account of the impact of donor lymphocyte&nbsp;…</a><div class="gs_gray">C Pocock, C Craddock, R Szydlo, J Klein, F Dazzi, E Olavarria, ...</div><div class="gs_gray">BLOOD 94 (10), 161A-161A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:eq2jaN3J8jMC" class="gsc_a_at">T-cell depletion plus adoptive immunotherapy with donor lymphocyte infusions as a strategy to treat patients with chronic myeloid leukemia undergoing stem cell transplantation&nbsp;…</a><div class="gs_gray">K Cwynarski, C Craddock, F Dazzi, R Szydlo, E Olavarria, J Kaeda, ...</div><div class="gs_gray">Blood 94 (10), 567A-567A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:9Nmd_mFXekcC" class="gsc_a_at">IMPACT OF DONOR LEUCOCYTE IN INFUSIONS ON OUTCOME AFTER T CELL DEPLETED VOLUNTEER UNRELATED DONOR (VUD) BONE MARROW TRANSPLANTATION IN PATIENTS WITH CML</a><div class="gs_gray">C Craddock, F Dazzi, R Szydlo, K Cwynarski, E Olavarria, P Brookes, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 105 (1S)<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:ML0RJ9NH7IQC" class="gsc_a_at">Donor lymphocyte infusion (DLI) for relapse of chronic myeloid leukemia (CML) after allogeneic stem cell transplant (SCT): Factors influencing the effective cell dose (ECD).</a><div class="gs_gray">F Dazzi, C Craddock, R Szydlo, J Kaeda, E Kanfer, NCP Cross, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 23, S43-S43<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:_Ybze24A_UAC" class="gsc_a_at">An update of the Hammersmith DLI programme and discussion of nursing issues.</a><div class="gs_gray">NG Swan, E Olavarria, F Dazzi</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 23, S269-S269<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:-_dYPAW6P2MC" class="gsc_a_at">Philadelphia-positive mast cell differentiation of CD34+ cells from chronic phase CML in NOD/SCID mice: Potential for predicting duration of chronic phase.</a><div class="gs_gray">F Dazzi, R Hasserjian, G Feldmann, D Capelli, F Cotter, M Corbo, ...</div><div class="gs_gray">BLOOD 92 (10), 243B-243B<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:z_wVstp3MssC" class="gsc_a_at">Anti-human FVIII antibodies generated in the mouse by subcutaneous versus intravenous FVIII injection recognise different epitopes in the antigenic moiety</a><div class="gs_gray">T Tison, F Dazzi, L Gorza, A Rosato, P Radossi, A Girolami, J Ware</div><div class="gs_gray">British Journal of Haematology 102 (1-I)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:9vf0nzSNQJEC" class="gsc_a_at">Validation of a mathematical model for improved antisense oligonucleotide therapy in haematological malignancies</a><div class="gs_gray">DA Fennell, M Corbo, B Kuss, F Dazzi, JM Goldman, FE Cotter</div><div class="gs_gray">British Journal of Haematology 102 (1-I)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:PELIpwtuRlgC" class="gsc_a_at">PHILADELPHIA-POSITIVE MAST CELL DIFFERENTIATION OF CD34+ CHRONIC PHASE CML CELLS AFTER LONG-TERM ENGRAFTMENT IN NOD/SCID MICE</a><div class="gs_gray">F Dazzi, D Capelli, R Hasserjian, F Cotter, M Corbo, MY Gordon, ...</div><div class="gs_gray">British Journal of Haematology 102 (1-I)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:nRpfm8aw39MC" class="gsc_a_at">Low incidence of GVHD using donor lymphocyte infusion (DLI) with an escalating dose protocol.</a><div class="gs_gray">E Olavarria, K Murphy, F Dazzi, C Craddock, NJ Philpott, JF Apperley, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 101, 69-69<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:JQOojiI6XY0C" class="gsc_a_at">Low incidence of GVHD using donor lymphocyte infusions (DLI) with an escalating dose protocol</a><div class="gs_gray">E Olavarria, K Murphy, F Dazzi, C Craddock, NJ Philpott, JF Apperley, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 101 (1S)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:UHK10RUVsp4C" class="gsc_a_at">Escalating doses of DLI identify a subset of CML patients in relapse after allografting in whom only a partial or transient response is achieved.</a><div class="gs_gray">JS Kaeda, F Dazzi, P Baker, P Raanani, E Kanfer, JF Apperley, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 21, S71-S71<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:QYdC8u9Cj1oC" class="gsc_a_at">Heparin Induces Apoptosis in Lymphocytes from B-cell Chronic Lymphocytic Leukemia</a><div class="gs_gray">F Vianello, A Poletti, C Giacon, P Radossi, D Sgarabotto, F Dazzi, T Tison, ...</div><div class="gs_gray">Hematology 3 (6), 451-463<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:K3LRdlH-MEoC" class="gsc_a_at">Myasthenic syndrome and oligoclonal lymphocytosis: evolution into chronic lymphocytic leukemia</a><div class="gs_gray">P Radossi, F Dazzi, G De Franchis, F Vianello, T Tison, C Menin, ...</div><div class="gs_gray">Annals of hematology 76 (1), 45-47<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:1yQoGdGgb4wC" class="gsc_a_at">Generation of anti-human FVIII antibodies in mouse: Epitope recognition varies with the route of administration. A potential for escaping FVII-inhibitors.</a><div class="gs_gray">T Tison, F Dazzi, L Gorza, AP Rosato, P Radossi, A Girolami, J Ware</div><div class="gs_gray">BLOOD 90 (10), 146-146<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:LjlpjdlvIbIC" class="gsc_a_at">Donor lymphocyte infusions (DLI) for treatment of CML in relapse after allogeneic BMT: Low incidence of GVHD using an escalation dose protocol.</a><div class="gs_gray">E Olavarria, F Dazzi, C Craddock, KM Murphy, NJ Philpott, E Kanfer, ...</div><div class="gs_gray">BLOOD 90 (10), 2621-2621<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:WqliGbK-hY8C" class="gsc_a_at">The incidence, kinetics and durability of response to donor leukocyte transfusions for CML patients who relapse after BMT.</a><div class="gs_gray">P Raanani, F Dazzi, J Sohal, RM Szydlo, F vanRhee, A Reiter, F Lin, ...</div><div class="gs_gray">BLOOD 90 (10), 2443-2443<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:35r97b3x0nAC" class="gsc_a_at">The kinetics of engraftment of CML cell lines and CML progenitor cells in SCID/NOD mice.</a><div class="gs_gray">F Dazzi, M Gordon, W Chinswangwatanakul, F Cotter, M Evans, A Poletti, ...</div><div class="gs_gray">EXPERIMENTAL HEMATOLOGY 25 (8), 186-186<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:EYYDruWGBe4C" class="gsc_a_at">Different role of biological or recombinant FVIII substitutes in the development of factor VIII inhibitors in previously untreated patients with haemophilia A: A meta-analysis</a><div class="gs_gray">E Bernardi, B Girolami, F Dazzi, B Vanzo, F Vianello, P Radossi, T Tison, ...</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS, P2660-P2660<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:fEOibwPWpKIC" class="gsc_a_at">Heparin-induced apoptosis: A possible mechanism of cell proliferation control</a><div class="gs_gray">F Vianello, P Radossi, T Tison, F Dazzi, L Scarano, A Girolami</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS, OC33-OC33<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:ZfRJV9d4-WMC" class="gsc_a_at">The risk of recurrent venous thromboembolism in patients with factor V Leiden mutation</a><div class="gs_gray">P Simioni, P Prandoni, AWA Lensing, A Scudeller, C Sardella, MR Prins, ...</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS, OC747-OC747<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:hkOj_22Ku90C" class="gsc_a_at">Non-coagulant anti factor VIII antibodies in haemophilia A patients show different reactivity against different sources of commercial factor VIII</a><div class="gs_gray">F Vianello, P Radossi, T Tison, F Dazzi, L Scarano, A Girolami</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS, P2651-P2651<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:UxriW0iASnsC" class="gsc_a_at">Unexpected low prevalence of FVIII gene inversion in severe hemophilia A patients from north-eastern Italy</a><div class="gs_gray">F Vianello, P Radossi, T Tison, G Tagariello, F Dazzi, A Girolami</div><div class="gs_gray">Blood coagulation &amp; fibrinolysis 7 (7), 711<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:abG-DnoFyZgC" class="gsc_a_at">Chronic B-cell lymphoproliferative disease: relationship between immunophenotype and clinical stage.</a><div class="gs_gray">F Dazzi, A Veronesi, E D'Andrea, D Sgarabotto, A Girolami</div><div class="gs_gray">Haematologica 75 (3), 243-248<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:u9iWguZQMMsC" class="gsc_a_at">Unusual Association of Hairy Cell Leukemia and Monoclonal Large Granular Lymphocyte Proliferation</a><div class="gs_gray">F Dazzi, E D'andrea, A Veronesi, M Chilosi, D Sgarabotto, A Girolami</div><div class="gs_gray">Leukemia &amp; lymphoma 2 (6), 433-436<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:1qzjygNMrQYC" class="gsc_a_at">Cytotoxic response to moloney murine sarcoma virus-induced tumors.</a><div class="gs_gray">G Biasi, L Saggin, F Dazzi, AD Rossi, DD Collavo</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:ubry08Y2EpUC" class="gsc_a_at">Bone marrow mesenchymal stem cells induce division arrest anergy of</a><div class="gs_gray">S Glennie, I Soeiro, PJ Dyson, EW Lam, F Dazzi</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:otzGkya1bYkC" class="gsc_a_at">COMPARISON OF CELL DOSE AND OUTCOME FOR CORD BLOOD TRANSPLANTATION (CBT) SOURCED FROM PLASMA DEPLETED (PD) VERSUS RED CELL DEPLETED (RD) CORD BLOOD INVENTORIES</a><div class="gs_gray">TOFVEC MEDIATES</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:Aul-kAQHnToC" class="gsc_a_at">Bone marrow mesenchymal stromal cells induce nitric oxide</a><div class="gs_gray">F Dazzi, CYW Dolcetti, M Serafini, V Bronte</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:IRz6iEL74y4C" class="gsc_a_at">Evaluating PKN2 as a target in the host-tumour microenvironment.</a><div class="gs_gray">P Parker, F Dazzi</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:_5tno0g5mFcC" class="gsc_a_at">Endothelial and Vascular Cells 242 Autologous cell sources in therapeutic vasculogenesis: In vitro and in vivo comparison of endothelial colony–forming cells from peripheral&nbsp;…</a><div class="gs_gray">J Galipeau, M Krampera, J Barrett, F Dazzi, RJ Deans, J DeBruijn, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:8d8msizDQcsC" class="gsc_a_at">Serial measurement of BCR-ABL transcripts in the peripheral blood after</a><div class="gs_gray">S Saunders, JS Khorashad, NC Cross, JM Goldman, JF Apperley, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:rmuvC79q63oC" class="gsc_a_at">European LeukemiaNet criteria for failure or sub-optimal response reliably</a><div class="gs_gray">JK Klammer, JM Goldman, JF Apperley, AG Reid, L Foroni, K Rezvani, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:PVjk1bu6vJQC" class="gsc_a_at">Bone marrow mesenchymal stem cells inhibit the response of naive and</a><div class="gs_gray">F Dazzi, M Krampera, S Glennie, J Dyson, D Scott, R Laylor, E Simpson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:5qfkUJPXOUwC" class="gsc_a_at">Oral Session: Supportive care and Regulatory issues</a><div class="gs_gray">F Dazzi, S Marktel, E Nadal, R Szydlo, E Olavarria, A Rahemtulla, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:hCrLmN-GePgC" class="gsc_a_at">Oral Session: Graft engineering and Cellular therapy</a><div class="gs_gray">F Dazzi, S Marktel, R Szydlo, C Crawley, E Olavarria, E Kanfer, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:FPJr55Dyh1AC" class="gsc_a_at">insideblood</a><div class="gs_gray">RA Larson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:geHnlv5EZngC" class="gsc_a_at">Responses to comments from first Reviewer.</a><div class="gs_gray">M Cazzola, F Dazzi</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=7-4XHiUAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=7-4XHiUAAAAJ:sSrBHYA8nusC" class="gsc_a_at">IMMUNOTERAPIA ADOTTIVA DOPO TRAPIANTO DI MIDOLLO OSSEO ALLOGENICO</a><div class="gs_gray">F Dazzi</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr></tbody></table><div id="gsc_a_sp" class=""></div><div id="gsc_a_err" class="gs_alrt">The system can't perform the operation now. Try again later.</div></div><div id="gsc_lwp"><span id="gsc_a_nn">Articles 1–371</span><div id="gsc_bpf"><button type="button" id="gsc_bpf_more" class="gs_btnPD gs_in_ib gs_btn_flat gs_btn_lrge gs_btn_lsu" disabled=""><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Show more</span></span></button></div></div></form></div></div></div></div><div id="gs_ftr_sp" role="presentation"></div><div id="gs_ftr" role="contentinfo"><div id="gs_ftr_rt"><a href="/intl/en/scholar/about.html">Help</a><a href="//www.google.com/intl/en/policies/privacy/">Privacy</a><a href="//www.google.com/intl/en/policies/terms/">Terms</a></div></div></div></body></html>